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1 INTRODUCTION 
 
1.1 PET 
  
1.1.1 Basics of PET 
Positron Emission Tomography (PET) is one of the most important techniques for in-vivo 
studies by the radiotracer method. During the last two decades it has been under development 
as a biochemical research tool for studies in medicine. Now it attracts the interest of many 
scientists in the broad area of life sciences, particularly in the fields of diagnostic applications 
and therapy control as an excellent and very sensitive method for examination of 
physiological functions. 
In the year 2000 PET had its international breakthrough as a method. This can clearly be 
illustrated by the broad applications of PET/CT, both in clinical research and healthcare. 
Moreover, during the last two years animal PET became available allowing to determine 
biochemical processes and biokinetics within small animals. In this particular international 
situation the radiopharmaceutical methods play the key role in PET applications since the 
spectrum of applications directly and, thus, strongly depends on the availability of compounds 
labelled with radionuclides appropriate for PET studies. 
In radiopharmacy it is the aim to develop and supply compounds of metabolic relevance for 
PET applications. Those compounds are labelled with short-lived radionuclides of the 
biologically important elements. 15O, 13N, 11C and 18F are the PET radionuclides of choice. 
Their main properties are the emission of positrons and the short half lives. In combination 
with the coincidence measuring technique and the modus of tomographic imaging, the 
directly localized registration of such compounds ("tracers") is possible. Moreover, the PET 
technique allows both the qualitative imaging and quantification of the particular metabolic 
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process under study. The radioactive decay of the PET radionuclides gives rise to emission of 
a positron, a positively charged particle with the mass of an electron[1]. A positron is the 
anti-particle of an electron so that after loss of its kinetic energy it forms a positronium 
together with an electron. After a few microseconds the two electron masses end up in form 
of annihilation radiation as two gamma photons with an energy of 511 keV each. Those 
gamma photons are emitted in an angle of almost 180° (Fig. 1). 
 
 
 
The production of two ϒ-quanta shortly after the positron emission allows the recording of 
this process by annihilation coincidence detection. Two detectors, oriented opposite to each 
other, are used to detect the two photons. The measuring system finally counts only those 
photons which are registered in coincidence within a pair of opposite detectors. The 
coincidence detector system also defines a volume between the two detectors as measured by 
two coincidence events[2].(Fig. 2). Events of this type are labelled as (A). Coincidence events 
outside this volume are not registered (B). However, coincidence events outside this volume 
involving scattering can also occur and are erroneously attached to the detection volume (C). 
The PET system is composed of a large number of coincidence detector pairs arranged in 
a ring. Each single detector is not only switched to coincidence with the diametrically 
Fig. 1. Radioactive decay by positron emission[1]. 
Unstable parent  
nucleus 
Two anti-parallel 511 keV 
photons produced 
Positron combines with 
electron and annihilates 
Proton is 
transformed to 
Neutron within the 
nucleus
A neutrino ν 
is emitted
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opposite detector but also with a greater number of detectors on the other side of the ring, 
forming a fan-shaped area of coincidence (Fig. 2). The visual field of the tomographic system 
is defined by the central area covered by all fan-shaped areas of coincidence. The body of the 
patient is placed in this visual field. 
 
If compounds labelled with positron emitting isotopes are accumulated in certain regions of 
the body, from the detected annihilation events an imaging of this region can be reconstructed 
to tomographic slices. Thus, the use of the PET technique is always combined with 
compounds labelled with PET radioisotopes (PET tracers). The most famous and most 
applied compound is 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG). This molecule is 
transported and phosphorylated like glucose, however, it does not take part in the succeeding 
metabolic processes. Therefore, [18F]FDG accumulates in glucose demanding tissues. Active 
cancer tissue can thus be detected because of its elevated glucose metabolism. On the other 
hand, success of cancer chemotherapy results in the death of the cancer cells and, 
consequently, in low or no accumulation of [18F]FDG. Another application is the investigation 
of the biodistribution of drugs in the body or the detection of receptors for certain 
biomolecules. 
 
 
Fig. 2.  Annihilation coincidence detection in PET[2]. 
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1.1.2 Radionuclides in PET 
To perform any type of PET investigations, compounds labelled with positrons are essential. 
The short-lived positron emitting radionuclides that have the greatest importance in PET are 
carbon-11, nitrogen-13, oxygen-15 and fluorine-18. This is to be understood in view of the 
fact that the first three of these isotopes belong to the elements of life and can be substituted 
for their stable counterparts without influencing the bioactivity of the molecule. While 
fluorine-18 is not a significant element in living system, its half-life and properties make its 
use in labelling of considerable value. Most importantly, it is applied in the concept of 
“blocked metabolism” as explained in case of [18F]FDG. Tab. 1 lists the physical properties of 
these radionuclides[3]. 
 
Tab. 1. Physical properties of some positron emitter radionuclides[3]. 
Isotope Half-life (min) 
Specific Activitya 
(GBq/mmol) 
Maximum 
Energy (MeV)
Range (mm) 
in Waterb 
Decay 
Product 
Fluorine-18 110 63.3 x 106 0.635 2.4 Oxygen-18 
Carbon-11 20.4 341.1 x 106 0.96 4.1 Boron-11 
Nitrogen-13 10 69.9 x 107 1.19 5.4 Carbon-13 
Oxygen-15 2.1 336.0 x 107 1.72 8.2 Nitrogen-15 
 
a) Theoretical maximal specific activity; in practice, specific activities are typically 5000 
times lower because of unavoidable dilution with the non radioactive isotope. 
b) Maximal linear range. 
 
 
 
The development of any radiotracer begins with the selection of an appropriate radionuclide. 
This depends on several factors. The first is whether the physical half-life of the radioisotope 
matches the biological half-life of the process under investigation. The precursor’s achievable 
INTRODUCTION 
 
5
 
specific activity (sec. 1.2.2) is also very important. In addition, the time necessary to prepare 
the precursor, and manipulate it through the subsequent synthetic pathways, and/or 
purifications are important for the decision. Finally, the kind of information needed from the 
PET measurement is also important in the selection of the radioisotope. Finally, the spatial 
distribution and regional concentrations of a target substance or neurotransmitter binding or 
uptake site are also very important. Tab. 2 gives a list of some  radiotracers and their 
applications[3]. 
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Tab. 2. Some important radiotracers and their applications[3,4]. 
Tracer Chemical name Use 
[15O] Tracers 
[15O]H2O [15O]water Blood flow 
[15O]CO [15O]carbon monoxide Blood volume 
[15O]O2 [15O]oxygen Oxygen consumption 
[11C] Tracers 
[11C]Carfentanil [methyl-11C]-4-[(1-oxypropyl)phenyl-amino]-1-(2-
phenylethyl)-4-piperidinecarboxylic acid methyl ester 
Opiate receptors in brain 
[11C]CFT [N-methyl-11C]-2-β-carbomethoxy-3-β-(4-
fluorophenyl)-tropane 
Dopamine re-uptake sites in brain 
[11C]Choline [N-methyl-11C](2-hydroxyethyl) trimethylammonium Choline metabolism, tumours 
[11C]CIT [N-methyl-11C]-2-β-carbomethoxy-3-β-(4-
iodophenyl)-tropane 
Dopamine re-uptake sites in brain 
[11C]FLB 457 [2-O-methyl-11C]-(S)-N-(1-ethyl-2-pyrrolidinyl)-5-
bromo-2,3-dimethoxybenzamide 
Extrastriatal dopamine D2 receptors in  
Brain 
[11C]Flumazenil 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-
imidazo[1,5-a][1,4]benzodiazipine-3-carboxylic acid 
ester 
Benzodiazepine receptors in brain 
[11C]MeAIB α-[11C]methylamino-isobutyric acid System A amino acid transport  
[11C]Methionine (S)-2-amino-4-([11C]methylsulfanyl)- 
butanoic acid 
Amino acid transport, tumours 
[11C]Metomidate O-[methyl-11C]-(R)-1-(1-phenethyl)-1H-imidazole-5-
carboxylic acid methyl ester 
11β-hydroxylase activity in adrernal  
cortical tissue 
[11C]MP4A N-[11C]-methylpiperidine-4-yl acetate Acetylcholine esterase activity in brain 
[11C]NMSP N-[11C]-methylspiperone Dopamine D2 and serotonin  
5HT2 receptors in brain 
[11C]NNC 756 [methyl-11C]-(S)-(+)-8-chloro-5-(2,3-dihydro-
benzofuran-7-yl)-7-hydroxy-3-methyl-2,3,4,5-
tetrahydro-1H-3-benzazepine 
Dopamine D1 receptors in brain 
[11C]Raclopride [6-O-methyl-11C]-(S)-N-(1-ethyl-2-pyrrolidinyl)-3,5-
dichloro-2-hydroxybenzamide 
striatal dopamine D2 receptors in brain 
[11C]SCH 23390 [methyl-11C]-(R)-(+)-8-chloro-5-2,3,4,5-tetrahydro-3-
methyl-5-phenyl-1H-3-benzazepin-7-ol 
Dopamine D1 receptors in brain 
[11C]SCH 39166 [11C]Ecopipam Dopamine D1 receptors in brain 
[18F] Tracers 
[18F]CFT 2β-carbomethoxy-3β-(4-[18F]fluorophenyl)tropane Dopamine re-uptake sites in brain 
[18F]FBPA 4-dihydroxyboryl-2-[18F]fluoro-L-phenylalanine Amino acid transport, boron carrier for 
BNCT 
[18F]FDG 2-[18F]fluoro-2-deoxy-D-glucose Glucose metabolism 
[18F]FDOPA 4,5-dihydroxy-2-[18F]fluoro-L-phenylalanine Pre-synaptic dopaminergic function in 
brain 
[18F]FETNIM 4-[18F]fluoro-2,3-dihydroxy-1-(2-nitroimidazole-1-yl)-
butanol 
Tissue hypoxia 
[18F]Fluorodop 
amine 
2-(4,5-dihydroxy-2-[18F]fluorophenyl)ethylamine Adrenergic innervation and tone in  
Heart 
[18F]Fluorometar 
aminol 
(1R,2S)-2-amino-1-(4-[18F]fluoro-3-hydroxyphenyl)-
1-propanol 
Adrenergic innervation in heart 
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1.1.3 Applications of PET 
The PET method is a highly sensitive method for the investigation of biochemical reactions in 
the body with sensitivity reaching below 10-12 g. This enables scanning of the body without 
affecting at all biochemical reactions or introducing toxicity. Thus distribution and 
metabolism of drugs and necessary life compounds can be monitored. In many cases PET 
added valuable information to the existing methods of investigation and the whole case of 
study and therapy were changed. An example is the following case[5]. 
 
Fig. 3. [18F]FDG PET scan of a patient with metastatic melanoma[5] 
 
As Fig. 3 shows, a PET image of a 71 year old male with metastatic melanoma. The CT scan 
of the patient demonstrated a tumour of the distal femur and adjacent soft tissue with negative 
findings in the abdomen. A bone scan showed an abnormal femur and four spine lesions. 
Using the PET method, a whole-body [18F]FDG PET scan demonstrated numerous lesions 
INTRODUCTION 
 
8 
throughout the body (Fig. 3). The patient was originally scheduled for an amputation based on 
CT and bone scan results.  After the PET scan found multiple lesions, treatment was changed. 
The surgery was cancelled, avoiding both the cost and the trauma of an operation that would 
not have been effective.  
 
 
1.2 Fluorine-18 
 
1.2.1 Production of Fluorine-18 
 
Fluorine-18 can be produced in a nucleophilic as well as an electrophilic form using various 
types of nuclear reactions. Tab. 3 shows the most important ones. Many labelling 
methods, based on both chemical forms of fluorine-18 (see 1.3), have been published in the 
last decade. 
Tab. 3. Important production methods for fluorine-18[3]. 
Reaction Target Beam energy (MeV) Product Production Rate (MBq/µAh) 
18O(p,n) H218O 
11 
15 
[18F-] 
[18F-] 
1500 
2200 
16O(3H,p) H2O 22 [18F-] 200-400 
16O(α, d) H2O 30 [18F-] 40 
20Ne(d, α) F2/Ne 11 [18F]F2 400 
20Ne(d, α) H2/Ne 11 H[18F] 400 
 
Nowadays, mainly two target-systems are used to produce fluorine-18, the neon-20 target 
(Tab. 3, line 5 and 6) and the 18O enriched water target (line 1). The use of an [18O]water 
target is widely applied due to its reliability and the high yield of the nuclear reaction. In 
a neon target, fluorine-18 can be produced as an electrophilic 18F reagent directly as [18F]F2 or 
in a chemically different form such as [18F]acetylhypofluorite. 
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The use of a 1 % fluorine/neon gas mixture in the target leads to the formation of [18F]F2. The 
[18F]F2 that is formed in the target is highly reactive and interacts strongly with the target 
wall. The target has to be treated in advance with F2 in order to coat the target wall with F2: 
the target is “passivated”. The fluorine acts as a kind of “carrier gas” by facilitating the 
transport of the radioactivity from the target to the laboratory. The addition of non-radioactive 
fluorine to the target results in a lower specific activity of the produced fluorine-18, so this 
production method is not applicable for the synthesis of receptor binding ligands which 
require a high specific activity. [18F]F2 can not be prepared as a no-carrier-added (nca) 
reagent. 
The addition of hydrogen gas to the neon target leads to the in-situ formation of H[18F]. The 
[18F]fluoride can be isolated from the target as anhydrous H[18F] by a stream of hydrogen gas 
or as aqueous [18F]fluoride by rinsing the target with a small volume of water. 
In an [18O]water target, [18F]fluoride is produced efficiently in high yields and in short time 
and so it is used widely nowadays in most PET centres. 
 
1.2.2 Specific Activity 
The extent to which a compound labelled with a radionuclide is diluted with the non 
radioactive isotopic compound is referred as the specific activity. The specific activity is 
calculated from the ratio of the amount of radioactivity (Becquerel, Bq or Curie, Ci) and the 
molar concentration of the compound (mol) and is usually expressed in GBq/µmol or 
Ci/mmol[6]. The maximum theoretical specific activity of fluorine-18, with a half-life of 110 
min, is 63,000 GBq/µmol (1.7 x 106 Ci/mmol). In practice much lower specific activities are 
obtained due to the unavoidable dilution with the non-radioactive stable element. The specific 
activity of a product is of importance, because many applications of PET (such as studying 
receptors in brain) require the administration of only a very small molar concentration of the 
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labelled biomolecule to the patient, hence a high specific activity is required which means 
also the no-carrier-added (nca) form. 
 
1.2.3 Properties of Fluorine-18 
Fluorine, as an element, is in many ways unique, both in chemical characteristics and 
usefulness in the pharmaceutical and chemical industries. Fluorine has a very small steric size 
and its bond with carbon exhibits very high bond energy. As fluorine is extremely 
electronegative, it can often produce significant and useful changes in physiochemical and 
biological properties of organic compounds[7]. In some cases, substitution with fluorine 
produces a derivative with improved pharmacological properties. Although sometimes 
considered as an isosteric replacement for hydrogen, the differences in electronegativity and 
hydrogen binding capability of fluorine make it more alike substituent for a hydroxyl group. 
Fluorine-18 (discovered as early as 1937) decays for 96.9 % by the emission of a positron (β+) 
and a neutrino. This emission is the result of a transformation of a proton into a neutron in the 
nucleus. The nuclide which is formed in this process is oxygen-18. The remaining 3.1 % of 
fluorine-18 decays by electron capture. 
 
18F  →   18O  +   β+  +  v 
 
 
 
The moderate length half-life of 110 minutes allows enough time in the synthesis of 
radiopharmaceuticals. Usually, a synthesis time of no more than three half lives of 
a radionuclide is applied. In case of 18F this means about 5.5 h. In practice lengthy procedures 
are rarely used. The relatively long half-life of fluorine-18 (in comparison, for example to 
carbon-11, oxygen-15 and nitrogen-13) permits large scale production of [18F]fluorine 
labelled radiopharmaceuticals and distribution to distant locations (the satellite concept)[3]. In 
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case of carbon-11, and because of the short half-life, the distribution is mainly limited 
applications on site (in-house production). 
 
1.2.4 Reactivity and Recovery of Fluorine-18 
Fluorine is the most electronegative element of the periodic table and it is one of the three 
elements (N, O and F) which can act as a H-bond acceptor. The fluoride ion is therefore 
strongly solvated in protic solvents such as water or methanol. The use of protic solvents or 
even the presence of water in the reaction mixture leads to a serious decrease in the reactivity 
of [18F]fluoride. Therefore, it is necessary to manipulate [18F]fluoride in such a way that it is 
obtained in an unsolvated form and reactions must be performed in aprotic solvents, such as 
DMSO or DMF. Methods for the recovery of [18O]water and the isolation of [18F]fluoride 
include simple distillation techniques or other methods such as electrolysis and the use of 
ion-exchange resins[3]. However, one of the main problems in the recovery of fluorine-18, like 
any other radioactivity, is the adherence to vessels used. In this case, a percentage of fluorine-
18 radioactivity is lost, depending on the type of material used for making a particular vessel. 
For [18F]fluoride, washing with water as a solvent can recover most of radioactivity. 
 
1.3 Electrophilic and Nucleophilic Aromatic Fluorination Reactions 
1.3.1 Fluorination Reactions 
Fluorine can be introduced into organic compounds using a variety of methods, such as the 
direct addition of fluorine, fluorine containing reagents to multiple bonds, or the substitution 
of a leaving group by electrophilic or nucleophilic fluorine or fluorine-containing reagents[7]. 
However, the number of fluorination methods is relatively limited when compared to other 
halogenations. This is because most fluorinating reagents are either very toxic, corrosive to 
glass and metals or very reactive. In most cases this limits the work of fluorination to solid or 
liquid non-volatile reagents[7]. The work with fluorine-18 (with good protection from 
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radiation) is safer because it is mostly performed automatically using commercially available 
modules. The number of reagents available for 19F fluorinations is larger than that for 18F 
reactions. The reason is related to the decay in case of the radioactive 18F and the need to 
establish all of the work, including the synthesis of reagents in-situ and the fluorination 
reaction within limited time. Whereas in 19F fluorination reactions it is easy to follow up the 
reaction by the usual spectroscopic techniques (1H NMR, 13C NMR, 19F NMR, .. etc), it is 
difficult to follow up the [18F]fluorination reactions unless the standard is available for quick 
comparison in TLC and HPLC[3,4]. Normally special radiochemical methods are needed. The 
large excess of the precursor relative to the 18F label gives the nonstochiometric labelling 
process special characteristics. Many 18F labelling reactions, therefore, are successful 
although they are difficult in the cold way, i.e. with 19F. In electrophilic fluorination reactions, 
where most reagents are very highly reactive, usually several sites are susceptible for attack, 
and in this case several products are obtained. However, the regioselectivity in these reactions 
can be optimised by introducing a very good leaving group in the right place. This usually 
increases the number of steps in any synthesis. In nucleophilic fluorinations, the reagents are 
less reactive and the presence of leaving groups other than hydrogen is assumed previously, 
so the regioselectivity is very high (unless there are several different leaving groups or in case 
of the fluoride ion acting as a base instead of a nucleophile). Tab. 4 gives a summary of the 
main methods used in fluorinationreactions.
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Tab. 4. General methods used for fluorination in lab or industrial scales[8]. 
Method of fluorination Types of compounds or reactions Common reagent 
1. Polychloroalkanes 
AHF/SbCl5 (liquid phase) 
AHF/Cr-based catalysts (vapour. Phase) 
SbF3/SbCl5 (lab. scale) 
2. Gem-dihalogeno-alkanes (or-cycloalkanes) HgO/AHF or HgO2; SbF3; AgBF4 
3. Monohalogenoalkanes KF; AgF; CuF; TBAF 
4. Allylic or benzylic “activated“ positions AHF; SbF3; AHF/SbCl5;  SbF3/SbCl5;  
5. Carbonyl compounds KF; AgF; AHF/Cr-based catalysts 
A. Halogen exchange: 
 
C-X → C-F 
6. “Activated“ nuclear halogeno-aromatics KF; [18F]KF ; HF; NaF 
1. Fluorodehydroxylation AHF/pyridine/NaF; SF4; SF4/AHF (C2H5)2NSF3 (DAST); (C2H5)2NCF2CHFX 
2. Ester fluorolysis (Ts = 4-CH3C6H4SO2; Tf = CF3SO2) KF; CsF; TBAF; TMAF 
3. Thermal fluorodecarboxylation of halogenoformates CaF2; COFCl; KF; AHF/pyridine BF3O(C2H5)2; AHF/AlF3 
4. Ring-opening of epoxides AHF/pyridine; AHF/ BF3O(C2H5)2 (i-C3H7)2NH.3HF 
B. Oxygen replacement: 
 
C-OX       → C-F [OX= OH, OSO2R, OC(O)F,  
                                  OC (epoxide components)] 
C=O         → CF2 
C(=O)OH → CF3 5. Replacement of oxygen in aldehydes, ketones and  
     carboxylic acids SF4(+HF or BF3); DAST 
1. Deaminative fluorination of α–amino acids AHF/pyridine/NaNO2 
2. Fluorodediazonisation of aromatic diazonium salts AHF/NaNO2; HBF4 aq or  NaBF4 
C. Nitrogen replacement: 
 
C-NH2  →  C-N2+  → C-F;    C-N-C  → CF-N-C 3. Ring-opening of azirine and aziridines AHF/pyridine 
1.Electrophilic fluorination with fluorine 
   a. Directly in aliphatic systems 
   b. Directly in aromatic systems 
F2/N2 
[18F]F2/Ne 
2. Electrophilic fluorination with “fluorine  
    carriers (prepared from F2) 
CF3OF; XeF2/HF, (C6H5SO2)2NF 
FClO3; (CF3SO2)2NF; (C6H5SO2)2NF 
D. Replacement of hydrogen: 
 
C-H → C-F 
3.Anodic fluorination of aromatic hydrocarbons  
   (Knunyants-Rozkhov ECF) TEAF; (C2H5)3N
.HF 
E. Addition to C=C or C=C bonds  
AHF/pyridine; AHF/pyridine/NBA or NBS 
AHF/pyridine/ NBS then AgF/AHF/ pyridine 
HF/SbCl5; KF/H2NCONH2; IF5/I2 
BrF3/Br2; XeF2 
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Tab. 4 shows that substitution methods are more important than addition methods in 
fluorination reactions. Moreover, methods for aliphatic fluorination are more numerous and 
variant than those for aromatic fluorination. Owing to the importance of this field of research, 
there has been extensive research and developments in the last decades, and numerous 
reviews and books were edited[7-10,15-17]. Since the development of PET and the need for new 
radiopharmaceuticals with new structures and new applications, fluorination reactions have 
been widely studied with the hope to find more suitable reagents and methods to facilitate the 
introduction of the fluorine atom into organic compounds. The introduction of a fluorine atom 
into an aromatic ring is still limited to a small number of reactions and remains always an 
active area of research. In this work the focus is limited only to the nucleophilic aromatic 
substitution by [18F]fluoride. 
 
1.3.2 Electrophilic Aromatic [18F]Fluorination Reactions  
These methods rely on fluorine [18F]F2 or reagents that can supply electrophilic fluorine[9]. 
These reagents create a chemical environment in which the fluorine atom is highly polarized 
with a partial positive charge[3]. Hence, it is possible to fluorinate a variety of electron-rich 
substrates like the aromatic compounds. Although electrophilic fluorination reactions are fast 
and efficient, labelling reactions with fluorine-18 can only provide low specific activity of 
fluorine-18 radiopharmaceuticals because they rely mostly on [18F]F2 (or reagents derived 
from it) which is always produced in the carrier-added mode. Thus, all electrophilic 
18F-fluorinations are necessarily carrier-added and result finally in radiotracers with low to 
at-best moderate specific activities. Unless there is a good leaving group in place of the 
incoming fluorine-18, most of these reactions are also non-regioselective, producing a mixture 
of [18F]fluorinated products. This has limited the usefulness of electrophilic fluorinations to 
the synthesis of radiopharmaceuticals for which there is no need of high specific activity, and 
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where the chemical species in question are not toxic. The following is a brief list of some 
electrophilic fluorination reagents[3]: 
1- Elemental fluorine, [18F]F2: This is the simplest reagent in this class. It is produced 
through the deuteron bombardment of a high-pressure neon gas target containing 
0.1 % to 2 % of carrier added F2 according to the following reaction: 
20Ne(d, α)18F 
The reagent is actually 18F–19F diluted in normal fluorine gas, i.e. 19F–19F. Several 
modifications were introduced into this method to improve the final specific activity.  
 
2- [18F]Trifluoromethyl hypofluorite, [18F]F-CF2O[18F]F: This reagent is produced by 
caesium fluoride mediated reaction between [18F]F2 and carbonylfluoride.  
[18F]F2  +   F2C=O      →      [18F]F-CF2O[18F]F 
Optimal conditions are obtained within 15 minutes of reaction at 110 °C producing 
yields up to 33 % of CF3O[18F]. 
 
3- [18F]Acetyl hypofluorite, [18F]CH3COOF: This reagent is produced by a well-known 
method according to the following reaction: 
[18F]F2  +   CH3COONH4      →      CH3COO18F (40 %)   +    NH418F 
this method was later improved by the following gas-solid reaction: 
[18F]F2  +   AcOH.AcOK      →      CH3COO18F    +    [18F]HF.AcOK 
 
4- [18F]Perchloryl fluoride, [18F]FClO3: The method for producing this reagent 
involves passing [18F]F2 through a column containing KClO3 maintained at 90 °C. 
[18F]F2  + KClO3    →     18FClO3     +   K18F 
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1.3.3 Nucleophilic [18F]Fluorination Reactions  
[18F]Fluoride is mainly obtained as an aqueous solution, most often as a product of direct 
irradiation of [18O]H2O target. In aqueous form [18F]fluoride is unreactive, and requires some 
simple but very important manipulations to provide a reactive nucleophilic reagent. The steps 
in preparing reactive [18F]fluoride are the following[3]: 
Addition of a cation: After irradiation of [18O]H2O target, the [18F]fluoride must be 
accompanied by a positively charged counterion. This is mainly solved by the addition of 
a cationic counterion (mostly potassium complexed by a cryptand such as Kryptofix 222®, or 
tetraalkylammonium salts) prior to the evaporation of the water. Many syntheses now utilize 
the potassium/Kryptofix® system, although examples of the use of tetraalkylammonium salts 
are frequently encountered in the literature. The carbonate ion CO3-2 is mostly used as the 
counterion because it has low nucleophilicity and moderate basicity. 
Water evaporation: Aqueous [18F]fluoride is quite unreactive. Hence, water is evaporated 
first by application of heat (130-160 °C) and second the use of a relatively volatile solvent 
such as acetonitrile (azeotropic distillation) under a mild stream of an inert gas like argon. 
This method provides practically anhydrous and reactive [18F]fluoride.  
Addition of the precursor solution: The residue from the last step contains [18F]fluoride in 
an excellent dry and “naked” form, suitable for the substitution reaction. The precursor is 
usually added to this residue as a solution. In general, dipolar aprotic solvents are used, 
because many organic compounds used as precursors dissolve only in them and they readily 
solubilize [18F]fluoride (particularly the K+/Kryptofix® pair). In addition, nucleophilic 
substitution reactions are favourable in dipolar aprotic solvents. Solvents such as DMSO and 
DMF are inert towards [18F]fluoride. In addition to being a strong nucleophile, [18F]fluoride is 
also a strong base, therefore all reactions performed in polar protic solvents (such as methanol 
and ethanol) fail. The majority of [18F]fluorination reactions using fluoride ion are done in 
solvents such as DMSO, DMF, DMAc or acetonitrile. 
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In these dipolar aprotic solvents, the nucleophilicities of halide ions in SNAr reactions follow 
the order[10]: F- >> Cl- > Br- > I-. However, nucleophilic [18F]fluorination reactions can be less 
frequently performed in other solvents such as THF and dichloromethane. The choice of 
solvent is predicted on the solubility of other reagents, the type of chemical reaction being 
performed, or simplification of the subsequent work-up and product isolation procedure. In 
the last few years, ionic liquids were applied successfully[11] as a media to carry out 
nucleophilic fluorination. These solvents can be recycled (they have practically no vapour 
pressure, hence they are safe for the environment). Another very important advantage is the 
fact that they tolerate the presence of water up to 20 % in solution. This is very important in 
fluorination reactions where traces of water can reduce the yield drastically. The use of ionic 
liquids as a media for [18F]fluorinations[12-14] is being extended now to other important tracers 
like [18F]FDG and [18F]FLT. 
 
1.3.4 Nucleophilic Aromatic [18F]Fluorination Reactions 
Aromatic nucleophilic substitution is an important reaction for introducing fluorine to a ring. 
This reaction is activated by electron withdrawing groups ortho and/or para to the leaving 
group. The mechanism is generally the SNAr. The leaving groups are usually NO2−, F−, Cl−, 
Br−, OTs−, NR3+ and others. The nucleophilic ways for putting a fluorine atom into the 
aromatic ring are generally less than for the other halogens, and normally involve one of the 
following:  
1- Fluorodenitration reactions (Ar-NO2  + F− →  Ar-F)[15-16]. 
2- Fluorodehalogenation reactions (Ar-X + F−  →   Ar-F),   X= Cl, Br, I and F (fluorine 
isotopic exchange)[15-16]. 
3- Fluorodediazonation reactions (ArN2+ + BF4-   →    Ar-F + N2 + BF3 )[17]. 
4- Fluorination via substitution of trimethyammonium group (Ar-NMe3+  + F−  →   Ar-F)[18]. 
5- Dialkyltriazine substrates (Ar-N=N-NR2  +  F−   →     Ar-F  +  N2 + R2N-) [19]. 
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6- Diaryliodonium substrates (Ar-I+-Ar' +  F−   →    Ar-F  +  Ar'-F) [20]. 
7- Fluorination via substitution of dimethylsulfonium group (Ar-SMe2+ + F−  →   Ar-F)[21]. 
Fluorination of aryl rings by nucleophilic displacement forms one example of significant 
differences between organic chemistry and radiochemistry. Nucleophilic aromatic substitution 
performed in the organic/medicinal laboratory often requires high temperatures and long 
reaction times with low-moderate yields. However, the reaction proceeds very rapidly, at 
moderate temperatures and in high yields when done at the nca level using [18F]fluoride. 
Nucleophilic aromatic substitution has thus become a method used widely in fluorine-18 
chemistry, and there are some common characteristics of all applications, noted in the 
following sections. 
 
(a) A good leaving group on the aromatic ring is needed. The nitro (-NO2) and the 
trimethylammoniumtriflate [-NMe3OTf] groups are the most widely utilized leaving groups in 
aromatic substitutions with [18F]fluoride. Less frequently halogens are used. The recent 
groups, such as diphenyliodonium (Ar-I+-Ar'), have the advantage of not needing activating 
groups on the ring but they have problems associated with specific activity limitations. Simple 
isotopic substitution, 18F for 19F, is also a very good method for the synthesis of radiotracers. 
However, the low specific activity from these isotopic substitutions make this process 
unsuitable and limits its use only to low-specific activity applications. 
 (b) The aromatic ring needs to be activated, for the aromatic nucleophilic substitution to 
proceed efficiently, by the presence of one or more electron-withdrawing groups (EWG), 
preferably ortho or para to the leaving group (sometimes with the meta position, good results 
are obtained). A wide variety of substituents can function as electron-withdrawing groups, 
including nitro, ketone, aldehyde, nitrile, ester, amide, halogens and groups derived from 
them (CX3). Studies[38,44] utilizing 13C NMR have shown a direct correlation between 
withdrawing power of a substituent and yields in nucleophilic aromatic substitutions by 
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[18F]fluoride. The choice of activating group often depends on the structure of the desired 
final product, or the sequence of synthetic steps to be followed after the introduction of 
[18F]fluoride. For example, the activating group may form a part of the desired product, and 
this is a very good case because it does not need further steps for removal. The activating 
group can also be conveniently transformed into the needed structural component. For 
example: 
CN             →           CH2NH2  
CN             →           CONH2  
                                                    CN             →           COOH  
                                                   CHO          →            CH2OH  
                                               CONH2          →            CH2NH2 
In some cases, activating groups can be temporarily placed on the aryl ring and subsequently 
completely removed. This process is necessary for the placement of [18F]fluoride at positions 
of a ring that cannot be activated towards substitution. An example here is the aldehyde group 
which can be removed by catalytic deformylation[22] (using Rh[PPh3]3Cl) or the carboxyl 
group which can also be removed by decarboxylation. 
 
1.4 Dopamine and Related Compounds 
 
1.4.1 Catecholamines 
Dopa (3,4-dihydroxyphenylalanine) is  a precursor of a family of biological compounds called 
catecholamines. The principal catecholamines are norepinephrine, epinephrine and dopamine. 
These compounds are formed initially from phenylalanine and tyrosine. Tyrosine is produced 
in the liver from phenylalanine through the action of phenylalanine hydroxylase. Tyrosine is 
then transported to catecholamine-secreting neurons where a series of reactions convert it to 
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Dopa, dopamine, norepinephrine and finally to epinephrine. These transformations are 
explained in Fig. 4. 
 
Fig. 4. Scheme for the synthesis of catecholamines from tyrosine. 
 
1.4.2 The Dopaminergic System and Dopamine 
 In brain several bodies of nerves containing dopamine are concentrated in the substantia 
nigra and project to the caudate nucleus (neostriatum): this is the nigrostriatal pathway. 
Dopamine systems with cell bodies dorsal to the interpeduncular nucleus (midbrain area) and 
with terminals in the nucleus accumbens and olfactory tubercle (forebrain areas) have also 
been  identified: this is the mesolimbic system. This dopaminergic system is shown in the 
Fig. 5. 
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Fig 5. The dopaminergic system[23]. 
 
Communication between neurons takes place through the release of several compounds such 
as dopamine, a neurotransmitter stored in presynaptic vesicles, which binds postsynaptic 
receptors. Dopamine, present in a free state or outside the presynaptic terminal, can be 
metabolized via distinct pathways. In the noradrenaline containing neurons, benzylic 
hydroxylation of dopamine, catalyzed by the enzyme dopamine-β-hydroxylase (DBH), 
produces the neurotransmitter norepinephrine. In dopaminergic neurons, dopamine can be 
degraded to homovanillic acid (HVA) and conjugates. The oxidative deamination to HVA 
proceeds via two steps. Most of the dopamine is converted to 3,4-dihydroxyphenylacetic acid 
(DOPAC) via the enzymes monoamine oxidase (MAO) and aldehyde reductase. There are 
two types of MAO: MAO-A and MAO-B. Most MAO is present outside the dopaminergic 
neuron. DOPAC is converted to HVA, catalyzed by the enzyme catechol-O-methyltransferase 
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(COMT). As the third pathway, dopamine can also be directly inactivated by the enzyme 
COMT, giving 3-methoxytyramine (3-MT) which is subsequently deaminated by MAO to 
give HVA. COMT is an enzyme, which is predominantly localized outside the catecholamine 
neurons. Fig. 6 illustrates these transformations[23]. 
 
OH
OH
NH2
OH
NH2MeO
OH
MeO COOH
OH
OH COOH
Dopamine
COMT
MAO
COMT
Conjugates
Conjugates
3-Methoxytyramine
HVA
MAO
 
Fig. 6. Scheme for the metabolic pathways of dopamine[23]. 
 
1.4.3 Biological Role of Dopamine and Dopa: Applications in Medicine and 
Pharmacy  
 
Parkinson's disease, which  is caused by a shortage of dopamine production in the nerve cells, 
is normally treated by giving patients L-dopa to supply the dopamine that is missing. The 
predominant neuropathologic feature in Parkinson's disease is a degeneration of the 
dopaminergic cells in the substantia nigra. This results in a marked loss of cerebral, especially 
striatal dopamine. The severity of neuronal loss correlates with the clinical severity of 
Parkinson's disease. Therefore, the most common therapeutic strategy has been directed along 
the metabolic pathways of dopamine, therefore L-dopa is currently the most effective therapy 
for Parkinson's disease. However, L-dopa only helps with symptoms and does not prevent the 
disease from progressing.  
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1.4.4 Dopa and Dopamine: Applications in PET  
For PET studies several 18F and 11C tracers, related to the structure of dopa and dopamine, 
were developed and were found to be very useful for studying dopamine production, transport 
and metabolism. Examples of such tracers include [18F]FDOPA and [18F]FTYR (meta and 
para). These internationally well-established tracers are used mostly for clinical investigations 
of cerebral disorders such as the Parkinson's disease. Therefore, research is directed towards 
developing commercial production methods which can be applied for large scale production 
suitable for multi analyses.    
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2 THE PROBLEM 
Among the several known neurotransmitter systems, special interest has been directed 
towards the study of the dopamine receptor system which is linked to a number of disorders 
such as Parkinson’s disease, Huntington’s Chorea, Tardive dyskinea and schizophrenia. 
Effects of variability in dopamine receptor density and information on the status of those 
receptors are of great interest for the study of pathogenesis as well as therapeutic 
interventions. Positron emission tomography (PET) provides direct access to the in-vivo 
biochemistry of those disorders and, consequently, to brain receptors. This scanning technique 
is a method for direct in-vivo quantification of the regional receptor distribution in the brain 
and other organs. For instance, PET imaging with a radiolabelled D2 receptor ligand allows 
in-vivo visualisation of the postsynaptic receptors.  
Since 1985, [18F]FDOPA (1) is an internationally well accepted and applied radiotracer for 
the evaluation of the presynaptic dopaminergic functions by means of PET. It is converted to 
6-[18F]fluorodopamine and subsequently metabolized similarly to the nonfluoro analogue. 
Thus, [18F]FDOPA is applied in patients with hemiparkinsonian symptoms and in Parkinson’s 
disease.  
 
OH
OH F18
COOH
NH2
 
[18F]FDOPA, (1) 
 
The production of [18F]FDOPA is still limited to a low scale. The labelling is mainly 
performed in the electrophilic way and that gives rise to serious problem of general 
importance: the specific activity is low because the product is obtained in the carrier added 
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form. In the nucleophilic way of labelling, however, the problem is how to optimize the 
structure and the conditions of the reaction in order to obtain both a high yield and a high 
specific activity. Tab. 5 gives a summary of some results obtained in the last twenty years. 
Syntheses reported in literature are not satisfactory (3-11 %), however, in the last few years 
the yields were improved (15-25 %) together with a high chemical, radiochemical and 
enantiomeric purity. Yet, data available until now are insufficient for applying the route of 
nucleophilic substitution in case of  [18F]FDOPA. 
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Tab. 5. Reported synthetic routes of [18F]FDOPA 
Type of 
reaction No 
Labelling 
reagents 
Labelling 
precursors
Leaving 
groups 
RCY 
(%) 
Synthesis 
time (min)  Ref. 
1 [18F]F2 (a) H 3 120 24 
2 (b) H 4 100 25 
3 (c) HgOCOCF3 8 50 26 
4 
[18F]AcOF 
(d) H 10-14 60 27 
5 (e) SiMe3 8 60 28 
Electrophilic 
Aromatic 
substitution 
6 [
18F]F2 (f) SnMe3 26 45-50 29 
7 (j) NMe3OTf 25-30 100 30 
8 (g) NO2 16 ± 5 110-120 31 
9 (g) NO2 5 100 32 
10 (h) NO2 5 100-110 33 
11 (g)/(h) NO2 5 110 34 
12 (j) NMe3OTf 11-15 90 35 
13 (g) NO2 6-13 85 33 
14 (g) NO2 1 125 36 
15 (j) NMe3OTf 4-9 80-85 37 
16 (h), (i) NO2 12 110 38 
Nucleophilic 
Aromatic 
substitution 
17 
[18F]F- 
(g)/(h) NO2 3-5 120 39 
Comp. R1 R2 R3 R4 R5 X 
(a) H H H H H H 
(b) Me MeCO Me H MeO H 
(c) Me Me Et H COCF3 HgOCOCF3
(d) H/Me3CCO Me3CCO H H H H 
(e) Me Me Et CArH SiMe3 
(f) BOC BOC ET H BOC/CHO SnMe3 
R1O
R2O X
COOR3
NR4R5
 
(a)- (f)  
MeO
MeO
CHO
G  
(g) G= NO2 
(j) G= NMe3OTf  
CHO
NO2
O
O
R
R
 
(h) R= H 
(i) R= CH3 
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For the electrophilic production commercial modules are available. The precursors can also be 
obtained commercially. However, for the nucleophilic production of [18F]FDOPA there are no 
such commercial modules and the process still needs a considerable effort for development. 
Although yields up to 30 % were reported in the last few years, the commercial application 
and the large scale production suitable for PET centers is still a challenge. To solve this 
problem, a systematic study for choosing the appropriate precursor including a better 
understanding of the theoretical background this is highly demanding. Therefore, the 
nucleophilic aromatic substitution is to be studied systematically with the focus on developing 
and/or finding new structures, new protection groups and new reaction conditions. In this 
work the development has to follow one of two parallel ways:   
1- Path A: improvement of the old, existing method (Fig. 7) which builds the tracer step by 
step starting from 6-substituted derivatives of veratraldehyde or piperonal (Tab. 5) by 
labelling in the first reaction, then building the side chain with the amino acid function 
and finally hydrolysing of all protected groups. These steps are to be optimized.  
 
RO
RO
CHO
NO2
RO
RO
CHO
F18
RO
RO
CH2I
F18
RO
RO F18
G OH
OH F18
NH2
COOH
 
Fig. 7. Scheme for reported synthetic pathway of [18F]FDOPA (path A) starting from 
6-nitroveratraldehyde (R= CH3). 
 
 
2- Path B: developing completely new precursors with different structures (Fig. 8). In this 
way, the precursor already contains the amino acid function and, thus, is ready for 
labelling by nucleophilic substitution (18F → 19F) followed by removal of the assisting 
electron withdrawing group (EWG) and hydrolysing of the protecting groups.  
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Fig. 8. Scheme for the suggested new synthetic pathway of [18F]FDOPA (path B). 
 
In order to get basically important information for solving the problem, in this work model 
precursors for the two pathways are to be examined and evaluated with respect to nucleophilic 
aromatic substitution by [18F]fluoride. For this approach aromatic substrates in which up to 
three different groups are present at the benzene ring. Most importantly, the substituents can 
be both electron donating such as the methoxy group or electron withdrawing such as the 
nitro group and it is to be found out if and how much the electron donating effect of even two 
groups can be compensated that labelling by nucleophilic substitution can be realised in good 
radiochemical yields. The data are important for the development in path A and B and for 
theoretical and mechanistic studies of these types of reactions.  
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3 RESULTS AND DISCUSSION 
3.1 Introduction 
 
In this study the radiochemical yields (RCY) are determined on the basis of the measurement 
by means of a gamma counter or bio imager and the data are calculated as the amount of 
radioactivity of the product related to the total activity present in solution. If necessary, the 
measurements are always corrected in a way to compensate the decay of the radionuclide. The 
dependencies of the RCY on temperature, concentration of precursor and on solvent were 
studied in detail at time periods of 5, 10, 20, 30 and 60 minutes for precursors of path A. For 
precursors of path B (see Chpt 3.6) and the aryl systems, usually one value for the RCY is 
determined at a fixed temperature and in one solvent within a reaction time of 10, 20 or 30 
minutes.  
The two main types of reactions studied here are: 
1- Fluorodenitration reactions:  Ar-NO2   →   Ar-18F 
2- Fluorodehalogenation reactions:  Ar-X   →   Ar-18F            (X= F, Br, Cl) 
The mechanism is generally the SNAr (Fig. 9) which involves two intermediate steps for the 
labelling with [18F]fluoride[40]. 
LG
F18 LG
F18
LG
F18
LG
F18
LG
F18
F18
LG
-
- -slow
fast
- + -
Step 1
Step 2
 
Fig. 9. Scheme for SNAr the mechanism of the nucleophilic aromatic substitution by 
[18F]fluoride. LG is a leaving group. 
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The protection of the hydroxyl groups is necessary in order to avoid the solvation of the 
fluoride-ion and to retain the activity of [18F]fluoride for the labelling reactions. For this 
purpose, methyl ethers (-OCH3), carboxylic esters (-OCOCH3, -OCOPh) and sulfonic esters 
(-OSO2Ph) were used. The results of the 18F labelling of aryl systems are presented, followed 
by the results of  [18F]FDOPA precursors (path A) and finally the results of  [18F]FDOPA 
precursors (path B). A general discussion following the results will summarise all data for 
comparison.   
  
3.2 Aromatic Nucleophilic Substitution by [18F]Fluoride on Aryl 
Systems 
  
3.2.1 Aryl Halides 
 
In general the labelling of mono substituted aryl halides gave very low yields because there 
are no SNAr enhancing groups and because the ability to act as a leaving group is less 
pronounced than in case of other groups. Bromobenzene gave yields in the range between 
0.4 % and 1.8 %. In case of disubstituted arylhalides the yields were improved to 5.6-15.7 % 
for the three dibromobenzenes but to a smaller extent for the three dichlorobenzenes 
(0.8-7.3 %). With trisubstituted arylhalides the activation is good enough and the yields were 
higher. Hence, two tribromobenzenes, i.e. the 1,2,4- and the 1,3,5- isomers gave RCYs in the 
range of 33.3-64.3 % within 20 min. These results are shown in Fig. 10 and 11. 
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Fig. 10. [18F] Labelling of bromobenzene derivatives (10 mg/mL) in DMF at 150 °C in 
dependence on time (Tab. 33 , App. 1). 
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Fig. 11. [18F] Labelling of three dichlorobenzene derivatives (10 mg/mL) in DMF at 
150 °C in dependence on time (Tab. 34 , App. 1). 
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3.2.2 Nitroaryl Derivatives  
 
Dinitrobenzenes (o-, m-, and p-) are particularly well activated for SNAr and the 18F labelling 
yields were expected to be high. In the case of the ortho isomer, this was observed previously. 
The labelling in DMF gave yields in the range of 78 % to 84 % within 20 min at temperatures 
between 80 °C and 120 °C. At higher temperatures the yields were smaller, so at 140 °C it 
started at 60 % within 5 min but decreased to only 15.2 % within 1 h. In acetonitrile, yields 
between 77 % and 84 % could be obtained within 20 min at temperatures between 60 °C and 
80 °C. Fig. 12 and Fig. 13 illustrate the results. 
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Fig. 12. [18F] Labelling of o-dinitrobenzene (10 mg/mL) in DMF. Dependence of the 
RCY on temperature (Tab. 35, App. 1). 
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Fig. 13. [18F] Labelling of o-dinitrobenzene (10 mg/mL) in acetonitrile. Dependence of 
the RCY on temperature (Tab. 35, App. 1). 
 
Halonitrobenzene derivatives are less activated than dinitrobenzene and they are expected to 
give lower yields. Moreover, the leaving group is also thought to be the most activated one, 
i.e. the halogen. In case of the three bromonitrobenzenes, the RCYs of the 
[18F]fluoronitrobenzene (conditions: DMF, 10 mg/ml, 150 °C, 10 min) followed the order:  
NO2
Br  
 
> 
NO2
Br
 
 
> 
NO2
Br  
(65.6 %) 
 
(46.5 %)  (30.0 %) 
 
The results are shown in Fig. 14. 
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Fig. 14. [18F] Labelling of three bromonitrobenzene isomers (10 mg/mL) in DMF at 
150 °C in dependence on time (Tab. 36, App. 1). 
 
3.2.3 Benzaldehyde Systems  
 
The aldehyde is a good electron withdrawing group, hence with a good leaving group the 
labelling yields are expected to be high. In fact, at high temperatures (> 100 °C) the labelling 
yields using o-nitrobenzaldehyde were in the range of 60-70 % within 20 min and increased 
slightly to 79 % within 1 h  (Fig. 15). 
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Fig. 15. [18F] Labelling of o-nitrobenzaldehyde (10 mg/mL) in DMF. Dependence of 
the RCY on temperature. (Tab. 37, App. 1). 
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For the other derivatives of benzaldehyde, Tab. 6 gives a summary of the labelling results 
together with those reported in literature. It can be seen that all the RCYs are between 65 % 
and 82 %. Moreover, the highest yields obtained are those compounds with the best leaving 
groups, i.e. with the nitro and the fluoro substituents. The yields using the para isomers are 
always higher than those of the ortho isomer. Compared to the literature, where only DMSO 
was used for labelling of all benzaldehyde precursors, it can be noticed that the yields are 
almost the same with respect to the 2-nitro derivative, and only improved a little bit in case of 
the 4-nitro isomer. The labelling yields of the halogeno precursors were highly improved 
when using DMF as a solvent. Hence, RCYs in the range 65-83 % could be obtained using 
DMF instead of 3-7 % using DMSO. Among halogens the ability to act as a leaving group 
was the following: 
F ≈ Br > Cl 
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Tab. 6. [18F] Labelling yields of ortho and para derivatives of benzaldehyde. 
(Conditions of this study: DMF(1 /mL), 10 mg/mL, 140-150 °C, 20 min). 
This work 
RCY (%) 
Literature 
Precursor 
TLC HPLC RCY (%) Conditions Ref. 
55.0 ± 10 DMSO (0.5 ml), 120-130 °C, 15 min 41 
78.0 DMSO (0.3 ml), 120 °C, 10 min 38 
65.0 DMSO (1 ml), 130-140 °C, 20 min 42 
53.0 DMSO (1 ml), 114 °C, 25 min 44 
50-60 DMSO (0.3 ml), MW, 4 min 45 
65.0 DMSO (1 ml), MW, 2 min 22 
2-Nitro 73.2 ± 0.2 (n=3) 74.4 
76.0 DMSO (0.2 ml), MW, 0,25 min 46 
2-Fluoro 75.0 ±  1.6 (n=1) 73.0 ±  2.5 - - - 
2-Bromo 73.0 ±  0.2 (n=3) 75.0 ±  3.2 - - - 
2-Chloro 65.0 ± 1.1 (n=3) 62.7 ±  4.6 - - - 
55 ± 10 DMSO (0.5 ml), 120-130 °C, 5 min 41 
70.0 DMSO (1.5 ml), 85-110 °C, 20 min 43 
65.0 DMSO (1 ml), 130-140 °C, 20 min 42 
53.0 DMSO (1 ml), 114 °C, 25 min 44 
65.0 DMSO (1 ml), 145 °C, 20 min 22 
50-60 DMSO (0.3 ml), MW, 4 min 45 
65.0 DMSO (1 ml), MW, 2 min 22 
4-Nitro 81.5 ±  5.9 (n=3) 82.8 ±   5.0 
75.0 DMSO (0.2 ml), MW, 0,5 min 46 
4-Fluoro 78.3 ±  0.5 (n=3) 80.0 ±  3.7 - - - 
3.0 DMSO (1.5 ml), 85-110 °C, 20 min 43 
4-Bromo 75.7 ±  0.5 (n=3) 82.0 ±  1.2 7.0 DMSO (0.2 ml), MW, 0,5 min 46 
1.0 DMSO (1.5 ml), 85-110 °C, 20 min 43 
4-Chloro 65.7 ±  3.3 (n=3) 69.7 ±  2.0 6.0 DMSO (0.2 ml), MW, 0,5 min 46 
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3.2.4 Acetophenone and Benzophenone Systems  
A different good electron withdrawing substituent is the ketone group (COR, COAr). With 
a nitro group as a good leaving substituent the labelling yields are expected to be high. So the 
labelling of 4-nitroacetophenone was studied in detail using DMF and DMSO, respectively 
(Fig. 16 and 17). A clear dependence on temperature was observed in both cases. In both 
solvents the yields within 30 min were comparable to those at temperatures 50-140 °C and 
increased at 160 °C to be 60-73 % in DMF and 50-60 % in DMSO.  
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Fig. 16. [18F] Labelling of p-nitroacetophenone (10 mg/mL) in DMF. Dependence of 
the RCY on temperature (Tab. 39, App. 1). 
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Fig 17. [18F] Labelling of p-nitroacetophenone (10 mg/mL) in DMSO. Dependence of 
the RCY on temperature. (Tab. 39, App. 1). 
 
 
Tab. 7 shows the results of [18F]labelling of ortho and para acetophenones. 
2-Nitroacetophenone gave unexpectedly very low yield in accordance with the values 
reported  in the literature. A possible explanation is the existence of o-nitroacetophenone 
mainly in the form of an enol. In the enol form, the hydroxy group can easily form hydrogen 
bonding with the nitro group only if it is in the ortho position. This is a general structural 
feature observed with acetophenones having an ortho group that can form hydrogen bonding 
with the enol form of acetophenone. Examples of such groups include -OH, -NH2 and -NO2. 
For example o-hydroxyacetophenone exists predominantly in the enol form[105] (Fig. 18). 
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Fig. 18. Scheme for the keto-enol tautomerism in 2-hydroxy and 2-nitro 
acetophenone (data from X-ray studies)[105]. 
 
The existence of the enol form with its free hydroxyl group (even up to 10 %) diminishes the 
reactivity of [18F]fluoride hence low yields are expected to be obtained with 
o-nitroacetophenone. This reasoning is also supported by the fact that other structures, which 
can not form stable enol forms, gave high yields in the nucleophilic aromatic substitution by 
[18F]fluoride. Examples include p-nitroacetophenone, o- and p-nitrobenzophenone. The 
highest labelling yields were obtained from the fluoro derivative (75 %). The labelling yields 
of the 2-bromo, 2-chloro and 4-bromo derivatives were comparable and they were in the 
range 35-40 %. The labelling yields of the 4-nitro and the 4-chloro derivatives were very 
close to each other (59-61 %) but smaller than those of the fluoro analogue. 
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Tab. 7. [18F] Labelling yields of ortho and para derivatives of acetophenone. 
(Conditions in this study: DMF, 10 mg/mL, 150 °C, 20 min). 
This study 
RCY (%) 
Literature 
Precursor 
TLC HPLC RCY (%) Conditions Ref.
15.0 ± 5 DMSO (0.5 ml), 120-130 °C, 15 min 41 
10-22 DMSO (1 ml), MW, 2.5-5 min 46 2-Nitro 13.3 ± 0.9 (n=3) 
13.3 ± 1.7 
(n=3) 
11.0 DMSO (0.2 ml), MW, 0,4 min 47 
2-Fluoro 70.1 ± 1.3 (n=3) 
75.0 ± 0.8 
(n=3) - 
- - 
2-Bromo 39.3 ±  2.9 (n=4) 
34.3 ±  2.6 
(n=4) - 
- - 
2-Chloro 37.7 ± 5.4  (n=34 
37.0 ±  5.9 
(n=4) - 
- - 
61 ± 10 DMSO (0.5 ml), 120-130 °C, 20 min 41 
34.0 DMSO (0.5 ml), 160 °C, 20 min 48 
40-50 DMSO (1 ml), MW, 5 min 45 
63.5 DMSO (1 ml), MW, 2.5 min 49 
4-Nitro 61.7 ± 3.9  (n=4) 
60.8 ± 2.5 
(n=4) 
71.0 DMSO , MW, 0,5 min 48 
4-Fluoro 74.7 ± 1.2 (n=2) 75.0 (n=1) 75 DMSO (0.5 ml), 160 °C, 20 min 48 
4-Bromo 35.3 ±  1.7  (n=4 
31.5 ±  3.2 
(n=4) 6.0 DMSO (0.5 ml), 160 °C, 20 min 48 
4-Chloro 59.0 ±  3.6 (n=4) 
58.7 ±  3.8 
(n=4) 28.0 DMSO (0.5 ml), 160 °C, 20 min 48 
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Tab. 8. [18F] Labelling yields of ortho and para derivatives of benzophenone. 
(Conditions in this study: DMF(1 mL), 10 mg/ mL, 140-150 °C, 20 min). 
This study 
RCY (%) 
Literature 
Precursor 
TLC HPLC RCY (%) Conditions Ref. 
2-Nitro 78.7 ± 1.9 (n=5) 
78.4 ± 4.3 
(n=5) - 
- - 
2-Fluoro 91.2 ± 1.0 (n=4) 
92.3 ± 0.6 
(n=4) - 
- - 
2-Chloro 6.6 ± 2.2  (n=7) 
6.2 ± 0.9 
(n=7) - 
- - 
93 ± 2 DMSO, 130 °C, 5 min 41 
4-Nitro 86.8 ± 4.8  (n=4) 
88.6 ± 3.3 
(n=4) 
52 DMSO, 160 °C, 20 min 50 
4-Fluoro 83.3 ± 3.0 (n=4) 
83.0 ± 1.9 
(n=4) - 
- - 
4-Bromo 76.0 ± 2.6  (n=4) 
76.5 ± 3.7 
(n=4) - 
- - 
4-Chloro 70.7 ±  3.6 (n=4) 
71.7 ±  4.5 
(n=4) - 
- - 
 
 
With regard to the benzophenone derivatives the results are illustrated in Tab. 8. With 
benzophenones the labelling yields were higher than those with acetophenones. That means 
that the -COPh group is better than the corresponding -COCH3 group for enhancing SNAr. 
Furthermore, the highest labelling yields (83-92 %) were obtained with the fluoro and the 
nitro derivatives. With the exception of the fluoro derivative, the para isomers gave higher 
yields than the ortho isomers. This can be explained by the steric hindrance provided by the 
second ring in the ortho position (because the fluorine atom is small, the steric hindrance in 
case of the 2-fluoro derivative is small, hence the yield still is high).  
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An order of the leaving group ability can be written here as:  
F> NO2 > Br > Cl             (ortho derivatives of benzophenone) 
NO2 > F > Br > Cl             (para derivatives of benzophenone) 
Unfortunately no literature data exist for most of these precursors for the purposes of 
comparison.  
3.3 The Calculation of Activation Energy by Means of the Arrhenius 
Equation 
 
From the curves showing the dependency of the RCY on temperature it is possible to 
determine the rate constants and the activation energy of these reactions. A labelling reaction 
is assumed to follow pseudo-first-order kinetics[44] since the organic substrates were present in 
extremely large excess over the nca [18F]fluoride. The equation for the speed of such 
a reaction is equivalent to the following differential equation: 
-d [18F-] / dt = k′[18F-]  
where k′ is the rate constant. Separating the variables gives: 
-d [18F-] / [18F-] = k′dt 
integrating this equation (boundary conditions Co → C and 0 → t) gives: 
-ln ([18F-]t / [18F-]o)  = k′t 
– (ln ([18F-]t – ln [18F-]o) = k′t 
ln [18F-]o – ln [18F-]t = k′t 
ln  ([18F-]o / [18F-]t)  = k′t  
introducing [18F-]t = [18F-]o – RCY      we get the following: 
ln  ([18F-]o / [18F-] o – RCY) = k′t        or         ln  (1 – RCY/ [18F-] o)  = k′t 
which is equivalent to:              ln  (1 – RCY)  = k′t 
hence a graph of ln (1-RCY) versus reaction time gives a linear function with the slope of –k′.  
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The temperature dependency of the labelling reactions is given by the temperature 
dependency of the rate constant[51]. The rate constant increases exponentially with increasing 
temperature. This is expressed usually by the following equation: 
k = A e-b/T 
where A and b are empirically determined constants. 
According to Arrhenius, the constant b can be replaced by –Eact/R, where Eact is the activation 
energy and R is the gas constant (R = 8.314 J/K mol). Therefore we can write this equation as: 
K = A e-Eact / (RT) 
which may be written in natural logarithmic way as: 
 
ln k = ln A – Eact / (RT) 
 
Hence, a plot of ln k against 1/T (K) gives a linear function with the slope of –Eact/R. The 
activation energy can be determined graphically in this way. With at least two rate constants 
for one reaction, measured at different temperatures, the activation energy can be determined 
also mathematically by the following formulae: 
for T1: ln k1 = ln A – Eact/(RT1) 
for T2: ln k2 = ln A – Eact/(RT2) 
subtraction of T2 from T1 leads to: 
ln (k1/k2) = EA/R (1/T2 – 1/T1) 
from this the activation energy is equivalent to: 
 
Eact = R[T1T2/(T1 – T2)] ln (k1/k2) 
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In dealing with the labelling reactions, and for purposes of calculating the Arrhenius 
constants, part of the graph of RCY versus time is chosen where the RCY is increasing. This 
gives reliable values and avoid the problems of meaningless negative values. The labelling 
process was noticed to be mainly in the first 5-10 min. After this, decomposition started 
which competes with the labelling reaction. Therefore, for purposes of simplifying the 
calculations, the first stage of the labelling reaction, i. e. 0-10 min is applied in calculating the 
rate constant and the activation energy graphically. The linearity of all graphs is evaluated by 
the correlation coefficient r. A reliable linear graph would be assumed to have r in the range 
0.85-1.00 or the same values in the negative region.          
 
3.4 Applications of the Arrhenius Calculations 
  
Applying the Arrhenius calculations, the following results were obtained for 
o-nitrobenzaldehyde and p-nitroacetophenone. 
 
3.4.1 o-Nitrobenzaldehyde 
 
This system is highly activated in nucleophilic aromatic substitution. The best linear range for 
Arrhenius calculations was found to be 0-10 min at temperatures 80-140 °C. By drawing the 
graph of ln (1-RCY) versus time, the rate constants as shown in Tab. 9 were obtained and an 
activation energy of 24 kJ/mol was calculated (Fig. 19). 
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Tab. 9. Rate constants (min-1) for the labelling of o-nitrobenzaldehyde at 
temperatures 80-140 °C. 
Temp. (°C) k’ (min-1) 
80 0.0919 
100 0.1058 
120 0.1076 
140 0.1181 
 
0,0024 0,0026 0,0028
-3,6
-3,2
-2,8
-2,4
-2,0
-1,6
r= -0.85
Y= 4.89 - 2821.96 X
ln
 k
1 / T (K)
 
Fig. 19. Plot of ln k versus 1/ T (K) for o-nitrobenzaldehyde. (Conditions: 0-10 min, 
80-140 °C) (Tab. 38, App. 1). 
 
 
 
3.4.2 p-Nitroacetophenone 
 
This system is also highly activated in nucleophilic aromatic substitution. The best linear 
range for Arrhenius calculations was found to be 0-10 min at temperatures 80-140 °C. By 
drawing the graph of ln (1-RCY) vs time, the rate constants as shown in Tab. 10 were 
obtained and an activation energy of  32 kJ/mol was calculated (Fig. 20) 
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Tab. 10. Rate constants (min-1) for the labelling of p-nitroacetophenone at 
temperatures 80-140 °C. 
Temp (°C) k’ (min-1) 
80 0.0136 
100 0.0298 
120 0.0420 
140 0.0683 
 
0,0024 0,0026 0,0028
-4,4
-4,0
-3,6
-3,2
-2,8
-2,4
r = - 0.99
Y = 6.52 - 3795.94 X
ln
 k
1 / T (K)
 
Fig. 20. Plot of ln k versus 1/ T (K) for p-nitroacetophenone. (Conditions: 0-10 min, 
80-140 °C) (Tab. 40, App. 1). 
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3.5 Aromatic Nucleophilic Substitution by [18F]Fluoride on Precursors 
for Path A of [18F]FDOPA 
  
3.5.1 Introduction 
 
The total synthesis of [18F]FDOPA via path A (see Chpt. 2) is well known in the literature and 
until now more than ten different approaches have been applied, depending on the type of 
starting precursor, type of protection of the hydroxyl groups and the amino acid function and 
on the reagents used to achieve the intermediate transformations. Tab. 5 shows the results. 
However, except for the latest syntheses (RCY 16-30 %), yields always were low (3-11 %). 
There principally are two main types of compounds used frequently for the labelling step 
(first step) in the total synthesis of [18F]FDOPA. Those are the 6-substituted veratraldehydes 
(2) and the 6-substituted piperonals (9). Two leaving groups used frequently are the nitro 
group and the trimethylammonium triflate. The nitro precursors are commercially available 
while the trimethylammonium triflates are not, and they generally have to be prepared 
relatively short before use. Therefore, a choice was made to investigate the commercially 
available precursors since one needs high quantities in high purity. Tab. 11 summarises the 
results for the labelling of [18F]FDOPA precursors for path A depending on 6-substituted 
veratraldehyde (i.e. synthesis of 6-[18F]fluoroveratraldehyde, 3) 
MeO
MeO
CHO
G
MeO
MeO
CHO
F18  
                          (2)                                              (3) 
 
(2a)     G= NO2 
(2b)     G= NMe3OTf 
(2c)     G= F 
(2d)     G= Br 
(2e)     G= Cl 
 
Fig. 21. Scheme for the synthesis of 6-[18F]fluoroveratraldehyde by nucleophilic 
aromatic substitution. 
 
 
RESULTS AND DISCUSSION 
 
48 
 
Tab. 11. Literature syntheses of 6-[18F]fluoroveratraldehyde (3). 
Precursor Leaving group Conditions a RCY (%) Ref. 
120 °C, 10 min 23 38 
20 min, 130 °C  
Microwave (300 W), 2 min 50 46 
25 min, 114 °C 52 44 
130 °C 50 52 
20 min, 130 °C 50-55 32 
20 min, 135 °C 25-35 39 
20 min, 130 °C 55 36 
20 min, 145 °C 27 53 
20 min, 145 °C   
Microwave (300 W), 2 min 50 22 
Microwave (300 W), 2 min 45-50 34 
2a NO2 
20 min, 130-140 °C 50 42 
110 °C 45-50 54 
20 min, 160 °C 30-35 37 2b NMe3OTf 
140 °C, 10 min 
Microwave (300 W), 1 min 45 ± 5 36 
2c F 
2d Br 
2e Cl 
New precursors (this work)  
 
a) Other reagents: K(18)F, DMSO, K2CO3, kryptofix [2.2.2]. 
 
3.5.2 6-Nitroveratraldehyde: Reaction Parameters and Activation Energy 
Calculation for the 18F labelling  
 
 
MeO
MeO
CHO
NO2  
 (2a) 
 
This compound is the most important precursor for [18F]FDOPA and it is used widely since it 
is commercially available, inexpensive and stable for long time. The literature yields 
(Tab. 11) for the 18F labelling were between 20 % and 55 % in DMSO within 10-20 min at 
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temperatures between 110 °C and 140 °C. A more investigation of the kinetics of 18F labelling 
of this precursor shows the results reported below. 
The reaction of nca [18F]fluoride with 6-nitroveratraldehyde was performed in DMF, DMAc, 
DMSO, sulfolane and 1,2-dimethoxyethane at 140 ºC with 20.0 mg/mL of precursor (Fig. 22).  
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Fig. 22. [18F] Labelling of 6-nitroveratraldehyde (20 mg/mL) at 140 °C. Dependence 
of the RCY on the type of solvent (Tab. 41, App. 2) 
 
DMF proved to be the best solvent for the labelling process. The labelling yield was 89 ± 2 % 
(n=15) after a reaction time of 10 min. Relatively fast kinetics were observed, i.e. within the 
first period of 10 min yields reached highest values or were already close to the maximum. 
While in DMSO and DMAc the labelling yields were slightly above 70 %, in sulfolane and 
1,2-dimethoxyethane the amount of labelled product was clearly lower. In the literature (see 
Tab. 11), where  DMSO was used as the solvent of choice, the radiochemical yields were not 
higher than 55 % at reaction temperatures of 120-150 ºC. Although at 140 ºC higher yields  
(70 %) were also observed in DMSO, the labelling process appears to be clearly improved 
when performed in DMF. 
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Sulfolane is a solvent less frequently used for nucleophilic fluorinations, yet it was chosen for 
this work because it has the advantage of allowing the applications of high reaction 
temperatures up to 300 ºC. However, the lowest yields in this series of experiments (40 % 
after 20 min) were observed.  
As expected because of the lower polarity, 1,2-dimethoxyethane did also not give high yields 
which were in the range of 55 % to 60 % within 10 min at 120 ºC and dropped afterwards to 
42 % at 60 min. 
Other aprotic solvents were tested without success. In acetonitrile (at 100 ºC) and benzonitrile 
the labelling reactions failed. Nitromethane and nitroethane could also be applied principally 
but these solvents appeared to react fast with the aldehyde group (Knoevenagel 
condensation),  resulting in labelled products of other than desired structure.  
All labelling experiments were repeated at least 4 to 10 times and the standard deviations 
calculated were in the range from 3 to 15 % of the reported values.  
Furthermore, nine reactions were performed under the best labelling conditions (140 °C, 
DMF, 20 mg) for 10 min in order to analyse the product by HPLC. The labelling yields were 
89 ± 3 %. Thus , it was clearly proven that the product was analysed without any impurities 
and the TLC data reported above are reliable. 
Since best labelling results were obtained in DMF, the effect of precursor concentration was 
studied in this solvent. The concentrations were varied from 0.5 mg/mL up to 50 mg/mL, the 
results are shown in Fig. 23.  
 
 
 
 
 
RESULTS AND DISCUSSION 
 
51
 
0 10 20 30 40 50 60 70
0
20
40
60
80
100
20 mg
10 mg
5 mg
3 mg
1 mg
0.5 mg
RC
Y 
(%
)
Time (min)
 
Fig. 23. [18F] Labelling of 6-nitroveratraldehyde in 1 mL DMF at 140 °C. Dependence 
of the RCY on the concentration of the precursor (Tab. 41, App. 2). 
 
 
At 0.5 mg/mL the yields remained below 35 %, but at 1 mg/mL and higher concentrations 
yields were above 60 %  within 10 min.  The amount of labelled product was between 80 % 
and 90 % when using a concentration of 20 mg/mL also within 10 min. Interestingly, higher 
concentrations did not end up in a really quantitative reaction. Therefore, 20 mg/mL was the 
concentration to perform the fluorination with best yields. 
The dependencies of the labelling yields on temperature are shown in Fig. 24 at 
concentrations of 20 mg/mL using DMF as the solvent.  
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Fig. 24. [18F] Labelling of 6-nitroveratraldehyde (20 mg/mL) in DMF. Dependence of 
the RCY on temperature (Tab. 41, App. 2). 
 
For purposes of improving visibility of the graph the 150 °C data are not shown because they 
were close to those at 140 °C exhibiting similar standard deviations. It was found that the best 
temperature for the [18F]labelling in different solvents was 140 °C. The RCY increased 
rapidly when going from 80 °C to 150 °C. At high temperatures (120-150 °C) very fast 
kinetics were observed. In this case it was necessary to study the reaction yields at very short 
time intervals (3, 5, 7 and 10 min).  
Like in case of many other precursors, the best linear range for Arrhenius calculations was 
found to be 0-10 min at temperatures of 80-140 °C. By drawing the graph of ln (1-RCY) vs 
time, the rate constants as shown in Tab. 12 were obtained and an activation energy of 
33 kJ/mol was calculated (Fig. 25). 
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Tab. 12. Rate constants (min-1) for the labelling of 6-nitroveratraldehyde at 
temperatures 80-140 °C. 
Temp. (°C) k’ (min-1) 
80 0.0432 
100 0.1114 
120 0.1621 
140 0.2271 
 
0,0024 0,0025 0,0026 0,0027 0,0028 0,0029
-3,2
-3,0
-2,8
-2,6
-2,4
-2,2
-2,0
-1,8
-1,6
-1,4
r = - 0.98
Y = 8.16 - 3944.0 X
ln
 k
1 / T (°K)
 
Fig. 25. Plot of ln k versus 1/ T (K) for 6-nitroveratraldehyde. (Conditions: 0-10 min, 
80-140 °C) (Tab. 42, App. 2). 
 
3.5.3 6-Fluoroveratraldehyde: Reaction Parameters and Activation Energy 
Calculation for the 18F Labelling 
 
MeO
MeO
CHO
F  
 (2c) 
 
Until now this precursor was not described in literature. In general, the aromatic  
fluorodenitration reactions are much more common than the fluorodehalogenation, because 
the nitro as a leaving group is better than the halogens (Br, Cl, I). However, in case of the 
fluorine atom as a leaving group the situation is different since the substitution proceeds as an 
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isotope exchange reaction as the results showed. So the ability to act as a leaving group is 
more or less the same as the nitro group. More investigation of the kinetics of labelling this 
precursor shows the following results. 
The reaction of [18F]fluoride with 6-fluoroveratraldehyde (18F for 19F exchange) was 
performed in four solvents: DMF, DMSO, DMAc and sulfolane (Fig 26). 
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Fig. 26. [18F] Labelling of 6-fluoroveratraldehyde (20 mg/mL) at 140 °C. Dependence 
of the RCY on the type of solvent (Tab. 43, App: 3). 
 
In DMF, which was the best solvent for carrying the labelling reaction, a maximum RCY of 
87.7 ± 1.2 % (n= 4) could be obtained within 5 min at 140 °C using 20 mg/mL of the 19F 
precursor. This was almost double the yield obtained in other solvents. Within 60 min the 
yield was always higher than 80 % in DMF but dropped to 27 % to 38 % for the other 
solvents with the lowest yield being in DMSO. 
For the 18F for 19F exchange in 6-fluoroveratraldehyde, the labelling highly depended on the 
precursor concentration at low concentrations, i. e. 0.5 -1.0 mg/mL, with yields ranging 
between 65 to 75 % in 5 min at 140 °C. At higher concentrations the yields were high and 
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almost very near in the range between 85 % and 87.7 % at the same conditions. The yields 
remained always high even after 30 min with 60.4 % for the concentration of 0.5 mg/mL and 
almost high as 87.4 % for the 50 mg/mL. This is shown in Fig 27. 
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Fig. 27. [18F] Labelling of 6-fluoroveratraldehyde in DMF (1 mL) at 140 °C. 
Dependence of the RCY on the concentration of the precursor (Tab. 43, 
App. 3). 
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Fig. 28. [18F] Labelling of 6-fluoroveratraldehyde (20 mg/mL) in DMF. Dependence of 
the RCY on temperature (Tab. 43, App. 3). 
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The 18F labelling of 6-fluoroveratraldehyde showed strong dependence on temperature 
(Fig 28). Within 10 min using a concentration of 20 mg/mL precursor in DMF, the minimum 
yield was 34.5 ± 5.5 % at 60 °C while at 140 °C it was as high as 85.0 ± 5.3 %. Surprisingly, 
the yields tended to be close to each other (78.4-82.6 %) for the three temperatures 120, 140 
and 160 °C but dropped for the 180 °C to 73 %.  
Using the best linear range for Arrhenius calculations (0-10 min at temperatures 80-140 °C), 
and by drawing the graph of ln (1-RCY) vs time, the rate constants (see Tab. 13) were 
obtained and an activation energy of 17 kJ/mol was calculated (Fig. 29). 
Tab. 13. Rate constants (min-1) for the 18F labelling of 6-fluoroveratraldehyde 
at temperatures 80-140 °C. 
Temp. (°C) k’ (min-1) 
80 0.0860 
100 0.1238 
120 0.1720 
140 0.1897 
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Fig. 29. Plot of ln k versus 1/ T (K) for 6-fluoroveratraldehyde. (Conditions: 0-10 min, 
80-140 °C) (Tab. 44, App. 3). 
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3.5.4 6-Bromoveratraldehyde: Reaction Parameters and Activation Energy 
Calculation for the 18F Labelling 
 
MeO
MeO
CHO
Br  
 (2d) 
 
Until now this precursor was not described in literature. The detailed investigation of the 
kinetics of 18F labelling of this precursor shows the following results. 
The reaction of nca [18F]fluoride with 6-bromoveratraldehyde was performed in different 
solvents i.e. DMF, DMAc, DMSO and sulfolane at 160 ºC with 20 mg/mL of precursor 
(Fig. 30).  
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Fig. 30. [18F] Labelling of 6-bromoveratraldehyde (20 mg/mL) at 160 °C. Dependence 
of the RCY on the type of solvent (Tab. 45, App. 4). 
 
Again DMF proved to be the best solvent for the labelling process. The labelling yields were  
44.5 ±  4.2 % (n=5) within 20 min. Fast kinetics were observed, i.e. within the first period of 
10 min yields reached highest values or were close to the maximum. While the yields were 
between 39 % and 45 % after 10 min in DMF, they were lower (22-27 %) in DMAc. In 
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sulfolane, the yields were very low in the first 5 min, but almost doubled (13.0 %) at 20 min. 
DMSO gave the lowest yields among all the solvents used (less than 4 %). The yields even 
did not improve with time in DMSO and they were in all cases by a factor of ten or more 
lower than the yields in DMF. The labelling started in DMSO only at temperatures higher 
than 140 °C whereas in other solvents it started at temperatures after 100 °C. The labelling in 
an equal mixture of DMF (0.5 mL) and DMSO (0.5 mL) did not improve at all and yields 
remained in the range 1-5 % indicating the great suppressing effect of DMSO as a solvent on 
the labelling of these halogenated precursors. Other aprotic solvents were tried without 
success either because of low boiling points (acetonitrile and 1,2-dimethoxyethane) or 
because solvents such as nitromethane and nitroethane give unwanted by-products by reacting 
fast with the aldehyde group (Knoevenagel condensation). 
Since best labelling results were obtained in DMF the effect of precursor concentration was 
studied in this solvent. The concentrations were varied from 0.5 up to 50 mg/mL at 160 °C. 
The results are shown in Fig. 31.  
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Fig. 31. [18F] Labelling of 6-bromoveratraldehyde in DMF at 160 °C. Dependence of 
the RCY on the concentration of the precursor (Tab. 45, App. 4). 
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At 0.5 mg/mL the yields remained below 7 % but almost doubled in going from 0.5 to 
1 mg/mL and from 1 up to 5 mg/mL. The increase was then not uniform at 10 mg/mL and it 
was very close to the 5 mg/mL. At high concentrations (20, 30 and 50 mg/mL) yields were 
between 40 % and 55 % and increased always with increasing the precursor concentration, to 
reach maximum of 58.1 % with 50 mg/mL within 30 min 
The study of the dependence of RCY on temperature was performed in DMF using 
a concentration of 20 mg/ mL. This is shown in Fig. 32. The RCY increased slowly at short 
times (5-20 min) when going from 80 to 120 °C but more rapidly after that (140 to 180 °C). 
At high temperatures (140-180 °C) very fast kinetics were observed and a RCY of 
45.7 ± 5.5 % could be obtained in 5 min at 180 °C. After 1 h the highest yield was 49.9 % at 
180 °C. 
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Fig. 32. [18F] Labelling of 6-bromoveratraldehyde (20 mg/mL) in DMF. Dependence 
of the RCY on temperature (Tab. 45, App. 4). 
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As with the fluoro analogue, and using the best linear range for Arrhenius calculations 
(0-10 min at temperatures 80-140 °C), the graph of ln (1-RCY) vs time gave the rate constants 
shown in Tab. 14. Hence, an activation energy of 60 kJ/mol was calculated (Fig. 33). 
 
Tab. 14. Rate constants (min-1) for the labelling of 6-bromoveratraldehyde at 
temperatures 80-140 °C. 
Temp. (°C) k’ (min-1) 
80 0.0024 
100 0.0089 
120 0.0206 
140 0.0493 
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Fig. 33. Plot of ln k versus 1/ T (K) for 6-bromoveratraldehyde. (Conditions: 0-10 min, 
80-140 °C) (Tab. 46, App. 4). 
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3.5.5 6-Chloroveratraldehyde: Reaction Parameters and Activation Energy 
Calculation for the 18F Labelling 
 
MeO
MeO
CHO
Cl  
 (2e) 
 
Until now this precursor was not described in literature. The detailed investigation of the 
kinetics of  18F labelling of this precursor showed the results as presented below. 
The reaction of [18F]fluoride with 6-chloroveratraldehyde was performed in the following 
solvents: DMF, DMAc, DMSO and sulfolane at 160 ºC with 20.0 mg/mL of precursor 
(Fig. 34). DMF proved to be the best solvent for the labelling process. The labelling yields 
were 57 % ± 5.1 % (n=5) which means it is slightly higher than in the case of the bromo 
precursor. Fast kinetics were observed also here, and in the period of the first 10 min yields 
reached highest values or were close to the maximum. Very strange here is the wide gab 
between the yields after 10 min in DMF (52-58 %) and in other solvents (3-12 %), which was 
not observed in case of the precursor. Hence in sulfolane the yields were very low and in the 
range between 7-9 % but were slightly higher in DMAc (9-12 %). 
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Fig. 34. [18F] Labelling of 6-chloroveratraldehyde (20 mg/mL) at 160 °C. Dependence 
of the RCY on the type of solvent (Tab. 47, App. 5). 
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Again DMSO gave the lowest yields among all the solvents used (1-4 %). The yields even did 
not improve with time in DMSO and they were in all times less then the yields in DMF by 
a factor of tenth or more. 
Since best labelling results were obtained in DMF the effect of precursor concentration was 
studied in this solvent. The concentrations were varied from 0.5 mg/mL up to 50 mg/mL and 
the results are shown in Fig. 35. 
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Fig. 35. [18F] Labelling of 6-chloroveratraldehyde (20 mg/mL) in DMF at 160 °C. 
Dependence of the RCY on the concentration of the precursor (Tab. 47, 
App. 5). 
 
At 0.5 mg/mL the yields remained below 14 % but almost doubled in going from 0.5 to 
1 mg/mL and from 1 to 5 mg/mL. The increase was then not uniform at 10, 20, 30 and 
50 mg/mL (high concentrations). At these concentrations the amount of labelled product was 
between 45 % and 66 %. The highest concentrations gave the highest yields in all times 
(63-66 %).  
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The study of the dependence of RCY on temperature was carried out in DMF using 
a concentration of 20 mg/mL. This is shown in Fig 36.  
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Fig. 36. [18F] Labelling of 6-chloroveratraldehyde (20 mg/mL) in DMF. Dependence of 
the RCY on temperature (Tab. 47, App. 5). 
 
The RCY slowly increased at short times (5 min up to 20 min) when going from 80 °C to 
120 °C but rapidly after that (120 °C to 180 °C) for the chloro precursor. At high temperatures 
(120-180 °C) very fast kinetics were observed and a RCY of 51.5 ± 4.4 % can be obtained in 
5 min at 180 °C. Unlike the behaviour of the bromo precursor, the highest yield for the chloro 
precursor after 1 h was obtained at 160 °C instead of 180 °C.  
The graph of ln (1-RCY) vs time gave the rate constants shown in Tab. 15. Hence, an 
activation energy of 63 kJ/mol was calculated (Fig. 37). 
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Tab. 15. Rate constants (min-1) for the labelling of 6-chloroveratraldehyde at 
temperatures 80-140 °C. 
Temp. (°C) k’ (min-1) 
80 0.0031 
100 0.0134 
120 0.0206 
140 0.0842 
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Fig. 37. Plot of ln k versus 1/ T (K) for 6-chloroveratraldehyde. (Conditions: 0-10 min, 
80-140 °C) (Tab. 48, App. 5). 
 
3.5.6 6-Nitropiperonal: Reaction Parameters and Activation Energy Calculation for 
the 18F Labelling 
 
CHO
O
O
NO2  
(9a) 
 
The derivatives of piperonal are the second of the most important precursors for the total 
synthesis of [18F]FDOPA. Tab. 16 gives a summary of the results for the labelling of 
RESULTS AND DISCUSSION 
 
65
[18F]FDOPA precursors for path A (see Chpt. 2) depending on 6-substituted piperonal (9). 
The reason for using these compounds is the desired smooth and milder deprotection at the 
end of synthesis of [18F]FDOPA as suggested in literature [36].   
 
CHO
GO
O CHO
F18O
O
 
                        (9)                                               (10) 
(9a)      G= NO2 
(9b)      G= Br 
(9c)       G= Cl 
Fig. 38. Scheme for the synthesis of 6-[18F]fluoropiperonal by nucleophilic 
aromatic substitution. 
 
 
Tab. 16. Literature syntheses of 6-[18F]fluoropiperonal (10). 
Precursor Leaving group Conditions a RCY (%) Ref. 
5 min, 180 °C 53 31 
10 min, 120 °C 68 54 
20 min, 135 °C 50 39 
25 min, 114 °C 44 44 
10 min, 120 °C 51 38 
20 min, 130 °C 55 36 
20 min, 130 °C 50-55 32 
9a NO2 
MW (300 W), 0.5 min 53 46 
9b Br 
9c Cl 
New precursors (this work)  
  
a) Other conditions: K(18)F, DMSO, K2CO3, Kryptofix 222. 
 
The detailed investigation of the kinetics of 18F labelling of this precursor showed the 
following results . 
The reaction of [18F]fluoride with 6-nitropiperonal was performed in the following solvents: 
DMF, DMAc, DMSO, sulfolane and 1,2-DME at 140 ºC with 20 mg/mL of precursor. The 
results are illustrated in Fig. 39. Unlike other [18F]FDOPA precursors, the labelling of this 
precursor showed the highest yields not in DMF but in DMAc. These two solvents are closely 
structurally related. The labelling yield was 75.3 ± 1.6 % after 10 min in DMAc, while in 
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DMF it was 67 ± 4.6 %. Surprisingly, in the other two solvents the yields were also very 
good. After 10 min in DMSO the yield was 56.4 3 ± 2.6 % and in sulfolane slightly higher 
(59 ± 3.1%). The lowest yields (14.4 ± 4.4 %) were obtained in the least polar solvent, i. e. in 
1,2-DME. Very fast kinetics were observed within 5 min. Except for 1,2-DME, the yields 
reached highest values in 5-10 min but in all cases a plateau is reached with slightly lower 
yields at 60 min. 
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Fig. 39. [18F] Labelling of 6-nitropiperonal (20 mg/mL) at 140 °C. Dependence of the 
RCY on the type of solvent (Tab. 49, App. 6). 
 
The effect of precursor concentration was studied in DMF at 140 °C. The concentrations were 
varied from 0.5 up to 50 mg/mL. The results are shown in Fig. 40. In all cases fast kinetics 
and thus highest yields were observed within 5 min. In the case 0.5 mg/mL the yield in 5 min 
was 36.3 ± 7  % but dropped within 1 h to 9.0 ± 0.9 %. The yields with the concentration of 
1 mg/mL and above were all in the range between 58.9 and 67.6 %. The decrease of yield 
within 1 h was also observed with the low concentrations of 1 mg/mL (from 58.9 ± 7.7 % to 
13.5 ± 1.3 %) and with the 5 mg/mL (from 62.0 ± 4.3 % to 35.3 ± 1.1 %). At high 
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concentrations (10-50 mg/mL) the yields did not drop sharply within 1 h. The dependence of 
the RCY on the concentration was not strong hence with 10 and 20 mg/mL almost the same 
highest yields were observed. In addition, with 30 and 50 mg/mL almost the same yields were 
also observed, but they were generally less than with the 10 or the 20 mg/mL. Hence the 
20 mg/mL was the optimum concentration to do the labelling.   
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Fig. 40. [18F] Labelling of 6-nitropiperonal in 1 mL DMF at 140 °C. Dependence of the 
RCY on the concentration of the precursor (Tab. 49, App. 6). 
 
The investigation of the effect of temperature (DMF, 20 mg/mL) also showed discrepancies 
among the results shown here in Fig. 41. At the temperatures between 80 and 180 °C the 
yields were in the range between 60 % and 70 % within 10 min and between 56 % and 64 % 
within 1h. For the labelling process the best temperature seemed to be at 120 °C. For better 
illustration of the effect of temperature, Fig. 42 showed the RCY dependence on temperature 
at all times. By changing temperatures between 80 °C and 100 °C the yield was almost 
constant, but when changing from 100 °C to 120 °C a maximum RCY is reached at all times, 
followed by descending to a valley at 140-160 °C and climbing again to reach another 
maximum at 180 °C. It is noticed also that the yields are directly proportional to the time 
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before 110 °C but inversely proportional after this temperature. Hence, at 110°C the yield is 
independent of the reaction time. 
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Fig. 41. [18F] Labelling of 6-nitropiperonal (20 mg/mL) in DMF. Dependence of the 
RCY on temperature (Tab. 49, App. 6). 
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Fig. 42. [18F] Labelling of 6-nitropiperonal (20 mg/mL) in DMF. Dependence of the 
RCY on temperature (Tab. 49, App. 6). 
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The graph of ln (1-RCY) versus time gave the following rate constants (see Tab. 17) from 
which the graph of ln k versus 1/T (K) gave an activation energy of 5 kJ/mol (Fig. 43). 
Tab. 17. Rate constants (min-1) for the labelling of 6-nitropiperonal at temperatures 
80-140 °C. 
Temp. (°C) k’ (min-1) 
80 0.0924 
100 0.0911 
120 0.1191 
140 0.1109 
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Fig. 43. Plot of ln k versus 1/ T (K) for 6-nitropiperonal. (Conditions: 0-10 min, 
80-140 °C). (Tab. 50, App. 6). 
 
3.5.7 6-Bromopiperonal: Reaction Parameters for the 18F Labelling 
 
CHO
O
O
Br  
(9b) 
 
Until now this precursor was not described in literature. In general, labelling of this precursor 
gave by-product which decreased the yields significantly. The yield of the by-product was 
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twice that of the labelled precursor. This by-product could have the ring-opened structure. 
The investigation of 18F labelling of this precursor in DMF (the best solvent) at temperatures 
80-180 °C is shown in Fig 44. The labelling yields were generally in the range between 6 % 
and 12 %. A general increase of yield was noticed with increasing temperatures up to 140 °C. 
After that the yields did not improve. In most cases the yields reached a maximum within 
30 min after which we got a plateau.  
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Fig. 44. [18F] Labelling of 6-Bromopiperonal (20 mg/mL) in DMF. Dependence of the RCY 
on temperature (Tab. 51, App. 7) 
 
 
 
3.5.8 6-Chloropiperonal: Reaction Parameters for the 18F Labelling 
 
CHO
O
O
Cl  
(9c) 
 
Until now this precursor was not described in literature. In general, labelling of this precursor 
gave in all cases a by-product which decreased the yield. The yield of the by-product was in 
most cases double that of the labelled precursor. The investigation of 18F labelling of this 
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precursor in DMF (in this work usually a very good solvent for labelling) at different 
temperatures is shown in Fig. 45. The labelling yields were low, generally between 4 % and 
12 % and they increased with increasing temperature. In most cases the yields reached 
a maximum within 10 min and did not change significantly thereafter.    
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Fig. 45. [18F] Labelling of 6-chloropiperonal (20 mg/mL) in DMF. Dependence of the 
RCY on temperature (Tab. 52, App. 8). 
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3.6     Aromatic Nucleophilic Substitution by [18F]Fluoride on Precursors 
for Path B of [18F]FDOPA  
 
 
3.6.1 Synthesis of Precursors and Standards  
To overcome some disadvantages encountered in path (A) (see Chpt. 2), like many steps 
involved (4-5) and the high enantiomeric purity required, a second path (B) is proposed, 
which utilizes a ready-to-label and protected [18F]FDOPA precursor (Chpt. 2, Fig. 8). In order 
to study this path systematically and to evaluate it, simple model precursors were chosen. 
These were mainly derivatives of the following four structures or their different isomers, as 
shown in Fig. 46. 
Fig. 46. General structure of model compounds used to study and evaluate the 
production of [18F]FDOPA via path (B). 
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X, Y, Z: NO2, Br, Cl, F, H 
R', R'': protection of the hydroxyl group [ethers (open or cyclic), carbonic esters 
(open), sulfonic esters (open)] 
 
Most of these precursors were synthesised directly from substituted benzaldehydes by 
halogenation or nitration. They however, can be prepared by the appropriate protection of 
substituted bromo or nitro phenols. The most important commercially available starting 
compounds are vanillin, o-vanillin, 2,3-dimethoxybenzaldehyde, 2,4-dimethoxybenzaldehyde, 
2,5-dimethoxybenzaldehyde, 3,5-dimethoxybenzaldehyde and 4-fluoroveratrole. The 
following figures show general schemes used for the synthesis of precursors. For details of 
experimental procedures see chapter 4.  
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The three compounds 4-acetoxy-2-bromo-5-methoxybenzaldehyde (6), 4-benzoyloxy-2-
bromo-5-methoxybenzaldehyde (8a) and 2-bromo-5-methoxybenzaldehyde-4-benzene 
sulfonate (8b) were prepared by acetylation of vanillin (4), bromination (5) then subsequent 
hydrolysis of the acetoxy group (6). This is followed by protection with the desired group. On 
the other hand, bromination of vanillin gave the 5-bromo derivative (7b) from which two 
precursors were prepared (8c, 8d) (Fig. 47). 
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(8)  
Fig. 47. Scheme for the synthesis of derivatives of 2- and 
3-bromo-4,5-dihydroxybenzaldehyde as precursors for path A of 
[18F]FDOPA. 
 
Fig. 48 shows the scheme for the preparation of the derivatives of 6-bromo-2-hydroxy-3-
methoxybenzaldehyde (compounds 13, 15a and 15b) [55]. 
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Fig. 48. Scheme for the synthesis of derivatives of 6-bromo-2-hydroxy-3-methoxy 
benzaldehyde as precursors for path B of  [18F]FDOPA 
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Fig. 49 shows the scheme for the preparation of the derivatives of 4 and 6-nitro-2-hydroxy-3-
methoxybenzaldehyde  (17a), (17b), (19a), (19b) and (19c)[56]. 
 
CHO
OH
OMe
CHO
OSO2Ph
OMe
CHO
OSO2Ph
OMe
O2N
CHO
OH
OMe
O2N
CHO
O-G
OMe
O2N
CHO
OSO2Ph
OMe
NO2
CHO
OH
OMe
NO2
CHO
OMe
NO2
OMe
(16)
(19)
(17a, 75 %)(11)
(18)
(19a) G= CH3
(19b) G= COCH3
(19c) G= COPh
(17b, 25 %) (20) (21)
(16)(11)
 
Fig. 49. Scheme for the synthesis of  derivatives of 4- and 6-nitro-2-hydroxy-3-
methoxybenzaldehyde as precursors for path B of [18F]FDOPA 
 
The reaction of 2,3-dimethoxybenzaldehyde (22) with NBS and NCS afforded the 6-bromo 
(23a) and 6-chloro (23b) derivatives, respectively, while the direct bromination or nitration 
gave the 5-bromo (24a) and the 5-nitro (24b)derivatives, respectively (Fig. 50). 
CHO
OMe
OMe
CHO
OMe
OMeX
CHO
OMe
OMe
G
NXS
(22)
(24a) G= Br
(24b) G= NO2
X= Br, Cl
(24)
(23)
(23a) X= Br
(23b) X= Cl
 
Fig. 50. Scheme for the synthesis of 5- and 6-substituted derivatives of 
2,3-dimethoxybenzaldehyde as precursors for path B of [18F]FDOPA. 
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Direct bromination of 2,4-dimethoxybenzaldehyde (25) gave the 5-bromo derivative (26) 
while for 2,5-dimethoxybenzaldehyde (27) it gave the 4-bromo derivative (28) (Fig. 51) 
CHO
OMe
OMe
CHO
OMe
OMe
Br
(25) (26)  
CHO
OMe
MeO
CHO
OMe
Br
MeO
(27) (28)  
Fig. 51. Scheme for the synthesis of 5-bromo-2,4-dimethoxybenzaldehyde and 
4-bromo-2,5-dimethoxybenzaldehyde as precursors for path B of 
[18F]FDOPA. 
 
For derivatives with substituents at positions 5 and 6 the starting is either 2-acetoxy-3-
methoxy benzaldehyde (12) or 2,3-dimethoxybenzaldehyde (22). Harsh bromination of (12) 
gave directly 2,3-dibromo-6-hydroxy-5-methoxybenzaldehyde (29) from which a number of 
OH-protected derivatives (30) were prepared (Fig. 52). 
 
CHO
OAc
OMe
CHO
OH
OMe
Br
Br
CHO
O-G
OMe
Br
Br
(12) (29) (30)
(30a) G= CH3
(30b) G= COCH3
(30c) G= COPh
(30d)  G= SO2Ph
 
 
Fig. 52. Scheme for the synthesis of derivatives of 2,3-dibromo-6-hydroxy 
-5-methoxybenzaldehyde as precursors for path B of [18F]FDOPA. 
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Bromination (bromine in acetic acid) of 2,3-dimethoxybenzaldehyde afforded the 5-bromo 
derivative (24a), which upon nitration gave 3-bromo-5,6-dimethoxy-2-nitrobenzaldehyde (31) 
(Fig. 53). 
CHO
OMeBr
OMe
CHO
OMeBr
OMeO2N
(24a) (31)  
 
Fig. 53. Scheme for the synthesis of 3-bromo-5,6-dimethoxy-2-nitrobenzaldehyde as 
precursor for path B of [18F]FDOPA. 
 
The reaction of (14) with BBr3 gave the dihydroxy compound (32) which upon protection 
with dibromomethane gave the 2,3-methylenedioxybenzaldehyde precursor (33) (the isomer 
of 6-bromopiepronal) (Fig. 54): 
 
CHO
OMe
OHBr
CHO
OH
OHBr
CHO
Br
O
O
(14) (32) (33)  
Fig. 54. Scheme for the synthesis of 6-bromo-2,3-methylenedioxybenzaldehyde as 
precursor for path B of [18F]FDOPA. 
 
Nitration of 3,5-dimethoxybenzaldehyde (34) gave the corresponding 2-nitro derivative (35) 
(Fig. 55) 
CHO
OMeMeO
CHO
MeO OMe
NO2
(34) (35)  
Fig. 55. Scheme for the  synthesis of 3,5-dimethoxy-2-nitrobenzaldehyde as 
precursor for path B of [18F]FDOPA. 
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Nitration or bromination (NBS) of 3,4-ethylenedioxybenzaldehyde (36) gave the 2-nitro (37a) 
and the 2-bromo (37b)derivatives (Fig. 56). 
O
O
CHO
O
O
CHO
NO2
O
O
CHO
Br
(36)
(37a)
(37b)  
 
Fig. 56. Scheme for the synthesis of 2-nitro- and 2-bromo-4,5-ethylenedioxy 
benzaldehyde as precursors for path B of [18F]FDOPA. 
 
Because of the difficulty in obtaining all the fluorine standards for this path, some of these 
standards are only prepared.  The main pathway for the synthesis of these standards (Fig. 57) 
starts from 4-fluoroveratraole (38) [57]. After lithiation and formylation, the standard (39) is 
obtained. Other standards (41a-c) are obtained following deprotection of the methoxy ortho to 
the aldehyde and then the proper protection of the hydroxyl is introduced.   
OMe
OMe
F OMe
OMe
F
CHO
OH
OMe
F
CHO
O-G
OMe
F
CHO
(38) (40)(39)
(41)
(41a) G= COCH3
(41b) G= COPh
(41c) G= SO2Ph
 
 
Fig. 57. Scheme for the synthesis of 6-fluoro-2-hydroxy-3-methoxybenzaldehyde and 
derivatives as standards for path B of [18F]FDOPA. 
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3.6.2 2,3-Dimethoxy-6-nitrobenzaldehyde as an Important Model Precursor for Path 
B of [18F]FDOPA: Reaction Parameters and Activation Energy Calculation for 
the 18F Labelling 
 
This precursor was chosen for full investigation of the kinetics of labelling with 18F because 
of the stability of the protection of the hydroxyl groups as ethers and also because the nitro 
group is much better than halogens as a leaving group in fluorination reactions. The detailed 
investigation of the kinetics of  18F labelling of this precursor showed the following results. 
The 18F labelling was performed in DMF, DMAc, DMSO, benzonitrile and sulfolane 
(Fig. 58). In general the labelling of most precursors here was best achieved in DMF. 
A maximum RCY of  28-30 % can be obtained using 20 mg/ml within 30 min at 140-150 °C. 
The labelling yields in  DMAc, DMSO, and benzonitrile were in the range 15-20 % and in 
sulfolane less than 10 %. The results are shown in Fig. 38. A second by-product was always 
observed which had an Rf value close to that of the product. Thus, the activity was always 
distributed between the standard [18F]fluoro product and the second compound. The yield of 
the second unknown compound was between 10 % and 20 %, hence the total incorporation of 
the activity was 30 % to 50 %.  
 
 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
 
79
 
 
0 10 20 30 40 50 60 70
0
5
10
15
20
25
30
35
benzonitrile
Sulfolane
DMSO
DMAc
DMF
R
C
Y 
(%
)
Time (min)
 
 
 
Fig. 58. [18F] Labelling of 2,3-dimethoxy-6-nitrobenzaldehyde (20 mg/mL) at 140 °C. 
Dependence of the RCY on the type of solvent (Tab. 53, App. 9). 
 
 
The temperature dependence for the [18F] labelling of this precursor was studied in DMF at 
temperatures 80-150 °C. The results are shown in Fig. 59. A strong dependence on 
temperature was observed. Thus with higher temperatures higher yields were obtained. It was 
observed that the by-product was dominating in low temperatures but at higher temperatures 
it was relatively unstable and gave lower yields.  
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Fig. 59. [18F] Labelling of 2,3-dimethoxy-6-nitrobenzaldehyde (20 mg/mL) in DMF. 
Dependence of the RCY on temperature (Tab. 53, App. 9). 
 
 
 
By drawing the graph of ln (1-RCY) vs time, the rate constants as shown in Tab. 18 were 
obtained and an activation energy of  34 kJ/mol was calculated (Fig. 60). 
Tab. 18. Rate constants (min-1) for the labelling of 2,3-dimethoxy-6-nitro 
benzaldehyde at temperatures 80-150 °C. 
Temp. (°C) k’ (min-1) 
80 0.0051 
100 0.0118 
120 0.0185 
130 0.0226 
140 0.0331 
150 0.0336 
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0,0023 0,0024 0,0025 0,0026 0,0027 0,0028 0,0029
-5,5
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ln
 k
1 / T (K)
 
Fig. 60. Plot of ln k versus 1/T (K) for 2,3-dimethoxy-6-nitrobenzaldehyde 
(Conditions: 0-10 min, 80-150 °C) (Tab. 54, App. 9). 
 
3.6.3 Precursors with Halogens as Leaving  Groups 
Tab. 19 shows the results of [18F] labelling of haloaryl precursors and their isomers for path B 
of [18F]FDOPA. These precursors were prepared by reactions illustrated in schemes shown in 
Fig. 5, 7, 8, 9, 11 and 12. Bromine was used mainly because it is easily introduced into the 
aromatic ring by a variety of ways. Experimental procedures described in details are found in 
chapter 4.  
The labelling reactions were performed at the usual optimum conditions found for other 
precursors of [18F]FDOPA. In general, the labelling yields ranged from 1 % up to 56 %. The 
reason is that the halogens (except for F) have less ability as leaving groups than others like 
NO2 or NMe3OTf. The stability of the protection group of the hydroxyl plays also important 
role. In case of protection as ethers such as the methoxy groups, the protection is very stable 
against the labelling conditions, hence the highest yields were found between 11 % and 56 %. 
The stability is lower for other types of protection like the esters and the yields tend to be 
lower (2.5-12 %). Bromine was better as a leaving group than chlorine which is the reverse 
case in the 6-haloveratraldehydes.     
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Tab. 19. [18F] Labelling of haloaryl systems for path (B) of [18F]FDOPA. (Unless 
otherwise stated, the conditions are: DMF, 150 °C, 10 mg/mL, 30 min). 
No Structure Comp. R1 R2 R3 RCY (%) Notes 
1 (39) CH3 F H 71.6 with standard 
2 (23a) CH3 Br H 18.9 with standard 
3 (30a) CH3 Br Br 13.0 assigned product 
4 (23b) CH3 Cl H 11.0 10 min, with standard 
5 (13) COCH3 Br H 2.5  120 °C, assigned product 
6 (15a) COPh Br H 4.6 assigned product 
7 (30b) COCH3 Br Br 10.6 assigned product 
8 (30c) COPh Br Br 13.7 assigned product 
9 
R2
R3
O
CHO
R1
OMe  
(24a) CH3 H Br 1.9 assigned product 
10 (2d) CH3 Br - 42.3 with standard 
11 (6) COCH3 Br - 2.5 assigned product 
12 
R2
CHO
OMe
O R1  (8a) COPh Br - 0 assigned product 
13 (8c) CH3 Br  2.2 assigned product 
14 
CHO
OMe
O R1
R2
 
(8d) COPh Br  7.9 assigned product 
15 
CHO
Br
OMe
MeO
 
(28) - 22.2 assigned product 
16 
CHO
OMe
Br
OMe  
(26) - 1.0 assigned product 
17 
O
O
CHO
Br  
(37b) - 9.4 ± 0.7 assigned product 
18 
Br
O
O
CHO
 
(33) - 33.5 ± 2.8 assigned product 
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3.6.4 Precursors with Nitro as A leaving  Group 
Using the nitro derivatives, the yields were better as shown in Tab. 20 . In general, the yields 
were in the range 25-90 % when the aldehyde is the only group ortho to the nitro. When two 
groups are both ortho to the aldehyde group, the yields are not high. Also when the aldehyde 
group is  meta to the nitro, the yields were very low (< 5 %).  
Tab. 20. [18F] Labelling of nitro-aryl systems for path B of [18F]FDOPA. (Unless
otherwise stated, the conditions are: DMF, 150 °C, 10 mg/mL, 30 min) 
No Structure Comp. R1 R2 R3 R4 RCY (%) Notes 
1 (19a) OCH3 NO2 H H 30.5 with standard 
2 (31) OCH3 NO2 Br H 18.4 assigned product 
3 (19b) OCOCH3 NO2 H H 24.5 30 min, 150 °C,  assigned product 
4 (19c) OCOPh NO2 H H 28.0 5 min 
5 (24b) OCH3 H NO2 H 4.5 with standard 
6 
R3
R1
CHO
OMe
R2
R4  
(21) OCH3 H H NO2 60.4 assigned product 
7 
CH O
O Me
O Me
N O2
 
(42h) - 89.8 
prepared by 
nitration of  
(42d) 
8 
NO2
O
O
CHO  
(9a) - 67.0 results in section 3.5.7 
9 
NO2
CHO
O
O  
(37a) - 66.4 [lit.[38] 0] 
prepared by 
nitration of  
(36) 
 
 
3.6.5 Benzenesulfonate Systems 
The common protections of phenols include carbonic ethers (ROR), carboxylic esters 
(ROCOR’, ROCOAr) and sulfonic asters (ROSO2R, ROSO2Ar). An attempt to carry out [18F] 
labelling of phenolic precursors protected with the benzenesulfonate group, i. e. OSO2Ph 
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resulted in an attack on the sulphur atom instead of the carbon holding the leaving group. The 
result was most likely always [18F]benzenesulfonylfluoride which is reported for the first time 
in this study. The fast attack of the strong 18F- nucleophile on the protection group (which is 
unstable in basic conditions) cleaves it readily. Within 5 min the RCY is 81-89 %. In the 
following, Tab. 21 gives the results of 18F labelling of some benzenesulfonates. 
 
Tab. 21. [18F] Labelling of benzenesulfonate systems for path B of [18F]FDOPA. 
(conditions: DMF, 150 °C, 10 mg/mL, 5 min). 
OSO2Ph
R1R2
R5R4
R3 PhSO2 F
18 ArO
(42)
(43)
+ -
 
No code R1 R2 R3 R4 R5 RCY (%) PhSO218F 
Notes 
1 (42a) H H H H H 81.0 
2 (42b) CHO H H H H 84.7 
3 (42c) H H CHO H H 85.2 
4 (16) CHO H H H OCH3 82.1 
5 (42d) OCH3 H CHO H H 83.2 
6 (8b) OCH3 H CHO Br H 87.3 
7 (42e) OCH3 NO2 CHO H H 88.6 
8 (15b) CHO Br H H OCH3 86.2 
9 (30d) CHO Br Br H OCH3 84.6 
10 (17a) CHO NO2 H H OCH3 85.0 
11 (17b) CHO H H NO2 OCH3 82.0 
12 (42f) OSO2Ph H NO2 H H 87.0 
13 (42g) OSO2Ph H NO2 CH3 H 81.0 
Standard product is 
detected by 
comparison in TLC 
and HPLC with 
authentic 19F sample. 
No detection of 
halogen or nitro 
substitution  by 
[18F]fluoride 
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3.6.6 Miscellaneous (Other Systems) 
 
In the following, Tab. 22 gives the results of the [18F] labelling of other aryl systems. (see 
chapter 4 for experimental details). Most of these are classified as electron rich aromatic 
compounds. As the results show, the RCY are high for those systems with a very good 
leaving group (like the nitro) and with very stable protection of the hydroxy groups (like the 
methyl ethers). Systems with no activation at all (toward SNAr) and with methyl group on the 
ring or protection of the hydroxyl groups as esters gave very bad yields and sometimes gave 
no yield at all.  
Tab. 22. [18F] Labelling of other aryl systems. (Assigned product. Unless otherwise 
stated, the conditions are: DMF, 150 °C, 10 mg/mL, 20 min, TLC results) 
No Structure Comp. RCY (%) Notes on preparation 
1 
CHO
OMe
OMe
NO2
MeO
 
(45) 68.6 ± 4.5 prepared by direct nitration of 3,4,5-trimethoxybenzaldehyde (44) 
2 
CHO
OMe
OMe
Br
MeO
 
(46) 8.6 ± 0.8 prepared by direct bromination of 3,4,5-trimethoxybenzaldehyde (44) 
3 
CHO
OMe
OMe
OMeO2N
 
(48) 66.2 ± 4.2 prepared by nitration of 2,3,4-trimethoxybenzaldehyde (47) 
4 
OMe
OO
OMeO2N
Br  
(49) 22.1 ± 0.2 prepared by the protection of the aldehyde group in compound (31) 
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Tab. 22. Continued 
5 
OMe
OO
OMeO2N
 
(50) 3.0  prepared by the protection of the aldehyde group in compound (19a) 
6 
OCOPh
OCOPh
O2N
 
(52) 1.0  
prepared by protection of the two OH’s 
in of 4-nitrocatechol (51) as benzoate 
esters 
7 
CH3
O2N
OMe
OMe  
(55a) 0 
8 
CH3 OCOPh
OCOPhO2N  
(55b) 0 
9 
CH3 OCOCH3
OCOCH3O2N  
(55c) 0 
prepared by nitration of 4-
methylcatechol (53) . The product (54) 
is then protected (the two OH’s) as 
arylmethyl ether (55a), benzoate (55b) 
or acetate (55c) esters 
 
10 
O2N O
O  
(57) 0 prepared by nitration of 1,3-benzodioxole (56) 
11 
O2N O
OCH3  
(59) 0 prepared by nitration of 3,4-methylenedioxytoluene (59) 
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3.7 General Discussion 
3.7.1 Structural Effects 
The discussion of the structural effects in the labelling by [18F]fluoride can be divided into 
four main categories according to the types and positions of the groups on the aromatic ring 
(whether these are electron donating, electron withdrawing, leaving or protecting groups). In 
the following sections, these types of structural effects are discussed in detail depending on 
the experimental results. It is assumed that the factor under investigation is the only one 
operating in every case and that all other factors or variables are constant (whether controlled 
such as temperature and concentration or uncontrolled such as quality of fluoride or 
impurities up to 5 % in the precursor sample). To overcome the problem of uncertainty, each 
value reported here is assumed to be repeated at least 4 times (n > 3). 
 
3.7.1.1 Positions of Different Groups on the Aromatic Ring 
One can get a better idea about this factor if we consider different isomers of the same 
compound labelled with [18F]fluoride under the same conditions. In the following, Tab. 23 
gives an idea of how the different positions of the same groups on the ring can affect the 
RCY. As it is expected, the labelling yields will be high if a good electron withdrawing group 
(EWG) is ortho or para to a good leaving group (LG) (in some cases where only two meta 
EWGs existed on the ring, the RCY also was good)[40]. The intermediate Meisenheimer 
complex is highly stabilised in this case by several resonance structures in which the 
particular EWG present can stabilise the negative charge.  
In case of the existence of one or two more EDGs on the ring the RCYs can still be very good 
if again a good EWG is ortho or para to a good LG. The ortho effect here is much more 
effective than the para. For entry 1 in Tab. 23 we see the lowest yield (4.5 %) in case of 
compound (1-a). The activation towards nucleophilic aromatic substitution (SNAr) is very 
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week here because the aldehyde is meta to the nitro, while two methoxy groups are present, 
one of them is para to the nitro.  
In compound (1-b) the yield is improved up to 16.6 % although the methoxy groups are now 
both ortho and para to the nitro. The reason for this is that the aldehyde is ortho to the nitro 
which means strong activation.  
A much better situation is present in case of compound (1-c) where we also have strong 
activation by an ortho aldehyde group. Only one methoxy group is para to the nitro (weak 
deactivation). A possible explanation is that the aldehyde group adopt a conformation in 
which it is perpendicular to the plane of the aromatic ring, i.e. the dihedral angle = 90°[96]. 
This was confirmed by X-ray structure analysis (Fig. 61, App. 9). This means the aldehyde 
group is less effective in stabilising the negative charge of the Meisenheimer complex, hence 
the yield would be low[93].  
 
Fig. 61. X-ray structure of 2,3-dimethoxy-6-nitrobenzaldehyde. 
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In case of compound (1-d) no sterical hindrance exists as in (1-c) and yields are higher. Yet, 
the activation by a para aldehyde group towards the nitro is less effective than in case of the 
ortho isomer. Therefore, the yield is higher than (1-c) but not as high as in (1-e) and (1-f). 
Consequently, the highest yields were obtained with compounds (1-e) and (1-f). In these 
precursors, which gave almost the same RCY, the activation is strong (an aldehyde is ortho to 
the nitro group). In addition, one methoxy is either ortho or para to the leaving group and 
another one is meta which render it inactive. A very important note here is that the aldehyde 
activates very well as the case in the last two compounds if it is not ortho to two other groups 
simultaneously (this means no sterical hindrance).  
A similar discussion also holds for the bromo precursors (Tab. 23, entry 2). Compounds (2-g), 
(2-h) and (2-i) are not activated at all (they gave the lowest yields between 1.0 % and 2.2 %) 
because  the aldehyde here is meta to the bromine while strong EDGs (two methoxy groups) 
are either ortho or para. In compound (2-j) the activation is better (an aldehyde is ortho to the 
bromine) and the yields (19 %) are better (although still low because the two methoxy groups 
are ortho and para to the bromine) . In compound (2-k) the yields (22.2 %) were still better 
(but still not very high because the aldehyde is ortho to two other groups (the same case as in 
the nitro analogue). Again the highest yields were obtained with structure (2-l) where the 
aldehyde is ortho to the leaving group (high activation) and  only one methoxy is para (low 
deactivation) to the leaving group. 
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Tab. 23. Structural effects in the labelling by [18F]fluoride. (A) Effect of different 
positions of the same groups (isomeric precursors) on the aromatic ring 
listed in order of increasing RCY. (Conditions: DMF, 20 mg/mL, 
140-150 °C, 20 min, results of TLC analyses). 
No Isomers / RCY (%) ± Sdv 
MeO
MeO
CHO
NO2  
 (a)  4.5 ± 0.8 
OMe
MeO
NO2
CHO  
(b) 16.6 ± 1.3 
MeO
MeO
CHO
NO2
 
(c) 30.5 ± 3.4 
1 
 
OMe
OMe
CHO
NO2  
(d) 60.4 ± 2.0 
OMe
OMe
CHO
NO2
 
(e) 89.8 ± 0.7 
MeO
MeO
CHO
NO2  
 
(f) 89.7 ± 2.0 
MeO
CHO
Br
OMe  
(g) 1.0 ± 0.3 
MeO
MeO
CHO
Br  
(h) 1.9 ± 0.5 
MeO
CHO
OMe
Br
 
(i) 2.2 ± 0.4  
2 
 
MeO
MeO
CHO
Br
 
(j) 19 ± 2.6 
MeO
Br
CHO
OMe  
(k) 22.2 ± 3.4 
MeO
MeO
CHO
Br  
(l)  42.3 ± 4.0 
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3.7.1.2 Type of Leaving Group 
In this work four types of leaving groups were used to investigate the labelling by 
[18F]fluoride. Those are NO2–, F–, Br– and Cl–. Except for some cases the order of leaving 
group ability followed the expected order[40] , i.e.  
NO2  ≈  F  >  Br  >  Cl  
[18F]fluorodenitration reactions and the fluorine isotopic exchange  (18F for 19F) gave the 
highest yields (all other variables are the same) indicating that the two groups NO2– and  F– 
are among the best leaving groups for the nucleophilic aromatic substitution by [18F]fluoride. 
To a smaller extent, the other halogens were used as leaving groups. The yields of Cl– or Br– 
substitution were lower than in case of NO2 or F. The relative order of the leaving group 
ability of  the bromine or the chlorine was not always the same. In most cases bromine was 
better leaving group. Tab. 24 illustrates the effect of the leaving group on the RCY by 
[18F]fluoride.  
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Tab. 24. Structural effects in the labelling by [18F]fluoride.  
(B) Type of leaving group (LG) 
(conditions: DMF, 150 °C, 20 mg/mL, 30 min, results of TLC analyses) 
LG / RCY (%) ± Sdv 
No Structure 
NO2 F Br Cl 
1 
MeO
CHO
LGMeO
 
30.5 ± 2.3 73.6 ± 4.6 19.3 ± 3.1 12.1 ± 2.0 
2 
MeO LG
CHOMeO
 
89.6 ± 1.4 87.7 ± 1.2 42.3 ± 3.9 56.4 ± 7.1 
3 
LG
CHO
 
73.2 ± 0.2 75.0 ± 1.6 73.0 ± 0.2 65.0 ± 1.1 
4 OHC LG
 
81.5 ± 5.9 78.3 ± 0.5 75.7 ± 0.5 65.7 ± 3.3 
5 
LG
COCH3
 
13.3 ± 0.9 70.1 ± 1.3 39.3 ± 2.9 37.7 ± 5.4  
6 LG
O
CH3  
61.7 ± 3.9 74.7 ± 4.5 35.3 ± 1.7 59.0 ± 3.6 
7 LG
O
Ph  
86.8 ± 4.8 83.3 ± 3.0 76.0 ± 2.6 70.7 ± 4.5 
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3.7.1.3 Type of Activation (Type of Electron Withdrawing Group EWG) 
 
The type of the EWG has a great effect on the RCY in the labelling by [18F]fluoride as in 
other types of nucleophilic substitutions. This effect can be studied systematically by 
changing the EWG in a defined aromatic system. This group should not contain free OH 
groups (as the case in COOH) in order to avoid solvation effects on the [18F]fluoride ion. 
Tab. 25 compares the results. The compounds are nitro or bromo derivatives of benzene, 
benzaldehyde, acetophenone and benzophenone (ortho or para). The RCYs indicated that the 
approximate order of electron withdrawing ability of different groups in the nucleophilic 
aromatic substitution by [18F]fluoride is the following: 
 
COPh ≈ NO2 > CHO > COCH3        (solvent: DMF, leaving group: NO2) 
 
The results showed that the groups COPh and  NO2 are powerful in the electron withdrawal 
effect (RCY were in the range 76-87 % in case of NO2 also as a leaving group). Smaller effect 
was found for the aldehyde group (RCY= 73-81 %), and it was smaller for the COCH3 group 
(RCY= 13-61 %). Using fluorine or bromine as leaving groups the situation is changed, and 
the order is: 
 
COPh ≈ CHO > NO2 > COCH3 > Br        (solvent: DMF, leaving groups: F, Br) 
 
In both cases the para effect of the EWG was more powerful than the ortho effect, and this 
was the reverse case with the electron-rich [18F]DOPA precursors. One group, which has the 
ability to act as a temporary EWG on the ring then can be removed afterwards, is the 
aldehyde. Hence, it is used in some applications to enhance the nucleophilic aromatic 
substitution by [18F]fluoride. It is removed afterwards catalytically [using the complex 
Rh(PPh3)3Cl]. 
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Tab. 25. Structural effects in the labelling by [18F]fluoride.  
(C) Type of activation by EWGs (EWG and not a leaving group). (Unless 
otherwise stated, the conditions are: DMF, 150 °C, 20 mg/mL, 20 min. 
Results of TLC analyses).  
EWG / RCY (%) ± Sdv 
Structure 
Br NO2 CHO COCH3 COPh 
EWG
NO2  
- 81.6 ±  5.4 73.2 ± 0.2 13.3 ± 1.0 78.7 ± 1.9 
EWG
O2N  
- 87.0 ± 2.1 81.5 ± 5.9 61.7 ± 3.9 86.8 ± 4.8 
EWG
Br  
10.9 ± 0.5 58.4 ±  9.1 73.0 ± 0.2 39.3 ± 2.9 - 
EWG
Br  
6.1 ±  2.9 66.7 ±  5.7 75.7 ± 0.5 35.3 ± 1.7 76.0 ± 2.6 
EWG
F  
- - 75 ± 1.6 70.1 ± 1.3 91.2 ± 1.0 
EWG
F  
- - 78.3 ± 0.5 74.7 ± 1.2 83.3 ± 3.0 
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3.7.1.4 Type of Protection of the Hydroxyl Group[58]. 
Protection of the hydroxyl group is necessary in the labelling by [18F]fluoride. If strong 
hydrogen bonding is formed between free OH or NH2 groups (present in the precursor, in 
traces of water in the solvent, in the solvent itself or even impurities present in the solution) 
and the fluoride ion, the nucleophilicity of the fluoride is reduced very much. In this case it 
becomes inactive in the nucleophilic fluorination reactions. This effect is a serious problem in 
case of 18F relative to 19F because in case of 18F this radiotracer is present in very small 
concentration in the solution.   
The protection of the hydroxyl group must be very stable against the labelling conditions 
(temperature:100-180 °C, pH: 8-10). In addition it should be stable against the conditions and 
reagents used in others steps if it is to be employed in the total synthesis of [18F]FDOPA. 
However, very few OH-protecting groups exist which sustain the labelling conditions. In 
choosing the specific protecting group there is a compromise. The protection should sustain 
the labelling and the subsequent conditions but it should be relatively easy to deprotect at the 
last step. Protection as ethers is very practical because it is relatively stable in all steps 
however, the deprotection needs drastic conditions (HI conc., 150 °C). On the other hand the 
protection as esters (carbonic, sulfonic, ...etc) is relatively easy and the deprotection is also 
easy, but they are relatively unstable towards the labelling and most of the subsequent steps. 
This is variable among different groups. Table 26 shows the effect of the labelling conditions 
on some common protection groups of the phenolic OH groups. We notice that the methyl 
ethers, aryl methanesulfonates and methylenedioxy derivatives are stable against all 
conditions. The acetates were unstable in most cases except in neutral conditions and high 
temperatures. The benzoates are stable in most cases but shows marginal stability against high 
pH and the use of K2CO3 / X−.  
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In this study the acetates were the least stable groups, providing several spots after labelling. 
The benzoates were more stable. The benzene sulfonates were the least stable and the 
sulfonate group is rapidly attacked by the strong nucleophile 18F− to provide the unwanted 
product PhSO218F. This finding is surprising because Tab. 26 shows the methanesulfonates to 
be stable under most conditions. However, in case of the benzene sulfonates the presence of 
the aromatic ring on both sides of the protecting group provides stability of the intermediates 
by conjugation with the ring, hence the attack of the fluoride on the protecting group is 
favoured (unlike in case of the methanesulfonates). 
Tab. 26. Stability of some phenolic OH groups against common labelling conditions 
by [18F]fluoride[58]. 
Type of OH protection pH 8.5-10 
pH 
10-12 
Nucleophilic *
X− 
Temp. ** 
100-250 °C 
K2CO3 
MeI 
Methyl ethers S S S S S 
Acetates US US S S US 
Benzoates S MS S S MS 
Aryl methanesulfonates S S S S S 
Methylenedioxy derivatives S S S S S 
 
Notes: 
1- S: protective group is stable under the reaction conditions. 
2- US: protective group is unstable under the reaction conditions and it is removed to yield 
the original OH group. 
3- MS: marginal stability. Depends on the exact other conditions of the reaction. 
4- *) Nature of X− is not specified. 
5- **) Neutral conditions: pH ≈ 7 
 
 
Tab 27 shows the structural effect played by protection of the OH group on the RCY by 
[18F]fluoride. In most the results cases fit generally with the expectations. The highest yields 
were obtained with the methyl ethers since they are the most stable. With respect to the esters, 
the benzoates gave higher yields than the acetates (in most cases the benzoates gave one or 
two spots, unlike the acetates which gave always several spots). In case of two ortho OH 
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groups the protection can be open or cyclic (Tab. 26, entry 5). It was found that best results 
were obtained with the open protection. The difference in the RCY from 89 % in the open 
structure to 66-68 % in the cyclic structures (five and six membered rings) suggests possibly 
that side reactions involving opening of the protection ring occurred with the labelling 
reaction which lowered the yields finally. The stability of open ethers is higher than cyclic 
ethers and this is supported by the fact that the deprotection occurs much faster and smoother 
in cyclic ethers than in open ethers. Finally, the protection of the catechols as five or six 
membered rings (cyclic ethers) seems not to affect the fluorodenitration or the 
fluorodehalogenation reactions on the aromatic ring.  This can be seen in table 27, entries 6 
and 7. The RCYs are very close (67.6 and 66.4 %) in case of fluorodenitration reactions on 
five and the six membered rings, respectively. The same holds for the fluorodehalogenation 
reactions where we got a RCY of 10.7 % and 9.4 % in case of the five and six membered 
rings, respectively. An exception was the results obtained from 6-bromo-2,3-dimethoxy 
benzaldehyde (entry 2, open protection) and 6-bromo-2,3-methylenedioxybenzaldehyde 
(entry 6, cyclic 5 membered ring protection) where we have better results from the cyclic 
structure. From this we can conclude that catecholic (2 o-OHs) precursors protected as cyclic 
ethers (five or six membered rings) will mostly give lower RCYs in the labelling by 
[18F]fluoride than open ethers. Moreover, the size of the protection ring has practically no 
effect on the RCY. Only five or six membered rings were tested because they are the easiest 
to prepare and deprotect back to the OH function.  
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Tab. 27. Structural effects in the labelling by [18F]fluoride.  
(D) Protection of two ortho OH groups (G is a protective group). 
 (conditions: DMF, 150 °C, 20 mg/mL, 20 min, results of TLC analyses) 
Open similar or different protection of two OH groups  
Type of protective group G / RCY (%) ± Sdv 
No. Precursor  structure CH3 
(methyl ethers) 
COCH3 
(acetates) 
COPh 
(benzoates) 
1 
MeO
CHO
NO2OG
 
30.5 ± 3.4 24.5 ± 2.4 28.0 ± 2.9 
2 
MeO
O
CHO
BrG
 
18.9 ± 2.6 2.5 ± 0.8 4.6 ± 1.2 
3 
MeO
O
CHO
Br
Br
G
 
13.0 ± 3.2 10.6 ± 2.8 13.7 ± 4.6 
4 
MeO
O Br
CHO
G
 
42.3 ±  4.0 2.5 ± 0.6  0  
5 
NO2
CHOO
O
G
G  
89.7 ± 2.0 - - 
Cyclic (5 or 6 membered ring) protection of the two OH groups 
Precursor 
structure NO2
CHO
O
O
 Br
CHO
O
O
 
Br
O
O
CHO
 
6 
RCY (%) 67.6 ± 5.2  10.9 ± 1.1  33.5 ± 2.7  
Precursor 
structure 
Cl
CHO
O
O
 NO2
CHOO
O  Br
CHOO
O  
7 
RCY (%) 7.1 ± 0.2  66.4 ± 4.7 9.4 ± 0.7 
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3.7.1.5 Other Structural Effects 
One structural effect that can be discussed but carefully is the total number of groups on the 
ring and whether these groups are EDGs or EWGs. Because the total net effect of the 
presence of many groups can not be estimated easily, the results can not always be 
generalised. Tab 28 shows the results. In case of successive increase of EWGs 
(bromobenzene derivatives, entry 2) the effect is high activation towards the nucleophilic 
aromatic substitution as it is expected. In case, however, of successive increase of EDGs 
(mono-, di- and trimethoxylated 2-nitrobenzaldehyde, entry 1) the total effect is surprising 
and it seems that the presence of the methoxy groups has no affect at all or has positive effect. 
Unlike methoxy, the presence of methyl groups on the ring has a negative effect on the 
labelling by [18F]fluoride. This was explained in methyl substituted nitrobenzaldehyde by 
formation of unreactive complex with the [18F]fluoride (perhaps relatively stable 
Meisenheimer complex)[44]. This would transform most of the [18F]fluoride into an unwanted 
product or intermediate. The high RCYs obtained with methoxylated nitrobenzaldehyde is  
one difference between the chemistry of 19F and that of 18F. Beside being very fast and giving 
high yields within few minutes, labelling by [18F]fluoride shows tolerance for the presence of 
even strong EDGs that would otherwise reduce the yields dramatically in 19F nucleophilic 
fluorinations or stop the reaction completely. It should be emphasised that the previous 
discussion holds for precursors with excellent leaving groups such as -NO2. For other 
precursors involving groups with a weaker ability to act as leaving groups, the predicted 
RCYs match with the experimental values (Tab. 28, entry 3). The highest yield (73 %) was 
obtained from o-bromobenzaldehyde. The successive addition of methoxy groups to the ring 
lowers the yields, and this also depends on the number of these groups. 
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Tab. 28. Structural effects in the labelling by [18F]fluoride.  
(E) Total number of groups on the ring. (Unless otherwise stated, the 
conditions are: DMF, 150 °C, 20 mg/mL, 20 min. Results of TLC analyses) 
No. Structure / RCY (%) ± Sdv 
1 
CHO
NO2
 
 
73.2 ± 0.2 
CHO
NO2
OMe  
 
66.7 ± 2.3 
CHO
NO2
OMe
 
 
87.0 ± 1.0 
CHO
NO2
OMe
OMe  
 
89.8 ± 0.7 
CHO
NO2
OMe
OMe
MeO
69.1 ± 4.5 
2 
Br
 
 
0.5 ± 0.1 
Br
Br
  
 
10.9 ± 0.5   
Br
Br  
 
13.3 ± 6.7 
Br
Br  
  
4.3 ± 2.8 
Br
Br
Br
 
 
48.6 ± 10   
Br
BrBr  
 
64.3 ± 6.9 
3 
CHO
Br
 
 
73.0 ± 0.2 
CHO
Br
MeO  
 
31.7 ± 2.5  
CHO
Br
MeO
MeO
 
 
19.0 ± 0.1 
CHO
Br
OMe
OMe
MeO
 
 
8.6 ± 0.7 
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3.7.2 Solvent Effects 
Solvents have generally great effects on most reactions and effects on the aromatic 
fluorination reactions are to be expected[59, 60] . In this study several solvents were used. Those 
mostly are dipolar aprotic solvents in which the fluoride is very soluble and free (not bonded 
to the solvent, which means increased nucleophilicity and basicity). In addition, those 
solvents stabilise the reaction intermediates. Examples are DMF, DMSO, DMAc, sulfolane, 
1,2-DME, NFP, NFM, pyridine, benzonitrile, acetonitrile, dioxane and nitromethane. Tab. 29 
shows the labelling of 6-nitroveratraldehyde (2a) in different solvents: 
Tab. 29. [18F] labelling of 6-nitroveratraldehyde in different solvents. (conditions: 
140 °C, 20 mg/mL, highest yields within10-20 min, results of TLC analyses)
Solvent DMF DMSO DMAc 1,2-DME Sulfolane Pyridine NFP Dioxane
RCY 
(%) 
89.7  
± 2.0 
71.4  
± 3.8 
75.6  
± 2.0 
59.9  
± 5.0 
40.1  
± 1.8 
56.1 
± 7.5 
59.2  
± 5.5 
18.7 
± 3.1 
 
 Most of those solvents have high boiling points and good thermal stabilities. DMF was 
mainly used in this study and it showed to be an excellent solvent for carrying out the 
labelling reactions. In all cases the less polar solvents such as 1,2-DME, dioxane or 
acetonitrile gave very poor results (note: maximum achievable temperature from these 
solvents is ≈110 °C, which appear to be low for the nucleophilic aromatic substitution). The 
choice of solvent depends also on the boiling point. However, for most nucleophilic aromatic 
labelling reactions by [18F]fluoride the range of 120-160 °C was found to be the best. Higher 
temperatures can be used but a general note is that solvent decomposition starts significantly 
around 200 °C (except for sulfolane which has a boiling point of 285 °C). The use of solvents 
with the amide function proved to be the best in this study, especially in two cases: the first is 
the fluorodehalogenation reactions which gave very good yields in DMF but poor results in 
other solvents. The other case is the electron-rich aromatic rings which again gave high yields 
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of labelling in DMF or DMAc but instead much lower yields in the case of DMSO or 
sulfolane. The reaction with the solvent molecules was noticed in the case of nitro methane 
and nitro ethane (Knoevenagel condensation). It should be mentioned that in nucleophilic 
labelling with [18F]fluoride, in literature two solvents used mostly are acetonitrile (for low 
temperatures up to 90 °C) and DMSO (for high temperatures up to 180 °C). 
 
3.7.3 Concentration Effects 
Generally in this work, where the concentration effects are studied in detail, the following 
concentrations were used: 0.5, 1, 5, 10, 20, 30 and 50 mg/mL (a concentration of 20 mg/mL 
was used in case of non-detailed studies). The dependence of the RCY on the precursor-
concentration was strong and investigation of the results showed that the concentration range 
20-30 mg/mL was the optimum range for the optimum RCY[32]. Another note is that at lower 
concentrations, i.e. 0.5-1 mg/mL the RCY tends to decrease rapidly after 20 min but at higher 
concentrations ( > 5 mg/mL) the RCY reaches a plateau which is not much different than the 
maximum yield obtained. In case of fluorodehalogenation reactions were the leaving groups 
are weaker (when related to NO2) the increase of precursor concentration was accompanied 
by increase in the RCY even up to 50 mg/mL. In fluorodenitration and fluorine isotopic 
exchange reactions, where high RCY can be obtained in short time and with low 
concentrations, the effect of increasing the concentrations on the RCY is not high, especially 
after 10 mg/mL. 
 
3.7.4 Temperature Effects 
The dependency of all types of reactions on temperature is well known and expected from the 
Arrhenius equations. In this study the temperature range used mainly is 80-180 °C for most 
compounds but also lower temperatures were used for very activated systems like 
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o-dinitrobenzene. At higher temperatures high amount of decomposition was observed either 
from the precursors and even from the solvent. In general, the optimum temperature range 
found to be the best for the labelling with [18F]fluoride was 140-150 °C although as in 
fluorodehalogenation reactions higher temperatures resulted also in an increase in the RCY. 
For very activated systems like o-dinitrobenzene, higher temperatures (> 120 °C) were found 
to have negatively lowering effect on the RCY.  
 
3.7.5 Energy of Activation  and Mechanistic Implications 
Calculations of the energy of activation [Eact(kJ/mol)] for selected aryl systems revealed the 
following sequence in general: 
fluorine isotopic exchange  <  fluorodenitration reactions  <  fluorodehalogenation reactions 
This is in agreement with the order of leaving group ability. The fluorine isotopic exchange 
should have the least Eact since the exchange here is for isotopes of the same element. 
Fluorodenitration reactions proceed with a lower Eact than fluorodehalogenation reactions 
because the nitro group is much more better than the halogens as a leaving group. The results 
are shown in Tab. 30. 
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Tab. 30. Eact values (kJ/mol) of selected aryl systems used in this work. 
Precursor Eact (kJ/mol) Reaction type 
CHO
F
MeO
MeO  
17 Fluorine isotopic exchange 
CHO
NO2  
24 
O2N COMe
 
32 
CHO
NO2
MeO
MeO
 
33 
MeO
MeO
CHO
NO2
 
36 
Fluorodenitration 
CHO
Br
MeO
MeO  
60 
CHO
Cl
MeO
MeO  
63 
Fluorodehalogenation 
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Tab. 31. Eact (kJ/mol) of selected nucleophilic aromatic substitution reactions. (X is 
substituted by the nucleophile. For details of reactions, see literature). 
No Substrate X Nucleophile Eact (kJ/mol) Lit. 
1 F 50.6 
2 Cl 53.1 
3 Br 56.4 
4 
1-(X)anthraquinones 
I 53.5 
5 F 58.9 
6 Cl 55.6 
7 Br 63.5 
8 
2-(X)anthraquinones 
I 78.2 
97 
9 PhSO 45.1 
10 Br 49.3 
11 Cl 48.5 
12 PhSO2 50.2 
13 p-NO2-C6H4O 43.9 
14 
1-(X)-2,4-dintrobenzene 
I 
Piperidine 
 
N
 
50.2 
98 
 6-(G)-2,4-di-NO2-chlorobenzene 
15 71.9 
16 76.9 
17 75.2 
18 84.0 
19 
        G= Cl 
              Ph 
              H  
              Me 
              MeO 
Cl OMe- 
94.9 
99 
 4-(G)-2-NO2-chlorobenzene 
20 70.2 
21 77.8 
22 84.9 
23 79.8 
24 85.3 
25 
           G= NO2 
                 MeSO2 
                 Me3N+ 
                 CH3CO 
                 CF3 
                 PhN=N 
Cl OMe- 
79.8 
99 
26 
1-Chloro-2,4-dintrobenzene 
(catalysed, under solid-solid-liquid 
phase transfer conditions )  
Cl F- 40.0 100 
27 Fluorobenzene 152.2 
28 2-Nitrofluorobenzene 120.8 
29 3-Nitrofluorobenzene 83.2 
30 4-Nitrofluorobenzene 84.0 
31 2,4-Dinitrofluorobenzene 51.4 
32 3,5-Dinitrofluorobenzene 
F OMe- 
90.7 
101 
 4-(G)-2-NO2-chlorobenzene 
33 96.2 
34 24.0 
35 74.0 
36 
          G= H 
                SMe2 . SO4 
                Sme 
                NMe3+ 
Cl OMe- 
92.8 
102 
37 Bromobenzene Br EtO- 237.0 103 
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Tab. 31 gives selected literature values for the activation energies (nucleophilic aromatic 
substitution reactions) using different substrates and nucleophiles. The activation energies are 
in the range between 40 kJ/mol and 240 kJ/mol with an average value of 75 kJ/mol. In this 
work, all Eact values (which are in the range of 16-62 kJ/mol) are in the low range or partly 
even lower than reported in literature for the nucleophilic aromatic substitution. The reason is 
that those reactions are very fast reactions[95]. The maximum yields are often obtained within 
10 min. Very activated systems like o-dinitrobenzene gave very low Eact (2 kJ/mol), which is 
expected since in these systems the reaction is very fast even at low temperatures. Other 
systems that gave very low Eact was 6-nitropiperonal (9a). For this compound, calculation of 
Eact revealed a value of exactly 5 kJ/mol, which is too low for fluorodenitration reactions. 
The low values of Eact obtained here for the nucleophilic reaction of [18F]fluoride can well be 
understood when compared to literature. An example is the investigation of the gas phase 
reaction between the fluoride ion and nitro benzene[95]. That was studied by FTICR mass 
spectrometry and DFT calculation. The displacement of the nitro group proceeds as an 
unusually fast reaction with a bimolecular rate constant of  k = 3x10-9 cm3molecule-1sec-1, the 
reaction was the following: 
F–    +     C6H5NO2     →     NO2–     +   C6H5F               
According to the DFT calculations the most stable complex between the fluoride ion and the 
nitrobenzene (structure 1) results from a fluoride ion bound loosely to the aromatic hydrogens 
in the para position. 
O2N H F O2N H F+
(1)  
Similar complexes were also formed as local minima for fluoride ions loosely bound to the 
meta and ortho aromatic hydrogens. Furthermore, two different stable complexes could be 
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identified by out-of-plane attack of the fluoride ion to the para and ipso carbon atoms 
(structures 2, 3). 
NO2
HF
F NO2F NO2 O
N
F
H
H O
 
     (2)           (3)  (4)                        (5) 
 
The stable ion molecule adduct (3) with a C-F bond length of 2.24 Å and an outside covalent 
bond proceeds then through a local transition state (4). Finally before the products, an ion 
molecule complex between fluorobenzene and the nitrite ion (5) is obtained. According to 
these calculations the prototype Meisenheimer complex (5) is a transition state and not a local 
minimum (in the gas phase). The energy of this transition state is 52.7 kJ/mol below the 
energy of the reactants (Fig. 62).  
(4)
(3)
(2)
(1)
Progress of reaction
∆ H
(kJ/mol)
(5)
-99.9
-70.6
-52.7
-116.2
-117.9
-159.3
NO2 + C6H5F-
F  + C6H5NO2
-
Fig. 62. Energy profile for the gas phase reaction of fluoride ion with nitrobenzene[95]. 
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The gas phase investigation clearly demonstrates that reaction of fluoride ion with 
nitrobenzene is intrinsically very fast. The fraction of collisions that yields products has been 
estimated to be 69 % which is far more than in most known reactions. 
In contrast to nitrobenzene the Meisenheimer complex between fluorobenzene and fluoride 
ion (4') is found to be a local minimum by theoretical calculations[104]. Again an ion molecule 
complex (1') was found to be lowest in energy. In this case the ion molecule complex (3') 
(where fluoride ion is loosely bound to the ipso carbon) is a transition state. The energy 
profile for the reaction between fluorobenzene and fluoride ion is illustrated in Fig. 63. 
F H F
F FF F
 
(1') (3') (4') 
 
(3')
0
-71.1
Progress of reaction
(1'*)
-9.2
(1')
0
C6H5F* + F'C6H5F +F*
-
∆ H
(kJ/mol)
(4')
-15.5
(3'*)
Fig. 63. Energy profile for the reaction of fluoride ion with fluorobenzene[104]. 
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The minimum energy barrier between the ion molecule complex F–......C6H5F and the transition 
state is 61.9 kJ/mol. For the substitution reaction of nitrobenzene and fluoride ion this value is 
63.5 kJ/mol. With respect to the starting compounds C6H5NO2 and C6H5F negative barriers 
for the overall reaction result (i.e. for C6H5NO2: –52.7 kJ/mol and for C6H5F: –9.2 kJ/mol). 
A negative overall barrier seems to be a paradox at first glance. The solution of this paradox is 
that an ion molecule complex is formed from C6H5X and the fluoride ion which is 
71.1 kJ/mol (X= F) and 116.2 kJ/mol (X= NO2), respectively more stable than the isolated 
reactants C6H5X + F–. The replacement of X– by F– starts from this ion molecule complex. 
Overall, the transition state of the substitution process is placed below the sum of the energies 
for C6H5X and F–., With respect to C6H5X and F– apparently "negative" energies of activation 
results. However, this term should be avoided because the negative barrier for the overall 
process is the result of the exothermic formation of stable ion molecule complex in the gas 
phase prior to the substitution process. 
In solution the PES profile may be modified to some extent. The major changes to be 
expected are strong ion-dipole interactions between the small F– ion and the dipolar solvents 
such as DMF. It seems possible that this stabilises the starting material more than the 
formation of the ion molecule complexes (1, 1'). Thus, it seems unlikely that in aprotic 
dipolar solvents the overall barrier for substitution will be negative (see Fig 64). 
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Progress of reaction
(5)
C6H5X +F (gas)-
∆ H
(1,1')
(3,3')
(4,4')
C6H5X +F (solv)- C6H5F +X (solv)-
 
Fig. 64. Hypothetically PES for the reaction C6H5X + F– in aprotic dipolar solvents. 
(Continuos line: X= F, dotted line: X= NO2. For structures of intermediates, 
see the text). 
 
The high efficiency of the overall process and, thus, the discussed gas-phase mechanism may 
still be valid. The labelling reactions with [18F]fluoride are performed using potassium as 
a counter ion and phase transfer catalysts thus assuming to deal with “naked” [18F]fluoride 
ions. That hypothesis could explain the small Eact values experimentally determined in this 
work when  DMF was used as a solvent. 
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4 EXPERIMENTAL SECTION 
 
4.1 Chemicals 
 
Chemicals for synthesis and labelling of precursors were obtained from the following 
companies: Aldrich (Germany), Sigma (Germany), Riedel-de Haёn (Germany), Fluka 
(Germany), Merck (Germany), Lancaster (England), ABCR (England). Tab. 32 gives the 
commercial source and the purity of these chemicals. 
Tab. 32. Chemicals used in this study and their commercial sources. (CS: 
Commercial Source,  A: Aldrich, B: ABCR, F: Fluka, L: Lancaster, M: 
Merck, R: Riedel-de Haёn) 
Substance CS Purity(%) Substance CS 
Purity 
(%) 
o-Vanillin F > 99 6-Nitropiperonal A 97 
Potassium bromide F > 99 6-Nitroveratraldehyde B 96 
Dimethylsulfate F > 99 6-Choroveratraldehyde L 98 
Benzoylchloride F > 98 6-Bromoveratraldehyde B 98 
Benzenesulfonyl chloride F > 97 Potassium carbonate M 99 
Acetic acid F >  99 Kryptofix [2.2.2]® M 99 
Acetic acid anhydride F 100 N-Formyl piperidine A 99 
2,3-Dimethoxy 
benzaldehyde F > 97 
2,4-Dimethoxy 
benzaldehyde F > 97 
2,5-Dimethoxy 
benzaldehyde F 98 
3,5-Dimethoxy 
benzaldehyde F 97 
Bromine F > 99 4-Fluoroveratrole L 97 
Ethyleneglycol R > 99 Butyllithium (2.5 M solution in hexane) F 97 
Toluene-4-sulfonic acid 
monohydrate F ∼99 Lithium chloride F > 99 
DMF (dry) F 100 THF (dry) F 100 
DMSO (dry) F 100 Methanol (dry) F 100 
DMAc (dry) F 100 Sulfolane (dry) A 100 
6-Bromopiperonal B 98 6-Chloropiperonal L 98 
NBS F > 97 Potassium hydroxide M 98 
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4.2 Analyses 
 
Mass spectra were obtained by using the following devices: EI-MS: Finnigan TSQ 70 e.V. 
(200 °C), FAB-MS: Finnigan 711A 8( kV), modified by AMD.  Unless otherwise stated, the 
method is always EI. Unless it is the molecular ion peak, important peaks (more than 10 %) 
are only reported. 
IR spectra were carried out on Perkin-Elmer spectrum-one FT-IR spectrometer. Important 
peaks are only reported in cm-1.  
1H NMR, 13C NMR and 19F NMR were carried out on Bruker DRX-250 spectrometer 
operating at 250 MHz. 1H NMR and 13C NMR chemical shifts (δ) were calibrated against the 
deuterated solvent (CDCl3 unless otherwise stated) multiplet and referenced to TMS. 19F 
NMR were measured also in CDCl3 and the data (δ) are reported relative to the standard 
CFCl3. 
Melting points (°C) were measured using Gallenkamp device and were uncorrected.  
Chromatography i.e. TLC was performed on silica gel plates (Polygram Silica G/UV254, 8 
X 4 cm, Macherey Nagel, Germany) and eluted with  1:1 or 1:2, ethylacetate / petroleum ether 
(v/v). HPLC was carried out by use of a Hewlet Packard Model 1050 equipped with a 
NaI(Tl)-scintillation detector and a UV detector (254 nm) (see p. 112). 
4.3 Production of [18F]Fluoride 
No-carrier-added (nca) [18F]Fluoride was produced at the cyclotron (PETtrace, GE Medical 
Systems, Uppsala) in the PET-Center, Tübingen, via the 18O(p,n)18F reaction by irradiating 
1.60 ml of  >95 % enriched [18O]water with 16.5 MeV protons. Activities were in the range 
between 10 and 20 GBq out of which 10  to 100 MBq were used for each labelling process. 
No kind of quality control was made for the resulting [18F]fluoride solution. 
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4.4 Labelling with [18F]Fluoride 
The activity was transferred into a 5.0 mL sealed vial containing 50 µL of 0.50 M K2CO3 and 
15 mg Kryptofix 222®. The 18F-fluoride solution was dried for 20 min under a mild stream of 
argon (ca. 2 mL/min) at 140 oC by azeotropic distillation with acetonitrile (2 x 1mL) and 
finally a dry residue of the complex [K/222]+18F-  remained as a white solid.  
The required quantity of the precursor in 1.0 mL (< 0.05 % H2O) solvent was added as 
a solution into the vial with the [K/222]+18F- complex. Then the vial, equipped with a screw 
cap and a silicone septum, was tightly closed and kept heated at the required temperature. 
TLC samples were withdrawn (1-5 µL) for the determination of the RCY at the required time 
(5, 10, 20, 30 and 60 min for some precursors and only at fixed time for others). 
4.5 Analytical Assay 
Product solutions were analyzed by thin layer chromatography (TLC) using  the silica gel 
plates described above. The non-radioactive fluoro-compound was used as a standard on the 
same TLC plate, and the spot was marked within light of 254 nm UV lamp. The radioactive 
spots were assessed quantitatively by means of an InstantImager (Canberra Packard, 
electronic autoradiography). Size of the TLC plate was made visible by radioactivity spotes, 
thus correlation between radioactive and nonradioactive spots was assured. 
High performance liquid chromatography (HPLC) was used for additional identification of 
the labelled product (in case of availability of standards). HPLC was carried out by means of 
a Hewlet Packard Model 1050 equipped with a NaI(Tl)-scintillation detector and a UV 
detector (254 nm) for identification and purity control. A Phenomenex, Luna (5µ C 18, 250 
mm x 10 mm) column with a flow rate of 2 mL/min was used. The eluent mixture was 
acetonitrile/water (30/70, v/v). In some cases a gradient was used starting from 97 % water up 
to 3 %. 
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4.6 Synthesis of Phenols and Catechols 
4.6.1 6-Bromo-2-hydroxy-3-methoxybenzaldehyde (14) 
 
2-Acetoxy-3-methoxybenzaldehyde (12) 
Prepared according to literature[55]. A solution of 50.0 g (0.33 mol) of o-vanillin (11) in 
50 mL pyridine and 35 mL (0.34 mmol) of acetic anhydride was stirred at room temperature 
for 24 h to give a white precipitate. The mixture was transferred to a flask containing 300 mL 
of 6 N HCl solution. The solid product was collected by filtration and washed with additional 
(500 mL) 6 N HCl solution followed by distilled water. Recrystallization from methanol gave 
white crystals : 63 g (98 %), mp 73-75 °C [lit[65] 75 °C].  
1H NMR: 10.12 (s, 1 H), 7.28-7.55 (m, 3 H), 3.89 (s, 3 H), 2.39 (s, 3 H).  
13C NMR: 19.2, 55.2, 117.0, 120.3, 125.9, 128.4, 140.7, 167.8, 187.8.  
Ms (m/z): 152 (M+, 100 %), 136, 122, 106, 81, 52, 43 .  
IR: 1763, 1694, 1680, 1580, 1484, 1441, 1404, 1372, 1319, 1275, 1253, 1211, 1201, 1149, 
1082, 1064, 1046, 1013, 901, 826, 780, 767, 669.  
 
2-Acetoxy-6-bromo-3-methoxybenzaldehyde (13) 
Prepared according to literature[55]. Compound (12) (50.0 g, 0.26 mol) was added in small 
portions to a solution of  100 g of KBr and 15 mL of bromine in 1.0 L of distilled water. The 
mixture was stirred for 3 h and the resulting precipitate collected by filtration. The crude 
product (pinkish solid) was recrystallized from diisopropyl ether to give white crystals.  
Yield: 57.5 g (96%),  mp 121 °C [lit.[66] 119-120 °C].  
1H NMR: 10.23 (s, 1 H), 7.00 (d, 1 H), 7.45 (d, 1 H), 3.82 (s, 3 H), 2.34 (s, 3 H).  
13C NMR: 190.3, 168.7, 151.9, 141.0, 131.5, 126.6, 117.8, 116.4, 55.5, 20.5.  
Ms (m/z): 272/274 (M+, 4 %), 230/232 (100 %), 201/203, 184/186, 105, 107, 94, 79, 51, 43. 
IR: 1760, 1693, 1570, 1465, 1439, 1399, 1371, 1296, 1266, 1175, 1077, 1013, 942, 915, 814, 
755, 718, 663. 
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6-Bromo-2-hydroxy-3-methoxybenzaldehyde (14) 
Prepared according to literature[55]. Compound (13) (50.0 g, 0.18 mol) was suspended in 1.5 L 
of 6 N HCl and stirred for 6 h at 50 °C. The yellow precipitate obtained was collected by 
filtration and recrystallized from isopropyl ether to give yellow crystals.  
Yield: 34 g (80 %), mp 104-106 °C [lit.[66] 105-106 °C].  
1H NMR: 12.19 (s, 1 H), 10.19 (1 H), 6.99 (d, 1 H), 6.84 (d, 1 H), 3.81 (s, 3 H).  
13C NMR: 198.8, 154.8, 148.8, 123.8, 118.5, 117.6, 116.8, 56.7. 
Ms (m/z): 230/232 ([M]+/[M+2]+, 100 %), 201, 184/186, 152, 133, 107, 94, 79, 51, 43.  
IR: 1634, 1579, 1460, 1423, 1299, 1246, 1080, 948, 886, 809. 
 
4.6.2 2,3-Dibromo-6-hydroxy-5-methoxybenzaldehyde (29) 
Prepared according to literature[75]. To a stirred solution of compound (12) (5 g, 25.7 mmol) 
in glacial acetic acid (30 mL) containing a small amount of iron powder (0.25 g) was added 
bromine (3.0 mL) in glacial acetic acid (30 mL) dropwise. It was stirred further for 5 h at 
room temperature, allowed to stand overnight, diluted with water (150 mL), and extracted 
with CH2Cl2. The CH2Cl2 layer was washed with 5% sodium thiosulfate, dried (MgSO4) and 
evaporated to yield a yellow solid which was recrystallized from isopropyl ether to give 
yellow crystals.  
Yield: 7.1 g (89 %), mp 144-146 °C [lit.[75] Reported without mp]. 
1H NMR: 12.47 (s, 1 H), 10.32 (m, 1 H), 7.16 (s, 1 H), 3.89 (s, 3 H). 
13C NMR: 199.2, 154.0, 148.8, 121.5, 118.6, 118.4, 115.1, 56.6 
Ms (m/z): 308/310/312 ([M]+/([M+2]+/([M+4]+, 100 %), 279, 262/264/266, 230/232, 214/216, 
185/187, 157/159, 129/131, 107, 77, 79. 
IR: 1643, 1570, 1453, 1433, 1399, 1294, 1270, 1245, 955, 873, 766. 
 
4.6.3 6-Bromo-2,3-dihydroxybenzaldehyde (32) 
Prepared according to literature[77]. To a stirred solution of BBr3 (1.87 g, 7.5 mmol) in CH2Cl2 
(15 mL) under nitrogen there was added a solution of compound (14) (1.22 gm, 5 mmol) in 
CH2Cl2 (5 mL) dropwise at 25 °C over 30 min. The mixture was stirred for 5 h and left to 
stand in open air for 24 h. Water (25 mL) was then added and the organic layer then 
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separated, washed with water, dried (MgSO4) and evaporated to yield a yellow solid which 
was recrystallized from toluene to give yellow needles (1 g, 87 %), mp 143-145 °C [lit [77] 
142-145 °C]. 
1H NMR (DMSO, d6): 11.76 (s, 1 H), 10.29 (s, 1 H), 10.0 (s, 1H), 7.11, 7.09 (dd, dd, 2 H). 
13C NMR (DMSO, d6): 197.1, 152.2, 146.1, 123.8, 122.5, 117.7, 113.6. 
Ms (m/z): 216/218 ([M]+/([M+2]+, 100 %), 198/200, 184/186170/172, 159/161, 107, 91, 79. 
IR: 3382, 1632, 1432, 1379, 1267, 1192, 1012, 891, 814, 715. 
 
4.6.4 2-Hydroxy-3-methoxy-6-nitrobenzaldehyde (18) 
3-Methoxybenzaldehyde-2-benzenesulfonate (16) 
Prepared according to literature[56]. A solution of o-vanillin (5.0 g, 32.9 mmol) in distilled 
water (33.5 mL) containing potassium hydroxide (2.0 g, 33.3 mmol) was treated with 
benzenesulfonyl chloride (5 mL, 39.3 mmol)  dropwise over a period of 30 min. CH2Cl2 
(1 mL) was then added and the mixture was stirred overnight. The resultant solid was 
extracted with CH2Cl2 (3 x 50 mL) and the organic layer washed with water (200 mL) and 
with 5 % KOH (100 mL). The solvent was dried in vacuo to give a brown solid which needed 
no further purification and was suitable for the next step.  
Yield: 11.5 g (94 %). Mp 117-119 °C [lit.[67] 119-120 °C].  
1H NMR: 10.12 (s, 1 H), 7.07-7.91 (m, 8 H), 3.53 (s, 3 H). 
13C NMR: 187.9, 152.5, 140.6, 135.9, 134.4, 131.3, 129.1, 128.6, 128.0, 119.6, 118.0, 55.9. 
Ms (m/z): 292 (M+, 15 %), 167, 151 (100%), 141, 123, 108, 93, 77. 
IR: 1697, 1578, 1479, 1446, 1371, 1277, 1246, 1197, 1190, 1151, 1064, 905, 853, 162, 753. 
 
3-Methoxy-6-nitrobenzaldehyde-2-benzenesulfonate (17a) 
Prepared according to literature[56]. Aldehyde (16) (20 g, 68.5 mole) was added to 90 % nitric 
acid (44 mL) with temperature maintained between –10 and 0° over a period of 30 min. The 
reaction mixture was stirred an additional hour, poured cautiously on ice-water mixture (250 
mL) and stirred for further 2 h. The white solid was collected by filtration and washed with 
water (200 mL). It was refluxed in acetone (150 mL) for 30 min, concentrated to 20 mL and 
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cooled to 0 °C. The resultant solid was collected by filtration and washed with cold acetone 
(10 mL) to give pure product as white crystals.  
Yield: 16.2 g (70 %), mp 144-146 °C [lit.[68] 145 °C]. 
1H NMR (acetone d6): 10.12 (s, 1 H), 8.17 (d, 1 H), 8.13 (d, 1 H), 7.55-7.94 (m, 5 H), 3.72 (s, 
3 H).  
13C NMR (acetone d6): 188.8, 158.3, 147.5, 136.3, 135.8, 134.7, 132.3,  129.3, 128.5, 118.8, 
114.0, 57.2.  
Ms (FAB, m/z): 338 ([M+1]+, 42 %), 80, 179, 141, 123, 106, 77.  
IR: 1697, 1578, 1516, 1479, 1448, 1431, 1375, 1346, 1322, 1289, 1193, 1169, 1088, 1067, 
993, 952, 914, 834, 822, 775, 757, 737, 691. 
 
3-Methoxy-4-nitrobenzaldehyde-2-benzenesulfonate (17b) 
Prepared as a by-product with compound (17a) in not more than 25 %. Colorless crystals.  
Mp 93-95 °C.  
1H NMR: 10.13 (s, 1 H), 7.78 (d, 1 H), 7.66 (d, 1 H), 7.56-7.75 (m, 7 H), 3.72 (s, 3 H). 
13C NMR: 192.9, 148.0, 147.7, 146.0, 135.4, 134.9, 134.3, 129.6, 128.5, 123.2, 122.9, 62.7. 
Ms (m/z): 337 (M+, 5 %), 320, 196, 141 (100 %), 125, 107, 77. 
IR: 1703, 1583, 1532, 1446, 1418, 1388, 1364, 1266, 1201, 1184, 1169, 1090, 1024, 997, 906, 
820, 769, 745, 732, 702, 686. 
 
2-Hydroxy-3-methoxy-6-nitrobenzaldehyde (18) 
Prepared according to literature[56]. Compound (17a) (12.1 g, 30.6 mmol) was added to 
methanol (160 mL) and the mixture was heated with vigorous stirring. NaOH (6 g) in distilled 
water (6 mL) was added dropwise maintaining reflux temperature. An orange precipitate 
formed which interfered with stirring. The reaction was heated to reflux for an additional 1 h. 
The solid was collected by filtration, washed with methanol and acetone and air dried. The 
solid was dissolved in distilled water and treated with concentrated hydrochloric acid 
dropwise until a yellow solid is formed (pH 3-5). Mp 104-106 °C [lit.[68] 104 °C]. 
1H NMR: 12.55 (s, 1 H), 10.47 (s, 1 H), 7.70 (dd, 1 H), 7.04 (dd, 1 H), 3.99 (s, 3 H).  
13C NMR: 194.9, 153.6, 142.5, 117.9, 113.6, 113.1, 112.9, 56.7 
Ms (m/z): 197 (M+, 56 %), 167, 152, 135, 123, 121, 106, 96, 81, 65, 51. 
IR: 1646, 1573, 1509, 1473, 1429, 1393, 1321, 1250, 1199, 1182, 1071, 972, 935, 840, 813, 
765, 727, 676. 
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4.6.5 6-Fluoro-2-hydroxy-3-methoxybenzaldehyde (40) 
 
6-Fluoro-2,3-dimethoxybenzaldehyde (39) 
Prepared according to literature[57]. Butyl lithium (2.5 M) in hexane (27.2 ml, 68.1 mmol) was 
added slowly (20 min) to a solution of 4-fluorovertratole (38) (10.8 g, 61.9 mmol) in 220 mL 
of dry THF at –65 °C under nitrogen. The solution was stirred at –65 °C for 30 min. DMF 
(5.3 mL, 68.1 mmol) was added dropwise to the solution . The mixture was allowed to warm 
up to room temperature, poured onto ice (500 mL) and extracted with ether. It was washed 
with saturated NaCl solution, dried (MgSO4) and evaporated to give a colorless oil which 
solidify on standing in the refrigerator for several days.  
Yield: 74 %. Mp 48-50 °C [lit.[57] reported without mp].  
1H NMR: 10.26 (s, 1 H), 6.42-7.01 (m, 2 H), 3.85 (s, 3 H), 3.70 (s, 3 H). 
13C NMR: 187.3, 157.9, 153.8, 149.3, 118.2, 110.5, 61.9, 56.2. 
19F NMR (400 MHz, CDCl3):  -126.3 (s, 1 F). 
Ms (m/z): 184 ([M]+, 100 %), 169, 166, 154, 141, 138, 126, 123, 113, 95, 83, 77, 65. 
IR: 1687, 1604, 1582, 1488, 1450, 1392, 1273, 1255, 1236, 1195, 1081, 1046, 961, 870, 817. 
 
6-Fluoro-2-hydroxy-3-methoxybenzaldehyde (40) 
Compound (39) (1 g, 5.4 mmol) and LiCl (0.76g, 18 mmol) were heated in boiling DMF (10 
mL) and the reaction was continued for 24 h. After this, 10 % NaOH (30 mL) was added. The 
mixture is washed with ether (2 x 25 mL) and then acidified with 10 % HCl (50 mL) and 
extracted with ether (2 x 25 mL). The solvent was evaporated and the residue purified through 
a silica column  with the mobile phase as 10 % ethyl acetate in petroleum ether.  
Yield: 74 %. Yellow solid. Mp 143-145 °C. 
1H NMR: 11.67 (s, 1 H), 10.20 (s, 1 H), 7.00 (d, 1 H), 6.55 (d, 1 H), 3.84 (s, 3 H). 
13C NMR: 192.6, 160.0., 156.0, 152.7, 144.8, 119.3, 110.7, 104.4, 56.8. 
Ms (m/z): 170 (M+, 100 %). 
IR: 1644, 1586, 1466, 1409, 1326, 1275, 1226, 1187, 1114, 1001, 955, 843, 632. 
 
EXPERIMENTAL SECTION 
 
119
 
4.6.6 2-Bromo-4-hydroxy-5-methoxybenzaldehyde (7a) 
4-Acetoxy-3-methoxybenzaldehyde (5) 
Prepared similarly to (12) starting from vanillin (4). Recrystallization from diisopropylether 
gave white crystals: 63 g (98 %), mp 77-78 °C [lit.[61] 77-78 °C]. 
1H NMR: 9.91 (s, 1 H), 7.46 (dd, 1 H), 7.21 (dd, 1 H), 3.88 (s, 3 H), 2.31 (s, 3 H). 
13C NMR: 191.0, 168.3, 152.0, 145.0, 135.3, 124.7, 123.5, 111.0, 56.1, 20.6. 
M (m/z): 152 ([M]+, 100 %), 151, 137, 123, 109, 95, 81, 65, 51, 43. 
IR: 1747, 1687, 1677, 1597, 1505, 1470, 1425, 1393, 1374, 1331, 1277, 1204, 1153, 1123, 
1032, 1013, 905, 1013, 905, 861, 829, 796, 737, 680. 
 
4-Acetoxy-2-bromo-3-methoxybenzaldehyde (6) 
Prepared similarly to (13) starting from vanillin acetate (5). Recrystallization from 
diisopropylether gave white crystals. Yield: 90 %, mp 109-110 °C [lit.[62] 109-110 °C]. 
1H NMR: 10.25 (s, 1 H), 7.50 (s, 1 H), 7.34 (s, 1 H), 3.87 (s, 3 H), 2.31 (s, 3H). 
13C NMR: 190.8, 167.9, 151.4, 145.1, 131.7, 128.0, 117.9, 112.2, 56.3, 20.5.  
Ms (m/z): 272/274 ([M]+/[ M +2]+,  8 %), 230/232 (100 %), 201/203, 187/189, 159/161, 152, 
151, 123, 122, 107, 79, 63, 51. 
IR: 1755, 1686, 1593, 1482, 1383, 1364, 1311, 1271, 1212, 1200, 1152, 1040, 1009, 979, 916, 
878, 862, 827, 742, 716. 
 
2-Bromo-4-hydroxy-5-methoxybenzaldehyde (7a) 
Prepared similarly to (14) starting from compound (6). Recrystallization from 
diisopropylether gave white crystals: yield: 77 %. Mp 104-106 °C [lit.[62] 104-104.5 °C]. 
1H NMR: 10.05 (s, 1 H), 7.34 (s, 1H), 7.08 (s, 1H), 3.86 (s, 3H). 
13C NMR: 189.3, 153.0, 147.3, 125.0, 119.2, 119.0, 110.5, 55.2. 
Ms (m/z): 230/232 ([M]+/[M+2]+, 100 %), 215/217, 201/203, 187/189, 159/161, 152, 151, 
123, 122, 107, 94, 79, 63, 51. 
IR: 3149, 1655, 1595, 1566, 1507, 1401, 1266, 1202, 1149, 1042, 981, 866, 733, 691. 
 
4.6.7 3-Bromo-4-hydroxy-5-methoxybenzaldehyde (7b) 
Prepared similar to (29) starting from vanillin (4). White solid, yield: 75 %, mp 166-168 °C 
[lit.[63] 166-169 °C]. 
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1H NMR: 9.82 (s, 1 H), 7.55 (s, 1 H), 7.33 (s, 1 H), 3.88 (s, 3 H). 
13C NMR: 189.4, 154.2, 148.3, 132.0, 128.6, 115.1, 109.3, 56.0 
M (m/z): 230/232 ([M]+/[M+2]+, 100 %), 215/217, 201/203, 187/189, 159/161, 15, 122, 79. 
IR: 32701672, 1579, 1499, 1462, 1447, 1422, 1404, 1352, 1288, 1145, 1044, 970, 853, 830. 
 
4.6.8 4-Methyl-5-nitrocatechol (54) 
Prepared according to literature[89]. 4-Methylcatechol (53) (2.0 g) and NaNO2 (3.0 g) were 
dissolved in water (100 mL). The solution was cooled down to - 10 °C. H2SO4 (25 mL, 20 %) 
was then added very slowly to the mixture with good stirring. The solution was stirred for 4 h 
at 0 °C. The resulting solid was then collected by filtration and washed thoroughly with water. 
Recrystallization from methanol gave brown crystals.  
Yield: 65 %, mp 180-183 °C [lit[89] 180-182 °C].  
1H NMR (acetone d6): 7.61 (s, 1 H), 6.91 (s, 1 H), 2.44 (s, 3 H). 
13C NMR (acetone d6): 151.3, 144.0, 144.9, 128.2, 119.0, 112.7, 20.5. 
Ms (m/z): 169 ([M]+, 48 %), 152 (100 %), 138, 124, 106, 96, 83, 77, 68, 51, 39. 
IR: 3435, 3186, 1638, 1587, 1523, 1493, 1429, 1361, 1318, 1277, 1227, 1184, 1144, 1045. 
 
 
4.7 Synthesis of Haloaryl Precursors 
4.7.1 General Method for Halogenation with NBS or NCS 
Halogenations with NXS (X= Br, Cl) are successful only for electron-rich (activated) 
aromatic rings. A general procedure for bromination with NBS involves the following. To a 
solution of the proper compound (15 mmol) in DMF (73 mL) is added dropwise NBS (3.92 g, 
22 mmol) in DMF (100 mL) within 30 min. After 48 h, the solution is poured onto ice and 
water (500 mL). The resulting precipitate is collected by filtration and washed thoroughly 
with water. The same procedure is used for chlorination with NCS using 2.94 g (22 mmol). 
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4.7.2 Haloaryl Precursors by Halogenation with NBS or NCS 
 
4.7.2.1 6-Bromo-2,3-dimethoxybenzaldehyde (23a) 
Prepared from 2,3-dimethoxybenzaldehyxde (22) and recrystallized from diisopropylether. 
White crystals. Yield: 78 %, mp 77-78 °C [lit.[71] 77-78 °C]. 
1H NMR: 10.24 (s, 1 H), 7.23 (d, 1 H), 7.9 (d, 1 H), 3.80 (s, 3 H), 3.78 (s, 3 H). 
13C NMR: 190.4, 152.7, 152.0, 129.2, 128.4, 117.5, 112.5,. 62.2, 56.1. 
Ms (m/z): 244/246 ([M]+/([M+2]+, 100 %), 229/231, 214/216, 198/200, 166, 148, 122. 
IR: 1685, 1570, 1468, 1432, 1388, 1296, 1264, 1234, 1056, 990, 922, 813, 770, 665. 
 
4.7.2.2 6-Chloro-2,3-dimethoxybenzaldehyde (23b) 
Prepared from 2,3-dimethoxybenzaldehyxde (22) and recrystallized from diisopropylether. 
White crystals,  yield: 69 %, mp  72-74 °C. 
1H NMR: 10.43 (s, 1 H), 7.12 (d, 1 H), 7.04 (d, 1 H), 3.93 (s, 3 H), 3.84 (s, 3 H). 
13C NMR: 189.5, 152.2, 127.5, 126,1, 125.8, 117.8, 117.3, 62.3, 56.5. 
Ms (m/z): 200/202 ([M]+/([M+2]+, 100 %). 
IR: 1689, 1574, 1470, 1434, 1393, 1298, 1267, 1236, 1177, 1060, 995, 931, 816, 772, 666. 
 
4.7.2.3 2-Bromo-4,5-ethylenedioxybenzaldehyde (37b) 
Prepared from 3,4-ethylenedioxybenzaldehyxde (36) and purified by MPLC. White solid,  
yield: 78 %, mp 146-149 °C [lit.[79] 149-150 °C].  
1H NMR: 10.43 (s, 1 H), 7.42 (s, 1 H), 7.06 (s, 1 H), 4.20 (t, 2 H), 4.08 (t, 2 H).  
13C NMR: 191.0, 153.1, 144.6, 128.4, 121.1, 119.3, 114.4, 63.6, 62. 
Ms (m/z): 242/244 ([M]+/([M+2]+, 100 %). 
IR: 1686, 1580, 1550, 1483, 1455, 1437, 1415, 1367, 1353, 1290, 1242, 1174, 1065, 935, 912, 
892, 852, 826, 700. 
 
4.7.2.4 2-Bromo-3,4,5-trimethoxybenzaldehyde (46) 
Prepared from 3,4,5-trimethoxybenzaldehyde (44) and purified by MPLC. White-pinkish 
crystals, yield: 83 %, mp 68- 71°C [lit [85] 67-69].  
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1H NMR: 10.38 (s, 1 H), 7.21 (s, 1 H), 4.05 (s, 3 H), 3.84 (s, 3 H), 3.80 (s, 3 H). 
13C NMR: 189.5, 153.2, 150.1, 147, 9, 130.8, 111.5, 110.1, 61.4, 60.6, 56.9. 
Ms (m/z): 274/276 ([M]+, 100 %), 259/261, 231/233, 203/205, 188/190, 180, 165, 152, 147, 
124, 109, 103, 77, 50, 40. 
IR: 1683, 1577, 1563, 1470, 1449, 1383, 1314, 1197, 1164, 1103, 1044, 1000, 980, 920, 859. 
 
4.7.3 General Method for Bromination with Br2/CH3COOH 
A general procedure for bromination with this reagent involves the following. The proper 
compound (18 mmol) is dissolved in glacial acetic acid (20 mL). To this solution there is 
slowly added a solution of bromine (3 g) in glacial acetic acid (4 mL) with good stirring. The 
temperature is maintained at 20 °C for 2 d. The solution is then poured onto water (100 mL) 
and the precipitate collected by filtration and washed thoroughly with water and with 5 % 
Na2S2O3 solution.  
4.7.4 Haloaryl Precursors by Bromination with Br2/CH3COOH 
 
4.7.4.1 5-Bromo-2,3-dimethoxybenzaldehyde (24a) 
Prepared from 2,3-dimethoxybenzaldehyxde (22) and recrystallized from methanol. White 
crystals. Yield: 80 %, mp 80-82 °C [lit.[72] 81 °C]. 
1H NMR: 10.22 (s, 1 H), 7.23 (s, 1 H), 7.43 (s, 1 H), 3.91 (s, 3 H), 3.89 (s, 3 H). 
13C NMR: 190.1, 152.2, 149.8, 126.4, 128.6, 119.2, 117.5, 60.6, 56.3. 
Ms (m/z): 244/246 ([M]+/([M+2]+, 100 %), 226/228, 215/217, 198/200, 185, 170, 148, 135, 
121, 107, 94, 79, 77, 51. 
IR: 1677, 1576, 1479, 1444, 1394, 1316, 1264, 1239, 1218, 1191, 1073, 987, 929, 852, 775. 
 
4.7.4.2 5-Bromo-2,4-dimethoxybenzaldehyde (26) 
Prepared from 2,5-dimethoxybenzaldehyxde (25). White solid. Yield: 73 %, mp 135-136 °C 
[lit.[73] 134-138 °C]. 
1H NMR: 10.00 (s, 1 H), 7.80 (s, 1 H), 6.49 (s, 1 H), 3.95 (s, 3 H), 3.80 (s, 3H). 
13C NMR: 189.4, 154.8, 150.0, 133.2, 122.3, 104.6, 99.1, 57.2, 55.6. 
Ms (m/z): 244/246 ([M]+/([M+2]+, 100 %), 229/231, 214/216, 198/200, 166. 
IR: 1663, 1593, 1487, 1463, 1434, 1397, 1369, 1320, 1275, 1209, 1165, 1149, 1051, 1018, 
912, 878, 850, 813, 714, 685. 
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4.7.4.3 4-Bromo-2,5-dimethoxybenzaldehyde (28) 
Prepared from 2,5-dimethoxybenzaldehyxde (27) and recrystallized from methanol. White 
crystals. Yield: 80 %, mp 121-122 °C [lit.[74] 122-124 °C]. 
1H NMR: 10.41 (s, 1 H), 7.30 (s, 1 H), 7.01 (s, 1 H), 3.83 (s, 3 H), 3.79 (s, 3 H). 
13C NMR: 190.3, 152.44, 154.0, 1247.1, 117.2, 116, 57.7, 56.3. 
Ms (m/z): 244/246 ([M]+/([M+2]+, 100 %), 229/231, 198/200, 186, 174, 157, 148, 135, 107. 
IR: 1676, 1598, 1483, 1448, 1392, 1272, 1250, 1211, 1183, 1018, 968, 880, 717. 
 
4.8 Synthesis of Nitroaryl Precursors 
 
4.8.1 General method for nitration with HNO3 
Direct nitration with HNO3 (50-60 %) was successful for most activated (SNAr) precursors in 
cold (0 °C) within short time (30-60 min). A general procedure for nitration with this reagent 
involves the following. One part of the compound is dissolved slowly in 20 parts of nitric acid 
(50-60 %) at 0 °C under good stirring. The temperature is kept at 0 °C for 30 min then at RT 
for another 30 min. The solution is poured then cautiously onto ice and water. The resulting 
precipitate is collected by filtration and thoroughly washed with water and 5 % K2CO3 to 
remove traces of the acid. 
4.8.2  Nitroaryl Precursors by Nitration with HNO3 
 
4.8.2.1  2,3-Dimethoxy-5-nitrobenzaldehyde (24b) 
Prepared from 2,3-dimethoxybenzaldehyxde (22) and recrystallized from diisopropylether. 
White crystals, yield: 76 %, mp 115-117 °C [lit.[72] 115 °C]. 
1H NMR: 10.09 (s, 1 H), 8.21 (s, 1 H), 8.10 (s, 1 H), 4.00 (s, 3 H), 3.71 (s, 3 H). 
13C NMR: 187.9, 155.7, 151.8, 146.4, 125.3, 120.4, 113.3, 60.6, 56.2. 
Ms (m/z): 211 ([M]+, 100 %), 193 (95 %), 182, 165 (50 %), 150, 135, 121, 107, 99, 79, 77. 
IR: 1685, 1583, 1515, 1481, 1433, 1352, 1334, 1276, 1243, 1183, 1089, 1066, 978, 950, 927, 
895, 797, 776, 758, 742, 704. 
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4.8.2.2  3-Bromo-5,6-dimethoxy-2-nitrobenzaldehyde (31) 
Prepared from 5-bromo-2,3-dimethoxybenzaldehyxde (24a) and recrystallized from aqueous 
ethanol. White crystals, yield: 69 %, mp 141 °C [lit.[75] 141 °C]. 
1H NMR: 10.25 (s, 1 H), 7.29 (s, 1 H), 4.02 (s, 3 H), 3.97 (s, 3 H). 
13C NMR: 189.5, 154.4, 147.8, 144.6, 131.6, 121.9, 120.2, 62.8, 56.4. 
Ms (m/z): 289/291 ([M]+/[M+2]+, 40 %), 272/274 (100 %), 259/261, 244/246, 218, 216, 203, 
179, 165, 157, 137, 121, 93, 77. 
IR: 1695, 1574, 1541, 1478, 1429, 1387, 1361, 1317, 1266, 1238, 1182, 1077, 1018, 957, 893, 
854, 808, 765, 729, 670. 
 
4.8.2.3  3,5-Dimethoxy-2-nitrobenzaldehyde (35) 
Prepared from 3,5-dimethoxybenzaldehyxde (34) and recrystallized from methanol. Yellow  
crystals: (yield: 69 %), mp 108-110 °C [lit.[78] 109-110 °C]. 
1H NMR: 10.49 (s, 1 H), 7.06 (s, 1 H), 6.92 (s, 1 H), 4.06 (s, 1 H), 3.83 (s, 1 H). 
13C NMR: 188.8, 157.9, 147.2, 132.4, 121.4, 114.1, 106.9, 56.6, 55.5. 
Ms (m/z): 211 ([M]+, 50 %), 194, 179, 164, 151, 136, 123, 105, 95, 77, 69. 
IR: 1700, 1590, 1529, 1492, 1430, 1386, 1369, 1334, 1311, 1231, 1198, 1185, 1166, 1118, 
1112, 852, 831, 775, 735, 695. 
 
4.8.2.4  4,5-Ethylenedioxy-2-nitrobenzaldehyde (37a) 
Prepared from 3,4-ethylenedioxybenzaldehyde (36) and purified by MPLC. Yellow crystals, 
yield: 91 %, mp 164-166 °C (dec.) [lit.[38] reported without mp]. 
1H NMR: 10.41 (s, 1 H), 7.63 (s, 1 H), 7.32 (s, 1 H), 4.45 (t, 2 H), 4.41 (t, 2 H). 
13C NMR: 188.8, 150.0, 148.3, 145.0, 126.5, 111.1, 108.5, 64.1, 63.7. 
Ms (m/z): 209 ([M]+, 9 %), 181, (100 %), 179, 151, 135, 107, 105, 79, 51. 
IR: 1679, 1612, 1577, 1512, 1456, 1416, 1237, 1287, 1194, 1153, 1053, 1004, 918, 900, 848. 
 
4.8.2.5  3-Methoxy-2-nitrobenzaldehyde-4-benzenesulfonate (42e) 
Prepared from vanillinbenzenesulfonate (42d) and recrystallized from diisopropylether. 
Colorless crystals. Yield: 84 %, mp 133 °C. 
1H NMR: 10.12 (s, 1 H), 7.55-7.75 (m, 5 H), 7.84 (d, 1 H), 7.44 (d, 1 H), 3.86 (s, 3 H). 
13C NMR: 189.1, 144.1, 141.2, 143.3, 125.7, 128.8, 122.6, 129.6, 129.2-135.0 (5 C), 61.4 
Ms( m/z): 337 ([M]+, 4 %), 196, 141 (84 %), 125, 107, 77 (100 %). 
IR: 1705, 1623, 1566, 1510, 1469, 1433, 1401, 1355, 1316, 1279, 1182, 1099, 994, 933, 845, 
822, 776, 747, 666. 
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4.8.2.6  3,4,5-Trimethoxy-2-nitrobenzaldehyde (45) 
Prepared from 3,4,5-trimethoxybenzaldehyde (45) and purified by MPLC. Yellow solid. 
Yield: 45 %, mp  78-80 °C [lit.[84] 80-82 °C]. 
1H NMR: 9.88 (s, 1 H), 7.02 (s, 1 H), 3.98 (m, 3 H), 3.81 (s, 3 H), 3.79 (s, 3 H). 
13C NMR: 188.9, 153.2, 151.6 150.6, 131.0, 127.5, 121.6, 120.0, 116.6, 106.5, 103.5, 90.1, 
63.0, 62.7, 56.6. 
Ms (m/z): 241 ([M+], 100 %), 211, 196, 181, 153, 137, 125, 109. 
IR: 1702, 1583, 1539, 1489, 1458, 1366, 1325, 1307, 1253, 1197, 1114, 1018, 961, 933, 920, 
879, 751, 681. 
 
4.8.2.7 2,3,4-Trimethoxy-6-nitrobenzaldehyde (48) 
Prepared from 2,3,4-trimethoxybenzaldehyde (47) and purified by MPLC. Yellow crystals, 
yield: 74 %, mp 80-82 °C [lit.[86] 80-82 °C]. 
1H NMR: 10.24 (s, 1 H), 7.30 (s, 1 H), 3.98 (s, 3 H), 3.97 (s, 3 H), 3.92 (s, 3 H). 
13C NMR: 187.0, 103.7, 62.9, 61.3, 56.7. 
Ms (m/z): 241 ([M+], 40 %), 211 (98 %), 196 (100 %), 181, 168 (70 %), 153 (73 %), 137, 
125, 109, 93, 77, 66, 53.  
IR: 1703, 1607, 1560, 1520, 1485, 1389, 1301, 1253, 1207, 1119, 1048, 1030, 963, 919, 885, 
799, 767, 731, 675. 
 
4.8.2.8 5-Nitro-1,3-benzodioxole (57) 
Prepared from 1,3-benzodioxole (57) and recrystallized from diisopropylether. Dark brown 
crystals, yield: 81 %, mp 147-148 °C [lit.[91] 146-149 °C] 
1H NMR: 8.22 (s, 1 H), 8.01 (d, 1 H), 7.23 (d, 1 H), 6.14 (s, 2 H). 
3C NMR:  150.2, 145.5, 142.0, 118.7, 108.3, 104.1, 101.6. 
Ms (m/z): 167 ([M]+, 100 %), 151, 137, 121, 107, 91, 79, 65, 63, 45. 
IR: 1500, 1485, 1434, 1379, 1333, 1266, 1236, 1171, 1113, 1030, 917, 869, 823, 808, 741, 
718. 
 
4.8.2.9 4,5-Methylenedioxy-2-nitrotoluene (59) 
Prepared from 3,4-methylenedioxytoluene (59) and recrystallized from diisopropylether. Dark 
yellow crystals, yield: 71 %, mp 80-82 °C [lit.[92] 82 °C] 
1H NMR: 7.55 (s, 1 H), 6.81 (s, 1 H), 6.11 (s, 2 H), 2.69 (s, 3 H). 
13C NMR: 150.1, 144.9, 142.2, 125.6, 112.9, 104.2, 102.3, 20.9. 
Ms (m/z):  181([M]+, 100 %), 166, 152, 136, 121, 107, 93, 77, 65, 39. 
IR: 1616, 1520, 1498, 1466, 1452, 1350, 1324, 1264, 1223, 1188, 1170, 1059, 1033, 1015, 
981, 869, 795, 755. 
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4.9 Synthesis of Ester-Protected Phenolic or Catecholic Precursors 
 
4.9.1 General Procedure 
A general procedure for protection of phenols as esters (acetates or benzoates) involves the 
following procedure. The proper phenol (10 mmol) in pyridine (50 mL) is treated slowly 
under good stirring with a solution of acetic acid anhydride (13 mmol) in pyridine (10 mL). 
After addition is completed, the solution is stirred further for 2 h. The solution is then poured 
onto ice and water (200 mL) and the precipitate is collected by filtration and washed 
thoroughly with water. The same procedure is used for the benzoates using 13 mmol of 
benzoylchloride. 
 
4.9.2 Ester-Protected Phenolic or Catecholic Precursors  
 
4.9.2.1 4-Benzoyloxy-2-bromo-5-methoxybenzaldehyde (8a) 
Prepared from 2-bromo-4-hydroxy-5-methoxybenzaldehyde (7a) and recrystallized from 
diisopropylether. White crystals, yield: 71 %, mp 119-121 °C. 
1H NMR: 10.22, 7.47 (s, 1 H), 7.28 (s, 1 H), 7.44-7.81 (m, 5 H), 3.96 (s, 3 H) 
13C NMR: 190.6, 165.5, 149.0, 145.1, 134.4, 131.3, 128.1-133.6 (5 C), 117.2, 114.1, 56.0 
Ms (m/z): 334/336 ([M]+/[M+2]+, < 1 %), 
IR: 1737, 1682, 1594, 1488, 1466, 1449, 1381, 1312, 1263, 1248, 1194, 1166, 1150, 1052, 
1020, 980, 914, 859, 798, 736, 706, 677. 
 
4.9.2.2 2-Benzoyloxy-6-bromo-3-methoxybenzaldehyde (15a) 
Prepared from 6-bromo-2-hydroxy-3-methoxybenzaldehyde (14) and recrystallized from 
diisopropylether. Colorless crystals, yield: 79 %, mp 158-160 °C. 
1H NMR: 10.27 (s, 1 H), 8.17 (d, 1 H), 7.08 (d, 1 H), 7.47-7.66 (m, 5 H), 3.82 (s, 3 H), 2.34. 
13C NMR: 190.6, 164.0, 152.4, 141.0, 134.2, 132.0, 130.9, 129.1, 129.0, 118.1, 116.3, 56.9. 
Ms (m/z): 334/336 ([M]+/[M+2]+, < 1 %), 230/232 (100 %), 201/203, 189,184/186, 159/161, 
132, 105/107, 79, 63, 51. 
IR: 1732, 1690, 1585, 1570, 1491, 1470, 1438, 1404, 1301, 1273, 1207, 1173, 1161, 1148, 
1075, 1058, 1022, 1161, 1075, 1058, 1022, 943, 825, 796, 744, 696. 
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4.9.2.3 2-Acetoxy-3-methoxy-6-nitrobenzaldehyde (19b) 
Prepared from 2-hydroxy-3-methoxy-6-nitrobenzaldehyde (18) and recrystallized from 
diisopropylether. Brown crystals, yield: 85 %, mp 131-132 °C [lit.[69] 134 °C]. 
1H NMR: 10.22 (s, 1 H), 7.83 (d, 1 H), 7.60 (d, 1 H), 3.96 (s, 3 H), 2.34 (s, 3 H). 
13C NMR: 189.0, 167.1, 153.1, 145.6, 141.3, 121.6, 120.9, 120.3, 56.3, 20.7. 
Ms (m/z): 239 ([M]+, 5 %).  
IR: 1774, 1700, 1578, 1515, 1479, 1433, 1370, 1341, 1277, 1177, 1070, 1015, 925, 875, 834, 
818, 758, 725, 671. 
 
4.9.2.4 2-Benzoyloxy-3-methoxy-6-nitrobenzaldehyde (19c) 
Prepared from 2-hydroxy-3-methoxy-6-nitrobenzaldehyde (18) and recrystallized from 
diisopropylether. Brown crystals, yield: 66 %, mp  125-127 °C.  
1H NMR: 10.26 (s, 1 H), 7.80 (d, 1 H), 7.33 (d, 1 H), 7.51-7.89 (m, 5 H), 3.99 (s, 3 H).  
13C NMR: 190.1, 163.3, 153.0, 146.6, 141.2, 129.5, 134.2, 131.9, 128.6, 122.0, 56.2. 
Ms (m/z): 301([M]+, < 1 %), 243, 271, 196, 105 (100 %), 77, 58, 43. 
IR: 1743, 1703, 1579, 1509, 1480, 1387, 1334, 1287, 1251, 1201, 1188, 1075, 1056, 1025, 
989, 955, 911, 818, 709, 663. 
 
4.9.2.5 2-Acetoxy-5,6-dibromo-3-methoxybenzaldehyde (30b) 
Prepared from 5,6-dibromo-2-hydroxy-3-methoxybenzaldehyde (29) and recrystallized from 
diisopropylether. White crystals, yield: 70 %, mp 138 °C (dec.).  
1H NMR: 10.12 (s, 1 H), 7.28 (m, 1 H), 3.86 (s, 3 H), 2.39 (s, 3 H).  
13C NMR: 189.1, 167.8, 151.9, 147.2, 134.6, 128.5, 121.1, 117.7, 56.6, 20.6 
Ms (m/z): 350/352/354 ([M]+/[M+2]+/[M+4]+, < 1 %), 308/310/312 (100 %), 262/264/266 
(60 %), 230/232, 214, 185, 159, 157, 129/131, 105/107, 79, 50, 43. 
IR: 1768, 1693, 1642, 1570, 1453, 1433, 1398, 1372, 1336, 1294, 1271, 1245, 1171, 1088, 
1011, 952, 873, 765, 725. 
 
4.9.2.6 2-Benzoyloxy-5,6-dibromo-3-methoxybenzaldehyde (30c) 
Prepared from 5,6-dibromo-2-hydroxy-3-methoxybenzaldehyde (29). White solid, yield: 
68 %, mp 147-149 °C. 
1H NMR: 10.12 (s, 1 H), 7.36 (s, 1 H), 7.42-7.63 (m, 5 H), 3.86 (s, 3 H). 
13C NMR: 189.4, 162.9, 151.0, 146.4, 132.9, 131.9, 131.0, 128.8, 128.1, 126.6, 120.4, 56.6. 
Ms (m/z): 412/414/416 ([M]+/[M+2]+/[M+4]+, < 1 %), 333/335, 307/309/311, 266, 228, 185, 
181, 157, 143, 122, 130, 105 (100 %), 77. 
IR: 1739, 1692, 1600, 1577, 1463, 1434, 1392, 1362, 1301, 1258, 1204, 1176, 1088, 1076, 
1058, 1021, 996, 947, 879, 779, 705. 
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4.9.2.7 2-Acetoxy-6-fluoro-3-methoxybenzaldehyde (41a) 
Prepared from 6-fluoro-2-hydroxy-3-methoxybenzaldehyde (40). White solid, yield: 66 %, 
mp 102 °C. 
1H NMR: 10.12 (s, 1 H), 7.24 (d, 1 H), 7.08 (d, 1 H), 3.99 (s, 3 H), 2.42 (s, 3 H). 
13C NMR: 188.1, 167.7, 158.5, 145.5, 144.0, 118.3, 117.7, 116.6, 56.4, 20.4. 
IR: 1757, 1681, 1600, 1571, 1477, 1436, 1371, 1277, 1234, 1155, 1019, 945, 830. 
 
4.9.2.8 2-Benzoyloxy-6-fluoro-3-methoxybenzaldehyde (41b) 
Prepared from 6-fluoro-2-hydroxy-3-methoxybenzaldehyde (40). Colorless crystals, yield: 73 
%, mp 117 °C. 
1H NMR: 10.22 (s, 1 H), 7.44-7.86 (m, 5 H), 7.33 (d, 1 H), 7.02 (d, 1 H), 3.98 (s, 3 H).  
13C NMR: 186.9, 163.0, 157.7, 146.6, 145.2, 134.1, 131.9, 130.0, 118.6, 117.0, 116.1, 56.5. 
Ms (m/z): 274 ([M]+, 1 %). 
IR: 1738, 1688, 1571, 1480, 1433, 1306, 1267, 1211, 1136, 1076, 964, 904, 855. 
 
4.9.2.9 4-Benzoyloxy-3-bromo-5-methoxybenzaldehyde (8d) 
Prepared from 3-bromo-4-hydroxy-5-methoxybenzaldehyde (7b).  
White solid, yield: 68 %, mp 131-132 °C. 
1H NMR: 10.36 (s, 1 H), 7.40-7.80 (m, 5 H), 7.38 (s, 1 H), 7.12 (s, 1 H), 3.86 (s, 3 H). 
13C NMR: 189.6, 164.0, 151.0, 145.7, 134.4, 132.1, 129.6, 128.6, 127.4, 113.6, 109.1, 56.0. 
Ms (m/z): 334/336 ([M]+/[M+2]+, < 1 %). 
IR: 1736, 1691, 1580, 1473, 1462, 1450, 1420, 1389, 1317, 1280, 1259, 1215, 1193, 1132, 
1051,. 1037, 1021, 967, 870, 852, 833, 799, 722, 702, 689. 
 
4.9.2.10 4-Nitrocatechol dibenzoate (52) 
Prepared from 4-Nitrocatechol (51) and recrystallized from diisopropylether. White crystals:, 
yield: 66 %, mp 150 °C. 
1H NMR: 7.37-8.33 (m, 13 H). 
13C NMR: 163.7, 163.4, 148.1, 145.6, 142.9, 134.3, 130.3, 128.7, 128.0, 124.1, 122.0, 119.8 
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4.9.2.11 4-Methyl-5-nitrocatechol dibenzoate (55b) 
Prepared from 4-methyl-5-nitrocatechol (54). Brown solid, yield: 47 %, mp 133-136 °C. 
1H NMR: 7.39-7.96 (m, 12 H), 2.79 (s, 3 H). 
13C NMR: 164.1, 163.4, 150.0, 146.9, 139.9, 126-134 (10 C), 124.4, 20.8. 
Ms (m/z): 377 ([M]+, < 1 %), 181 , 136, 105 (100 %), 77, 51. 
IR: 1741, 1597, 1482, 1524, 1495, 1448, 1386, 1347, 1301, 1240, 1171, 1146, 1050, 901, 843, 
810, 757, 740, 703, 690, 669. 
 
 
4.9.2.12 4-Methyl-5-nitrocatechol diacetate (55c) 
Prepared from 4-methyl-5-nitrocatechol (54). Brown solid, yield: 54 %, mp 100 °C [lit.[88] 
103-105 °C]. 
1H NMR: 7.92 (s, 1 H), 7.19 (s, 1 H), 2.60 (s, 3 H), 2.56 (s, 3 H), 20.3 (s, 3 H). 
13C NMR: 167.7, 167.4, 145.9, 145.6, 140.3, 133.0, 127.2, 120.7, 20.6, 20.5. 
Ms (m/z): 253 ([M]+, < 1 %).  
 
 
 
4.10 Synthesis of Ether-Protected Phenolic or Catecholic Precursors 
 
4.10.1 Open Ethers: General Procedures 
 
A general procedure for protection of phenols as arylmethyl ethers involves the following: 
anhydrous K2CO3 (3.2 g) is cautiously added to a stirred solution of the proper phenol 
(13.4 mmol) in DMF (50 mL) at 60 °C. The mixture is kept at 110-120 °C during the 
portionwise addition of dimethyl sulfate (2.7 mL, 21.4 mmol). The mixture is stirred at 
110-120 ° for 5 h, cooled down to room temperature and poured onto ice-water (400 mL). The 
precipitate is collected by filtration and washed thoroughly with water. For two OH groups 
(protection of catechols as open ethers) the quantities are simply doubled. 
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4.10.2 Ether-Protected Phenolic or Catecholic Precursors  
 
4.10.2.1 3-Bromo-4,5-dimethoxybenzaldehyde (8c) 
Prepared from 3-bromo-4-hydroxy-5-methoxybenzaldehyde (7b). Recrystallization from 
diisopropyl ether gave white crystals. Yield: 86 %, mp 65-66 °C [lit.[64] 64-66 °C].  
1H NMR: 9.96 (s, 1 H), 7.58 (s, 1 H), 7.50 (s, 1 H),  3.86 (s, 3 H), 3.82 (s, 3 H). 
13C NMR: 190.0, 153.0, 149.2, 133.3, 128.4, 112.0, 110.0, 61.2, 56.0. 
Ms (m/z): 244/246 ([M]+/[M+2]+, 100 %). 
IR: 1686, 1586, 1563, 1484, 1449, 1419, 1392, 1379, 1310, 1278, 1238, 1128, 1044, 986, 855, 
837, 817, 786, 750, 742, 696, 665. 
 
4.10.2.2 2,3-Dimethoxy-6-nitrobenzaldehyde (19a) 
Prepared from 2-hydroxy-3-methoxy-6-nitrobenzaldehyde (18). Recrystallization from  
acetone gave white crystals. Yield: 70 %, mp 108-110 °C [lit.[68] 108-110 °C]. 
1H NMR: 10.35 (s, 1 H), 7.96 (d, 1 H), 7.05, (d, 1 H), 4.00 (s, 3 H), 3.96 (s, 3 H). 
13C NMR: 188.3, 158.6, 148.0, 130.4, 121.5, 112.6, 62.7, 56.6. 
Ms (m/z): 211 ([M]+, 20 %), 194, 181, 166 (100 %), 152, 138, 123, 107, 95, 77, 65, 51.  
IR: 1694, 1572, 1511, 1477, 1405, 1325, 1275, 1240, 1195, 1072, 1027, 988, 947, 897, 824. 
 
4.10.2.3 3,4-Dimethoxy-2-nitrobenzaldehyde (42h) 
Prepared from 3-methoxy-2-nitrobenzaldehyde-4-benzenesulfonate (42e). White powder. 
Yield: 58 %, mp 63-65 °C [lit.[80] 63.5-64 °C]. 
1H NMR:  10.0 (s, 1 H), 7.66 (d, 1 H), 7.12, (d, 1 H), 3.84 (s, 3 H), 3.80 (s, 3 H). 
13C NMR: 187.0, 144.2, 141.4, 156.6, 128.6, 122.1, 62.0, 56.7. 
Ms (m/z): 211 ([M]+, 40 %), 194, 181, 166, 152, 138, 123.  
IR: 1685, 1566, 1501, 1434, 1409, 1336, 1270, 1249, 1179, 1070, 1033, 984, 941, 900, 813. 
  
4.10.2.4 2,3-Dibromo-5,6-dimethoxybenzaldehyde (30a) 
Prepared from 2,3-dibromo-6-hydroxy-5-methoxybenzaldehyde (29). Light yellow solid. 
Yield: 70 %, mp 144 °C.  
1H NMR: 10.32 (s, 1 H), 7.25 (s, 1 H), 3.89 (s, 3 H), 3.86 (s, 3 H).  
13C NMR: 190.2, 152.9, 150.3, 131.4, 121.3, 120.6, 119.6, 114.7, 62.6, 60.5. 
Ms (m/z): 322/324/326  ([M]+/[M+2]+/[M+4]+,  100 %), . 
IR: 1694, 1569, 1556, 1456, 1429, 1397, 1298, 1258, 1232, 1202, 1179, 1069, 996, 975, 937, 
866, 813, 749, 699. 
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4.10.2.5 1,2-Dimethoxy-4-methyl-5-nitrobenzene (55a) 
Prepared from 4-methyl-5-nitrocatechol (54) and recrystallized from diisopropylether. Yellow 
solid. Yield: 69 %, mp 116-120 °C [lit.[90] 119-120 °C]. 
1H NMR: 7.65 (s, 1 H), 6.72 (s, 1 H), 3.96 (s, 3 H), 3.93 (s, 3 H), 2.62 (s, 3H). 
13C NMR: 153.0, 147.1, 129.0, 114.0, 108.2, 56.3, 21.3. 
Ms (m/z): 197 ([M]+, 100 %). 
IR: 1616, 1581, 1520, 1466, 1452, 1350, 1324, 1264, 1223, 1188, 1170, 1059, 981, 869, 795. 
 
 
4.10.3 Cyclic Ethers: General Procedure for five Membered Rings 
A general procedure for protection of catechols as cyclic five membered rings involves the 
following. A solution of the proper catechol (25 mmol) and freshly distilled acetone 
(30 mmol) in dry toluene (50 mL) is treated with good stirring under nitrogen over a period of 
30 min with PCl3 (40 mmol). Stirring is continued for another 30 until TLC shows the 
disappearance of the starting catechol. The solution is then treated with NaOH before being 
extracted with CH2Cl2. 
  
4.10.4 Five Membered Ring  Ether-Protected Catecholic Precursors 
 
4.10.4.1 6-Bromo-2,3-methylenedioxybenzaldehyde (33) 
 
Prepared from 6-Bromo-2,3-dihydroxybenzaldehyde (32). Colorless solid. Yield: 55 %, 
mp 156-159 °C [lit.[77] 158-160 °C]. 
1H NMR: 10.28 (s, 1 H), 7.12 (d, 1 H), 6.87 (d, 1 H), 6.16 (s, 2 H). 
13C NMR: 190.4, 149.5, 148.8, 126.2, 117.2, 115.6, 113.6, 103.4. 
Ms (m/z): 228/230 ([M]+/[M+2]+, 100 %), 199/201, 185/187, 171, 157/159, 143/145, 121. 
IR: 1677, 1617, 1586, 1505, 1450, 1396, 1348, 1240, 1210, 1115, 1048, 1017, 920, 876, 806, 
758, 701. 
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4.11 Synthesis of Phenolic or Catecholic Precursors Protected as Open 
Sulfonate Esters 
 
4.11.1 General Procedure 
A general procedure for the preparation of these precursors from the phenols (or catechols) 
involves the following. The proper phenol (10 mmol) in water (50 mL) is treated with KOH 
(12 mmol, 0.72 g). To this mixture there is added dropwise benzenesulfonyl chloride 
(10 mmol, 1.77 g, 1.3 mL) within 20-30 min. Stirring is continued over 24 h. The resulting 
solid is filtered, washed thoroughly with water (500 mL) and with 5 % KOH solution  (100 
mL). If the product is still oily, it is extracted first with CH2Cl2 (3 X 50 mL). The organic 
phase is washed with water and 5 % KOH and dried (MgSO4). The solvent is removed under 
vacuum at a rotational evaporator. 
4.11.2 Phenolic or Catecholic Precursors Protected as Open Sulfonate Esters 
 
4.11.2.1 2-Bromo-5-methoxybenzaldehyde-4-benzenesulfonate (8b) 
Prepared from 2-Bromo-4-hydroxy-5-methoxybenzaldehyde (7) and recrystallized from 
diisopropylether. White crystals: (yield: 85 %), mp  135-137 °C. 
1H NMR: 10.18 (s, 1 H), 7.28 (d, 1 H), 7.55 (d, 1 H), 3.86 (s, 3 H). 
13C NMR: 189.0, 152.9, 144.3,136.3, 134.4, 133.1, 129.0, 128.5, 117.5, 113.0, 56.2. 
Ms (m/z): 370/372 ([M]+/[M+2]+,80 %) 229/231 (85 %), 201/2032, 173/175, 141 (100 %).  
IR: 1691, 1589, 1481, 1448, 1370, 1304, 1267, 1190, 1140, 1089, 1037, 978, 882, 856, 764, 
750, 720, 700. 
 
4.11.2.2 6-Bromo-3-methoxybenzaldehyde-2-benzenesulfonate (15b) 
Prepared from 6-Bromo-2-hydroxy-3-methoxybenzaldehyde (14) and recrystallized from 
diisopropylether. White crystals: (yield: 93 %), mp 122-124 °C. 
1H NMR: 10.11 (s, 1 H), 7.92 (d, 1 H), 6.88 (d, 1 H), 7.27-7.70 (m, 5 H), 3.53 (s, 3 H). 
13C NMR: 188.3, 152.4, 136.3, 134.4, 133.1, 129.0, 128.5, 117.5, 113.0, 56.2. 
Ms (m/z): 370/372 ([M]+/[M+2]+, 30 %), 245/247, 229/231 (100 %), 214/216, 200/202, 
186/188, 173/175, 141, 121, 107, 94, 77. 
IR (cm-1): 1698, 1584, 1566, 1465, 1399, 1372, 1300, 1273, 1195, 1183, 1168, 1090, 1077, 
938, 896, 822, 775, 748, 682. 
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4.11.2.3 2,3-Dibromo-5-methoxybenzaldehyde-6-benzenesulfonate (30d) 
Prepared from 2,3-dibromo-6-hydroxy-5-methoxybenzaldehyde (29).  
White solid. yield: 81 %, mp 155 °C. 
1H NMR: 10.23 (s, 1 H), 7.49 (s, 3 H), 7.51-7.82 (m, 5 H), 3.91 (s, 3 H). 
13C NMR: 191.0, 147.4, 140.1, 139.7, 135.5, 127.5-133.0 (7 C), 122.9, 120.4, 56.0 
Ms (m/z): 448/450/452 ([M]+/[M+2]+[M+4]+, 10 %), 369/371, 323/325/327, 307/309/311 
(100 %), 292/294/296, 291, 266, 253, 185/187, 157/159, 141, 77, 51. 
IR: 1708, 1581, 1553, 1451, 1427, 1378, 1292, 1259, 1174, 1165, 1086, 998, 942, 904, 843, 
788, 768, 753, 730, 677. 
 
4.11.2.4 6-Fluoro-3-methoxybenzaldehyde-2-benzenesulfonate (41c) 
Prepared from 6-fluoro-2-hydroxy-3-methoxybenzaldehyde (40).  
White solid. Yield 76 %, mp  133 °C. 
1H NMR: 10.66 (s, 1 H), 7.28 (d, 1 H), 7.02 (d, 1 H), 7.39-7.73 (m, 5 H), 4.02 (s, 3 H). 
Ms (m/z): 310 ([M]+, 15 %), 203, 185, 169 (100 %), 154,. 141, 125, 98, 77, 70, 51.  
 
4.11.2.5 Phenylbenzenesulfonate (42a) 
Prepared from phenol. Identified by comparison of its melting point with the reported value. 
Oily material which solidify on standing in refrigerator for several days. Yield 87 %, mp 
35-39 °C [lit.[81] 36-37 °C]. 
4.11.2.6 Benzaldehyde-2-benzenesulfonate (42b) 
Prepared from 2-hydroxybenzaldehyde. Identified by comparison of its melting point with the 
reported value. Pink solid. Yield 76 %, mp  57-59 °C [lit.[81] 56-58.5 °C]. 
4.11.2.7 Benzaldehyde-4-benzenesulfonate (42c) 
Prepared from 4-hydroxybenzaldehyde. Identified by comparison of its melting point with the 
reported value. Pink solid. Yield 80 %, mp 80-82 °C [lit. [82] 81-82]. 
4.11.2.8 3-Methoxybenzaldehyde-4-benzenesulfonate (42d) 
Prepared from 3-methoxy-4-hydroxybenzaldehyde (4).  
White solid. Yield 76 %, mp 69-70 °C [lit.[67] 69-70 °C]. 
1H NMR: 10.12 (s, 1 H), 7.10-7.85 (m,  8 H), 3.55 (s, 3 H). 
13C NMR: 191.3, 154.5, 142.3, 135.9, 133.6, 131.3, 129.4, 128.9, 127.5, 112.6, 118.0, 55.9. 
Ms (m/z):  292 ([M]+, 15 %), 176, 152, 151 (100 %), 141, 123, 109, 95, 81, 77.  
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IR: 1683, 1597, 1497, 1463, 1450, 1398, 1382, 1321, 1274, 1192, 1202, 1175, 1143, 1118, 
1086, 1025, 960, 857, 844, 833, 754, 726, 691. 
 
4.11.2.9  4-Nitrocatechol dibenzenesulfonate (42f) 
Prepared from 4-nitrocatechol (51). White solid. Yield 76 %, mp 135-139 °C [lit.[83] 
136-137 °C].  
1H NMR: 8.42 (s, 1 H), 8.05 (d, 1 H), 7.76 (d, 1 H), 7.61-7.85 (m, 10 H).  
13C NMR: 144.47, 142.9, 139.8, 122.6, 118.9, 115.4, 129-134 (12 C). 
Ms (FAB, m/z): 371 ([M+1]+, 33 %).  
IR: 1591, 1529, 1489, 1376, 1361, 1300, 1255, 1244, 1129, 1055, 970, 854, 780, 722, 671. 
 
4.11.2.10  4-Methyl-5-nitrocatechol dibenzenesulfonate (42g) 
Prepared from 4-methyl-5-nitrocatechol (54). White solid. Yield 76 %, mp 155 °C. 
1H NMR: 8.26 (s, 1 H), 7.28 (s, 1 H), 7.55-7.84 (m, 10 H), 2.69 (s, 3 H). 
13C NMR: 147.5, 141.3, 138.0, 129.3-135.2 (12 C), 128.0, 122.0, 114.2, 20.9. 
Ms (FAB, m/z): 386 ([M+1]+, 20 %).  
IR: 1585, 1535, 1498, 1360, 1348, 1279, 1213, 1172, 1155, 1129, 1034, 967, 883, 831, 799, 
761, 701, 677. 
 
 
4.12 Miscellaneous 
 
4.12.1 Aldehydic Precursors Protected as Cyclic Acetals: General Procedure 
The protection of the aldehyde group as cyclic acetals can be achieved by the following 
general procedure. The proper aldehyde (7.5 mmol), ethylene glycol (6.4 g, 10.3 mmol) and 
p-toluenesulfonic acid monohydrate (200 mg) are dissolved in toluene (75 mL) and the 
mixture is refluxed in the Dean-Stark apparatus for 2.5 d. The solution is then poured on 
water (100 mL). The organic phase is separated, washed with water and saturated NaHCO3 
and dried (MgSO4). It is then removed in vacuo. 
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4.12.2  Aldehydic Precursors Protected as Cyclic Acetals 
 
4.12.2.1  3-Bromo-5,6-dimethoxy-2-nitrobenzaldehyde ethyleneacetal (49) 
Prepared from 3-Bromo-5,6-dimethoxy-2-nitrobenzaldehyde (31) and purified by MPLC. 
White solid. Yield 68 %, mp  79.5-80.5 °C.  
1H NMR: 7.14 (s, 1 H), 6.17 (s, 1 H), 3.91 (s, 3 H), 3.89 (s, 3 H), 4.02 (t, 2 H), 4.00 (t, 2 H). 
Ms (FD, m/z): 3357336 ([M]+/[M+2]+). 
IR: 1577, 1534, 1477, 1430, 1382, 1357, 1310, 1268, 1229, 1172, 1128, 1060, 1018, 956, 939, 
835, 800, 771, 745, 660. 
 
4.12.2.2  2,3-Dimethoxy-6-nitrobenzaldehyde ethyleneacetal (50) 
Prepared from 2,3-dimethoxy-6-nitrobenzaldehyde (19a) and purified by MPLC. White solid. 
Yield 75 %, mp 74-76°C [lit.[87] 74-76 °C]. 
1H NMR: 7.26 (d, 1 H), 7.13 (d, 1 H), 6.18 (s, 1 H), 3.91 (s, 3 H), 3.89 (s, 3 H), 4.10 (t, 2 H), 
3.99 (t, 2 H). 
Ms (m/z): 256 ([M+1]+, 25 %), 255 ([M]+, 8 %), 205, 180, 163, 150, 136, 122, 107, 93, 73. 
IR: 1583, 1538, 1483, 1440, 1374, 1363, 1309, 1275, 1238, 1178, 1112, 1016, 971, 938, 860, 
821, 810, 773, 735, 655. 
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5 SUMMARY 
 
The objective of this work was to investigate the nucleophilic aromatic substitution using 
[18F]fluoride as nucleophile. Therefore, structures ranging from simple monosubstituted 
aromatic systems to complicated multi-substituted aromatic systems were tested, and several 
effects were studied in detail, including the following: 
1- Structural effects (positions and number of groups on the ring, type of activation or 
deactivation, type of possible leaving groups and type of protection of OH groups). 
2- Solvent effects (was studied using a variety of dipolar aprotic solvents) 
3-  Concentration effects (was studied using concentrations 1-50 mg/mL). 
4- Temperature effects (was studied using temperatures 60-180 °C). 
 
Two types of reactions were studied. Those are: 
1- Fluorodenitration reactions:  Ar-NO2   →   Ar-18F 
2- Fluorodehalogenation reactions:  Ar-X   →   Ar-18F            (X= F, Br, Cl) 
 
The study was divided into 3 parts. In the first part, aryl systems (including haloaryls, 
nitroaryls, benzaldehydes, acetophenones and benzophenones) were tested. In the second part, 
the focus was on optimising the conditions for the production of [18F]FDOPA precursors for 
path A (chapter 2). In the last part, model systems for producing [18F]FDOPA via path B 
(chapter 2) were tested in the nucleophilic aromatic substitution by [18F]fluoride. The 
radiochemical yields (RCYs) obtained from some precursors were used further to calculate 
the rate constants and the energy of activation for this process.  
 
 
The main results can be summarised in the following points: 
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1- Fluorodenitration reactions can be used efficiently to produce nca [18F]arylfluorides. DMF 
is the best solvent but DMSO and DMAc can be used also. For very activated systems, 
acetonitrile can be used at lower temperatures. The optimum temperature range is 120-150 
°C, although lower temperatures can be used for very activated systems. The optimum 
concentration range is  15-30 mg/mL and optimum time is 10-20 min.  
2- Fluorodehalogenation (X= F) reactions can also be a good alternative for the synthesis of  
[18F]arylfluorides. DMF is the best solvent and most other solvents proved to be less 
efficient for carrying out this process. Optimum conditions being nearly the same as in 
fluorodenitration reactions.  
3- Fluorodehalogenation (X= Br, Cl) reactions can also be used for the synthesis of  nca 
[18F]arylfluorides when the conditions are well optimised. For this, DMF is the best 
solvent and most other solvents proved to be not useful. Aromatic systems with electron 
withdrawing groups only on the ring gave yields which were almost comparable to those 
from fluorodenitration reactions. However, with the increasing introduction of electron 
donating groups on the aromatic ring, the yield tend to be much lower compared to similar 
nitro systems. The RCYs were always directly proportional both to concentrations up to 
50 mg/mL and temperatures as high as 180 °C. 
 
Calculations of the activation energy for the previous processes reveals low values in the 
range 16-63 kJ/mole for most compounds but even lower values were obtained for very 
highly activated compounds towards SNAr. These values indicate very fast reactions between 
the fluoride ion and the substituted nitro or halo benzene derivatives. In all cases the yields 
from the nitro derivatives were better than the halo derivatives. Within the halogens, the 
fluoro precursors gave always the highest yields.  
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7 APPENDICIES 
 
 
6.1 Appendix 1: Data for Aryl Systems 
 
Tab. 33. [18F] Labelling data for  mono, di and tribromobenzenes. 
RCY (%) 
5 min 10 min 20 min 30 min 60 min Precursor n 
Mean Sdv Mean Sdv Mean Sdv Mean Sdv Mean Sdv
Mono 2 1.4 0.4 1.1 0.2 1.4 0.2 1.8 0.4 0.5 0.2
o-dibromo 3 5.6 2.2 8.2 2.7 10.0 1.9 10.9 0.5 10.7 3.9
m-dibromo 4 6.7 2.6 9.1 3.5 12.2 2.2 15.7 4.0 12.9 4.1
p-dibromo 4 2.3 0.9 3.7 1.6 4.9 1.1 6.1 2.9 5.7 1.6
1,2,4-tribromo 5 33.3 11.0 45.1 11.7 46.9 11.4 48.6 3.3 50.8 5.7
1,3,5-tribromo 4 56.9 10.8 62.6 9.3 63.3 7.4 64.3 8.0 57.9 6.1
 
Tab. 34. [18F] Labelling data for dichlorobenzenes. 
RCY (%) 
5 min 10 min 20 min 30 min 60 min Precursor n 
Mean Sdv Mean Sdv Mean Sdv Mean Sdv Mean Sdv 
o-dichloro 3 2.9 1.6 3.5 1.5 3.5 0.8 3.8 0.2 3.4 0.5 
m-dichloro 3 2.6 0.3 3.5 0.4 4.1 0.6 4.3 0.4 7.3 0.8 
p-dichloro 3 0.8 0.4 1.3 0.6 1.3 0.3 1.4 0.5 1.6 0.2 
 
Tab. 35. [18F] Labelling data for o-dinitrobenzene in DMF and CH3CN 
RCY (%) 
5 min 10 min 20 min 30 min 60 min Solvent Temp.(°C) n 
Mean Sdv Mean Sdv Mean Sdv Mean Sdv Mean Sdv
80 4 79.1 7.8 80.3 7.8 82.0 6.1 81.6 5.4 83.6 5.4
100 4 82.0 2.6 81.3 2.0 82.5 1.4 80.6 3.4 75.2 6.4
120 4 81.4 4.7 77.8 6.8 74.2 9.6 69.8 10.2 63.6 12.6
DMF 
140 4 58.4 9.1 46.5 9.1 35.5 5.6 27.7 6.5 15.2 2.3
40  3 51.4 8.0 57.1 2.3 64.5 0.6 66.7 3.0 69.6 5.4
60 3 77.8 5.6 79.9 5.1 81.4 1.0 83.4 4.4 73.4 3.9CH3CN 
80 5 77.5 2.5 78.8 4.0 84.7 3.8 82.4 5.5 80.4 3.0
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Tab. 36. [18F] Labelling data for the three bromonitrobenzene isomers  
RCY (%) 
5 min 10 min 20 min 30 min 60 min Precursor n 
Mean Sdv Mean Sdv Mean Sdv Mean Sdv Mean Sdv
o-isomer 4 58.4 9.1 46.5 9.0 35.5 5.6 27.7 6.5 15.2 2.3
m-isomer- 4 25.7 3.3 30.1 2.7 30.0 3.1 28.6 2.1 23.9 3.2
p-isomer 3 65.6 8.8 66.7 5.7 60.3 5. 56.6 8.8 43.7 9.9
 
 
Tab. 37. [18F] Labelling data for o-nitrobenzaldehyde in DMF. 
RCY (%) 
5 min 10 min 20 min 30 min 60 min Temp. (°C) n 
Mean Sdv Mean Sdv Mean Sdv Mean Sdv Mean Sdv 
50  3 12.2 5.8 21.0 7.7 31.0 8.9 43.8 12.6 54.3 11.8 
80 4 51.7 0.8 60.1 2.3 65.2 5.8 72.7 2.1 77.5 1.4 
100 3 61.6 7.1 65.3 7.1 64.3 2.4 65.5 4.8 70.0 5.5 
120 4 63.0 4.9 65.9 6.7 68.4 1.2 70.5 4.8 74.0 5.2 
140 4 64.8 4.9 69.3 4.4 69.3 4.0 73.2 0.2 78.1 0.9 
160 1 70.0 3.1 74.0 2.6 75.5 2.1 76.5 3.6 78.6 1.7 
 
Tab. 38. Calculations of activation energy and rate constants for 
o-nitrobenzaldehyde in DMF. 
ln (1-RCY) Temp. 
(°C) 5 min 10 min 20 min 30 min 60 min 
80 -0.7277 -0.9188 -1.0556 -1.2983 -1.4917 
100 -0.9571 -1.0584 -1.0300 -1.0642 -1.2040 
120 -0.9943 -1.0759 -1.1520 -1.2208 -1.3471 
140 -1.0441 -1.1809 -1.1809 -1.3168 -1.5187 
Temp. 
(°C) 
Best linear graph for  
ln (1-RCY) vs time  
Correlation 
coefficient k’ (min
-1) ln k’ 
80 Y= - 0.0894 – 0.0919 X -0.95 0.0919 -3.3871 
100 Y= - 0.1426 – 0.1058 X -0.91 0.1058 -2.2462 
120 Y= - 0.1521 – 0.1076 X -0.90 0.1076 -2.2293 
140 Y= - 0.1521 – 0.1181X -0.91 0.1181 -2.1362 
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Tab. 39. [18F] Labelling data for p-nitroacetophenone in DMF and DMSO 
RCY (%) 
5 min 10 min 20 min 30 min 60 min Solvent Temp. (°C) n 
Mean Sdv Mean Sdv Mean Sdv Mean Sdv Mean Sdv
50 2 0 0 0.4 0.1 0.7 0.1 1.2 0.4 1.7 0.5
80 2 7.9 2,3 12.7 2,6 17.7 3,3 21.1 1,6 25.3 4.0
100 2 19.7 1.7 25.8 2.0 32.8 0.3 38.0 5.6 41.8 7.0
120 2 26.4 6.5 34.3 7.7 42.0 8.2 47.3 9.5 49.2 9.8
140 2 43.1 13.2 49.5 8.4 50.7 3.3 50.5 4.5 50.8 5.6
DMF 
160 2 59.5 1.4 63.3 1.7 67.0 11.7 72.5 13.7 61.0 8.1
50 3 0 0 0.3 0 0.4 0 0.4 0 0.6 0 
80 3 5.9 1.2 11.0 2.3 17.0 4.1 19.8 3.8 20.7 4.5
100 3 13.5 1.9 20.7 3.9 27.0 4.4 31.6 4.1 40.4 6.6
120 4 25.0 5.0 37.0 4.1 41.2 3.9 49.6 7.9 53.6 11.1
140 4 40.6 6.6 50.2 8.9 57.8 8.1 60.7 6.4 60.3 10.3
DMSO 
160 4 52.3 7.7 59.6 6.5 60.4 8.6 60 8.3 48.8 10.1
 
 
Tab. 40. Calculations of activation energy and rate constants for 
p-nitroacetophenone in DMF. 
ln (1-RCY) Temp. 
(°C) 
5 min 10 min 20 min 30 min 60 min 
80 -0.0823 -0.1358 -0.1948 -0.2370 -0.2917 
100 -0.2194 -0.2984 -0.3975 -0.4780 -0.5413 
120 -0.3065 -0.4201 -0.5447 -0.6401 -0.6773 
140 -0.5639 -0.6832 -0.7072 -0.7032 -0.7093 
Temp. 
(°C) 
Best linear graph for  
ln (1-RCY) vs time  
Correlation 
coefficient k’ (min
-1) ln k’ 
80 Y= - 0.0048 – 0.0136 X - 0.99 0.0136 -4.2977 
100 Y= - 0.0234 –  0.0298X -0.97 0.0298 -3.5132 
120 Y= - 0.0322 –  0.0420X -0.97 0.0420 -3.1701 
140 Y= - 0.0741 – 0.0683 X -0.93 0.0683 -2.6838 
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6.2 Appendix 2: Data for 6-Nitroveratraldehyde 
 
 
 
 
Tab. 41. [18F] Labelling data for 6-nitroveratraldehyde. Conditions: 
a) 20 mg/mL,140 °C. b) DMF (1 mL), 140 °C. c) 20 mg/mL, DMF (1 mL). 
RCY (%) ± Sdv 
Variable 
5 min 10 min 20 min 30 min 60 min 
DMF 83.2 ± 6.3 89.7 ± 2.0 88.7 ± 1.8 85.9 ± 2.7 82.3 ± 3.6 
DMAc 68.1 ± 0.1 75.6 ± 2.0 75.1 ± 3.0 74.4 ± 4.3 71.9 ± 1.5 
DMSO 69.0 ± 1.9 70.5 ± 1.9 71.4 ± 3.8 69.6 ± 3.9 65.8 ± 3.4 
Sulfolane 33.3 ± 0.1 37.5 ± 3.8 40.1 ± 1.8 39.7 ± 3.0 37.7 ± 0.7 So
lv
en
t a
 
1,2-DME 56.9 ± 7.0 59.9 ± 5.0 49.7 ± 7.8 45.5 ± 3.9 42.0 ± 0.1 
0.5 29.0 ± 0.7 31.4 ± 1.6 27.4 ± 4.9 26.2 ± 5.6 21.6 ± 2.6 
1 62.4 ± 8.0 63.3 ± 6.4 59.9 ± 6.1 53.6 ± 4.8 41.9 ± 2.9 
3 60.5 ± 1.3 63.9 ± 0.7 66.8 ± 3.5 64.8 ± 1.1 56.2 ± 7.0 
6 68.7 ± 4.3 68.7 ± 3.7 68.5 ± 4.4 66.2 ± 4.2 66.0 ± 0.1 
10 75.5 ± 6.0 75.5 ± 5.3 76.9 ± 6.0 77.8 ± 6.3 73.2 ± 9.8 
20 83.2 ± 6.3 89.7 ± 2.0 88.7 ± 1.8 85.9 ± 2.7 82.3 ± 3.6 
30 85.9 ± 2.3 85.5 ± 2.1 82.6 ± 0.1 81.6 ± 0.8 80.9 ± 0.1 Co
nc
en
tr
at
io
n 
b  
(m
g/
m
L
) 
50 85.5 ± 1.6 84.7 ± 1.1 81.9 ± 0.8 82.6 ± 0.2 81.0 ± 0.1 
80 36.0 ± 0.1 35.1 ± 6.0 45.1 ± 6.2 48.8 ± 4.4 63.5 ± 4.4 
100 60.6 ± 7.6 67.2 ± 9.9 70.1 ± 10.1 72.3 ± 5.9 78.6 ± 10.9 
120 64.4 ± 0.1 80.2 ± 12.7 80.9 ± 9.4 82.4 ± 8.8 77.2 ± 9.6 
140 83.2 ± 6.3 89.7 ± 2.0 88.7 ± 1.8 85.9 ± 2.7 82.3 ± 3.6 
T
em
pe
ra
tu
r 
c  
(°C
) 
150 85.4 ± 5.3 87.0 ± 3.2 89.6 ± 1.4 87.2 ± 3.7 85.4 ± 3.3 
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Tab. 42. Calculations of activation energy and rate constants for 
6-nitroveratraldehyde. 
ln (1-RCY) 
Time  
(min) 
80 °C 100 °C 120 °C 140 °C 150 °C 
5 -0.4463 -0.9314 -1.0328 -1.7838 -1.9241 
10 -0.4323 -1.1147 -1.6210 -2.2711 -2.0379 
20 -0.5997 -1.2073 -1.6570 -2.1813 -2.2672 
30 -0.6694 -1.2837 -1.7390 -1.9618 -2.0557 
60 -1.0079 -1.5418 -1.4784 -1.7293 -1.9262 
Temp. 
(°C) 
Best linear graph for  
ln (1-RCY) vs time  
Correlation 
coefficient k’ (min
-1) ln k’ 
80 Y= - 0.0768 – 0.0432 X -0.85 0.0432 -3.1419 
100 Y= - 0.1247 – 0.1114 X -0.93 0.1114 -2.1946 
120 Y= - 0.0741 – 0.1621 X -0.99 0.1621 -1.8195 
140 Y= - 0.2161 – 0.2271 X -0.95 0.2271 -1.4824 
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6.3 Appendix 3: Data for 6-Fluoroveratraldehyde 
 
 
 
 
Tab. 43. [18F] Labelling data for 6-fluoroveratraldehyde. Conditions: 
a) 20 mg/mL,140 °C. b) DMF (1 mL), 140 °C. c) 20 mg/mL, DMF (1 mL). 
RCY (%) ± Sdv 
Variable 
5 min 10 min 20 min 30 min 60 min 
DMF 87.7 ± 1.2 85.0 ± 5.3 85.0 ± 1.7 82.7 ± 0.3 80.4 ± 1.8 
DMAc 53.4 ± 4.9 45.1 ± 5.3 41.5 ± 5.0 37.3 ± 2.7 37.5 ± 2.1 
DMSO 44.4 ± 0.8 35.6 ± 3.9 31.6 ± 3.5 28.6 ± 5.3 26.9 ± 1.8 
So
lv
en
t a
 
Sulfolane 42.7 ± 5.2 41.8 ± 3.8 42.0 ± 0.6 41.3 ± 2.9 38.7 ± 1.1 
0.5 64.5 ± 0.5 67.1 ± 2.5 66.7 ± 4.7 60.4 ± 6.2 59.4 ± 0.9 
1 75.2 ± 3.9 71.2 ± 3.9 69.1 ± 4.4 64.5 ± 7.7 64.5 ± 2.3 
5 85.0 ± 0.8 84.1 ± 2.4 81.5 ± 1.6 79.9 ± 4.7 78.5 ± 3.3 
10 85.5 ± 2.2 86.3 ± 4.0 83.6 ± 3.8 80.4 ± 6.2 79.9 ± 0.6 
20 87.7 ± 1.2 85.0 ± 5.3 85.0 ± 1.7 82.6 ± 0.3 80.4 ± 1.8 
30 87.4 ± 1.3 86.1 ± 1.7 86.9 ± 1.0 83.6 ± 1.3 81.4 ± 0.7 Co
nc
en
tr
at
io
n 
b  
(m
g/
m
L
) 
50 87.7 ± 1.4 87.1 ± 0.8 87.5 ± 1.3 87.4 ± 1.4 85.6 ± 1.0 
60 32.5 ± 8.8 34.5 ± 8.5 37.9 ± 7.4 40.4 ± 7.7 44.2 ± 2.9 
80 51.4 ± 7.6 57.7 ± 1.7 61.6 ± 1.7 63.2 ± 2.0 63.3 ± 2.3 
100 66.7 ± 9.3 71.0 ± 5.5 72.2 ± 6.0 71.7 ± 3.1 68.1 ± 2.0 
120 81.0 ± 4.3 82.1 ± 4.5 80.9 ± 2.8 80.4 ± 5.3 77.7 ± 3.7 
140 87.7 ± 1.2 85.0 ± 5.3 85.0 ± 1.7 82.7 ± 0.3 80.4 ± 1.8 
160 86.8 ± 2.3 82.1 ± 1.7 79.8 ± 3.0 78.4 ± 4.0 78.4 ± 2.5 Te
m
pe
ra
tu
r 
c  
(°C
) 
180 85.9 ± 3.6 82.0 ± 5.0 78.6 ± 3.8 73.8 ± 3.3 73.1 ± 1.2 
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Tab. 44. Calculations of activation energy and rate constants for 
6-fluoroveratraldehyde. 
Time  
(min) ln (1-RCY) 
 60 °C 80 °C 100 °C 120 °C 140 °C 160 °C 180 °C 
5 -0.3930 -0.7215 -1.0996 -1.6607 -2.0956 -2.0249 -1.9590 
10 -0.4231 -0.8604 -1.2379 -1.7204 -1.8971 -1.7204 -1.7148 
20 -0.4764 -0.9571 -1.2801 -1.6555 -1.8971 -1.5995 -1.5418 
30 -0.5175 -0.9996 -1.2623 -1.6296 -1.7545 -1.5325 -1.3394 
60 -0.5834 -1.0024 -1.1426 -1.5006 -1.6296 -1.5325 -1.3130 
Temp. 
(°C) 
Best linear graph for  
ln (1-RCY) vs time  
Correlation 
coefficient k’ (min
-1) ln k’ 
80 Y= - 0.0971 – 0.0860 X -0.93 0.0860 -2.4534 
100 Y= - 0.1602 – 0.1238 X -0.91 0.1238 -2.0891 
120 Y= - 0.2668 – 0.1720 X -0.88 0.1720 -1.7603 
140 Y= - 0.3824 – 0.1897 X -0.82 0.1897 -1.6623 
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6.4 Appendix 4: Data for 6-Bromoveratraldehyde 
 
 
 
Tab. 45. [18F] Labelling data for 6-bromoveratraldehyde. Conditions: 
a) 20 mg/mL,160 °C. b) DMF (1 mL), 160 °C. c) 20 mg/mL, DMF (1 mL).
RCY (%) ± Sdv 
Variable 
5 min 10 min 20 min 30 min 60 min 
DMF 30.8 ± 6.6 38.9 ± 5.6 44.5 ± 5.0 44.7 ± 4.0 45.5 ± 5.4 
DMAc 19.8 ± 5.3 22.1 ± 3.3 23.4 ± 2.3 25.6 ± 2.1 27.2 ± 0.2 
DMSO 3.2 ± 0.7 3.2 ± 1.2 3.5 ± 0.9 2.7 ± 1.0 2.4 ± 1.0 
So
lv
en
t a
 
Sulfolane 6.8 ± 2.5 10.2 ± 2.6 13.0 ± 3.1 11.4 ± 2.3 11.4 ± 0.3 
0.5 4.4 ± 0.9 6.6 ± 1.7 6.1 ± 3.1 5.1 ± 3.5 5.6 ± 1.7 
1 15.9 ± 4.5 17.6 ± 5.1 17.2 ± 4.3 15.9 ± 2.2 16.5 ± 1.1 
5 23.4 ± 3.4 27.4 ± 3.8 30.1 ± 2.8 31.1 ± 4.2 32.8 ± 0.9 
10 24.8 ± 1.9 28.9 ± 0.7 31.1 ± 1.7 32.2 ± 0.7 35.3 ± 0.7 
20 30.8 ± 6.6 38.9 ± 5.6 44.5 ± 5.0 44.7 ± 4.0 45.5 ± 5.4 
30 41.4 ± 6.8 44.5 ± 4.4 45.5 ± 1.8 50.3 ± 4.6 51.3 ± 4.2 Co
nc
en
tr
at
io
n 
b  
(m
g/
m
L
) 
50 50.4 ± 1.7 54.2 ± 2.2 56.9 ± 0.9 58.1 ± 0.4 58.1 ± 0.8 
80 1.3 ± 0.7 2.4 ± 0.7 2.7 ± 1.0 3.5 ± 1.0 5.1 ± 0.3 
100 5.1 ± 1.1 8.5 ± 1.6 12.8 ± 3.1 14.3 ± 2.9 16.2 ± 0.8 
120 15.3 ± 3.4 18.6 ± 5.1 23.9 ± 5.9 27.2 ± 4.7 29.1 ± 2.4 
140 36.7 ± 2.9 38.9 ± 2.6 42.3 ± 4.0 4.3 ± 3.9 40.5 ± 1.8 
160 30.8 ± 6.6 38.9 ± 5.6 44.5 ± 5.0 44.7 ± 4.0 45.5 ± 5.4 Te
m
pe
ra
tu
r 
c  
(°C
) 
180 45.7 ± 9.0 49.8 ± 9.3 50.2 ± 9.6 49.2 ± 8.5 49.9 ± 11.1 
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Tab. 46. Calculations of activation energy and rate constants for 
6-bromoveratraldehyde. 
ln (1-RCY) 
Time  
(min) 
80 °C 100 °C 120 °C 140 °C 160 °C 180 °C 
5 -0.0131 -0.0523 -0.1661 -0.4573 -0.3682 -0.6106 
10 -0.0243 -0.0888 -0.2058 -0.4927 -0.4927 -0.6892 
20 -0.0274 -0.1370 -0.2731 -0.5499 -0.5888 -0.6972 
30 -0.0356 -0.1543 -0.3175 -0.5499 -0.5924 -0.6773 
60 -0.0523 -0.1767 -0.3439 -0.5192 -0.6070 -0.6911 
Temp. 
(°C) 
Best linear graph for  
ln (1-RCY) vs time  
Correlation 
coefficient k’ (min
-1) ln k’ 
80 Y= - 3.1667E-4 – 0.0024 X -1.00 0.0024 -6.0323 
100 Y= - 0.0026 – 0.0089 X -0.99 0.0089 -4.7217 
120 Y= - 0.0211 – 0.0206 X -094 0.0206 -3.8825 
140 Y= - 0.0703 – 0.0493 X -0.90 0.0493 -3.0098 
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6.5 Appendix 5: Data for 6-Chloroveratraldehyde 
 
 
 
 
Tab. 47. [18F] Labelling data for 6-chloroveratraldehyde. Conditions: 
a) 20 mg/mL,160 °C. b) DMF (1 mL), 160 °C. c) 20 mg/mL, DMF (1 mL). 
RCY (%) ± Sdv 
Variable 
5 min 10 min 20 min 30 min 60 min 
DMF 45.8 ± 8.9 52.0 ± 9.7 56.5 ± 6.7 56.4 ± 7.1 57.4 ± 5.6 
DMAc 9.3 ± 3.2 10.9 ± 3.1 11.3 ± 4.6 11.5 ± 4.4 11.8 ± 1.6 
DMSO 1.6 ± 0.8 3.3 ± 0.9 3.7 ± 1.1 3.6 ± 0.7 3.3 ± 0.4 
So
lv
en
t a
 
Sulfolane 6.9 ± 1.6 6.1 ± 1.6 7.5 ± 1.3 7.7 ± 1.6 9.1 ± 0.3 
0.5 8.1 ± 2.7 11.7 ± 2.3 12.0 ± 1.3 12.9 ± 1.6 13.8 ± 0.4 
1 19.1 ± 4.2 22.7 ± 5.5 22.1 ± 4.4 22.2 ± 4.2 24.5 ± 1.4 
5 39.5 ± 4.4 43.2 ± 4.5 46.0 ± 5.1 44.7 ± 9.1 46.5 ± 2.5 
10 44.6 ± 3.1 46.5 ± 4.7 50.1 ± 3.8 52.4 ± 3.0 56.5 ± 1.2 
20 45.8 ± 8.9 52.0 ± 9.7 56.5 ± 6.7 56.4 ± 7.1 57.4 ± 5.6 
30 56.9 ± 6.9 59.3 ± 4.5 60.4 ± 6.1 60.0 ± 2.1 60.1 ± 1.2 Co
nc
en
tr
at
io
n 
b  
(m
g/
m
L
) 
50 63.5 ± 5.2 64.0 ± 1.4 65.6 ± 3.6 63.4 ± 5.5 52.8 ± 5.4 
80 1.9 ± 0.9 3.0 ± 0.6 3.9 ± 0.7 4.4 ± 1.2 4.8 ± 0.2 
100 8.0 ± 3.5 12.5 ± 3.4 17.1 ± 3.9 17.7 ± 3.8 19.9 ± 1.6 
120 12.4 ± 5.6 18.6 ± 5.4 26.9 ± 8.6 30.8 ± 8.6 34.3 ± 8.1 
140 53.1 ± 1.3 56.9 ± 6.6 54.8 ± 5.5 52.3 ± 4.1 51.5 ± 1.0 
160 45.8 ± 8.9 52.0 ± 9.7 56.5 ± 6.7 56.4 ± 7.1 57.4 ± 5.6 Te
m
pe
ra
tu
r 
c  
(°C
) 
180 51.5 ± 10.9 54.1 ± 9.5 57.3 ± 7.8 52.5 ± 10.2 53.0 ± 4.8 
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Tab. 48. Calculations of activation energy and rate constants for 
6-chloroveratraldehyde. 
ln (1-RCY) 
Time  
(min) 
80 °C 100 °C 120 °C 140 °C 160 °C 180 °C 
5 -0.0192 -0.0834 -0.1324 -0.7572 -0.6125 -0.7236 
10 -0.0305 -0.1335 -0.2058 -0.8416 -0.7340 -0.7787 
20 -0.0398 -0.1875 -0.3133 -0.7941 -0.8324 -0.8510 
30 -0.0450 -0.1948 -0.3682 -0.7402 -0.8301 -0.7444 
60 -0.0492 -0.2219 -0.4201 -0.7236 -0.7444 -0.7550 
Temp. 
(°C) 
Best linear graph for  
ln (1-RCY) vs time  
Correlation 
coefficient k’ (min
-1) ln k’ 
80 Y= - 0.0013 – 0.0031 X -0.99 0.0031 -5.7764 
100 Y= - 0.0056 – 0.0134 X -0.99 0.0134 -4.3125 
120 Y= - 0.0098 – 0.0206 X .0.99 0.0206 -3.8825 
140 Y= - 0.1121 – 0.0842 X -0.91 0.0842 -2.4746 
160 Y= - 0.0818 – 0.0734 X -0.93 0.0734 -2.6118 
180 Y= - 0.1114 – 0.0779 X -0.90 0.0779 -2.5523 
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6.6 Appendix 6: Data for 6-Nitropiperonal 
 
 
 
Tab. 49. [18F] Labelling data for 6-nitropiperonal. Conditions: a) 20 mg/mL,140 °C. 
b) DMF (1 mL), 140 °C. c) 20 mg/mL, DMF (1 mL). 
RCY (%) ± Sdv 
Variable 
5 min 10 min 20 min 30 min 60 min 
DMF 67.6 ± 5.2 67.0 ± 6.6 61.3 ± 5.1 59.4 ± 4.6 58.1 ± 4.8 
DMAc 70.8 ± 0.4 75.3 ± 1.6 73.6 ± 2.3 72.1 ± 2.2 67.8 ± 1.2 
DMSO 57.2 ± 4.2 56.4 ± 2.6 53.6 ± 2.7 52.4 ± 2.3 51.5 ± 1.4 
Sulfolane 59.3 ± 2.6 59.1 ± 3.1 54.7 ± 2.1 53.5 ± 2.2 51.1 ± 1.3 So
lv
en
t a
 
1,2-DME 10.7 ± 5.7 14.4 ± 4.4 21.3 ± 2.5 29.2 ± 2.8 31.8 ± 2.6 
0.5 36.3 ± 7.7 26.5 ± 6.8 15.5 ± 4.7 9.7 ± 1.9 9.0 ± 0.9 
1 58.9 ± 7.7 47.5 ± 3.5 30.7 ± 5.3 16.0 ± 1.4 13.5 ± 1.3 
5 62.0 ± 4.3 55.8 ± 6.1 43.5 ± 5.9 35.0 ± 5.1 35.3 ± 1.1 
10 60.9 ± 5.7 62.9 ± 5.1 61.7 ± 7.6 59.8 ± 8.9 57.4 ± 3.0 
20 67.6 ± 5.2 67.0 ± 6.6 61.3 ± 5.1 59.4 ± 4.6 58.1 ± 4.8 
30 56.6 ± 7.0 54.0 ± 6.6 54.9 ± 8.0 53.8 ± 4.2 51.58 ± 1.5 Co
nc
en
tr
at
io
n 
b  
(m
g/
m
L
) 
50 57.0 ± 7.4 54.2 ± 8.0 51.3 ± 6.3 51.1 ± 5.7 52.0 ± 6.6 
80 57.7 ± 3.8 60.3 ± 2.7 61.7 ± 2.4 62.1 ± 1.6 59.9 ± 1.1 
100 57.7 ± 4.7 59.8 ± 5.7 61.4 ± 6.0 61.2 ± 5.4 63.2 ± 7.7 
120 72.0 ± 3.6 69.6 ± 6.1 69.8 ± 1.4 67.3 ± 3.2 63.8 ± 3.2 
140 67.6 ± 5.2 67.0 ± 6.6 61.3 ± 5.1 59.4 ± 4.6 58.1 ± 4.8 
160 66.7 ± 2.4 64.7 ± 3.2 60.3 ± 3.3 57.7 ± 5.0 56.7 ± 2.1 Te
m
pe
ra
tu
r 
c  
(°C
) 
180 72.8 ± 1.9 70.1 ± 0.7 65.1 ± 2.6 61.7 ± 1.4 59.4 ± 0.9 
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Tab. 50. Calculations of activation energy and rate constants for 6-nitropiperonal.
ln (1-RCY) 
Time  
(min) 
80 °C 100 °C 120 °C 140 °C 160 °C 180 °C 
5 -0.8604 -0.8604 -1.2730 -1.1270 -1.0996 -1.3020 
10 -0.9238 -0.9113 -1.1907 -1.1087 -1.0413 -1.2073 
20 -0.9597 -0.9519 -1.1973 -0.9493 -0.9238 -1.0527 
30 -0.9702 -0.9467 -1.1178 -0.9014 -0.8604 -0.9597 
60 -0.9138 -0,9997 -1.0161 -0.8700 -0.8370 -0.9014 
Temp. 
(°C) 
Best linear graph for  
ln (1-RCY) vs time  
Correlation 
coefficient k’ (min
-1) ln k’ 
80 Y= - 0.1328 – 0.0924 X -0.90 0.0924 -2.3816 
100 Y= - 0.1349 – 0.0911 X -0.89 0.0911 -2.3958 
120 Y= - 0.2256 – 0.1191 X -0.84 0.1191 -2.1278 
140 Y= - 0.1909 – 0.1109 X -0.86 0.1109 -2.1991 
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6.7 Appendix 7: Data for 6-Bromopiperonal 
 
 
 
Tab. 51. [18F] Labelling data for 6-bromopiperonal 
RCY (%) 
5 min 10 min 20 min 30 min 60 min Temp. 
(°C) n 
Mean Sdv Mean Sdv Mean Sdv Mean Sdv Mean Sdv 
80 4 5.7 0.3 7.3 0.6 9.4 0.9 10.0 0.8 9.1 0.5 
100 5 7.3 0.9 8.9 0.7 9.6 0.9 10.5 0.5 10.2 0.5 
120 4 7.7 0.6 9.1 1.0 10.1 0.8 10.3 0.6 10.6 0.4 
140 5 9.7 0.5 11.4 1.1 11.1 1.0 11.8 1.1 11.7 1.0 
160 5 10.4 0.3 11.0 1.3 10.9 1.1 10.0 0.7 9.9 1.1 
180 4 6.2 0.2 6.7 1.3 10.2 0.6 10.6 0.8 11.0 1.2 
 
 
 
6.8 Appendix 8: Data for 6-Chloropiperonal 
 
 
Tab. 52. [18F] Labelling data for 6-chloropiperonal 
RCY (%) 
5 min 10 min 20 min 30 min 60 min 
Temp. 
(°C) n 
Mean Sdv Mean Sdv Mean Sdv Mean Sdv Mean Sdv 
80 4 3.8 0.4 4.3 0.5 4.9 0.6 4.4 0.4 4.5 0.2 
100 5 5.3 1.1 6.6 0.5 5.4 0.5 5.2 0.3 5.0 0.2 
120 4 8.5 0.5 7.9 0.2 7.5 0.9 6.6 0.1 6.6 0.1 
140 10 9.7 0.6 11.3 1.4 10.2 0.9 9.3 1.2 9.4 0.4 
160 5 8.6 0.1 7.8 1.0 7.1 0.2 7.4 0.1 7.3 0.3 
180 3 9.2 0.3 9.8 1.4 10.9 0.5 11.5 1.8 10.7 05 
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6.9 Appendix 9: Data for 2,3-Dimethoxy-6-nitrobenzaldehyde 
 
 
 
 
 
Tab. 53. [18F] Labelling data for 2,3-dimethoxy-6-nitrobenzaldehyde. 
Conditions: a) 20 mg/mL,140 °C . b) DMF (1 mL), 140 °C. 
c) 20 mg/mL, DMF (1 mL). 
RCY (%) ± Sdv 
Variable 
5 min 10 min 20 min 30 min 60 min 
DMF 21.6 ± 0.6 28.2 ± 3.8 30.5 ± 3.4 27.5 ± 2.1 28.1 ± 1.8 
DMAc 12.3 ± 4.6 16.6 ± 3.6 17.7 ± 3.0 17.8 ± 2.1 8.5 ± 0.2 
DMSO 16.4 ± 3.2 18.8 ± 5.0 19.5 ± 3.3 20.2 ± 0.4 19.4 ± 2.1 
Sulfolane 6.9 ± 2.2 8.6 ± 2.4 9.1 ± 1.3 8.6 ± 2.2 8.3 ± 2.3 So
lv
en
t a
 
benzonitrile 11.9 ± 3.5 16.3 ± 4.2 15.0 ± 2.0 14.9 ± 1.8 16.1 ± 1.5 
10 19.8 ± 2.1 23.9 ± 3.1 28.3 ± 3.6 25.7 ± 1.8  26.2 ± 2.2 
C
on
ce
nt
ra
tio
n 
b  
(m
g/
m
L
) 
20 21.6 ± 0.6 28.2 ± 3.8 30.5 ± 3.4 27.5 ± 2.1 28.1 ± 1.8 
80 2.8 ± 0.6 5.0 ± 1.0 9.3 ± 1.6 11.5 ± 1.9 12.9 ± 2.7 
100 7.3 ± 1.4 16.9 ± 3.1 16.3 ± 2.7 15.4 ± 1.9 13.9 ± 3.3 
120 8.0 ± 0.8 11.1 ± 0.6 14.1 ± 2.5 15.0 ± 2.6 14.8 ± 0.6 
130 16.3 ± 4.6 20.2 ± 4.7 21.4 ± 4.4 21.5 ± 4.9 22.5 ± 4.3 
140 21.6 ± 0.6 28.2 ± 3.8 30.5 ± 3.4 27.5 ± 2.1 28.1 ± 1.8 Te
m
pe
ra
tu
r 
c  
(°C
) 
150 20.3 ± 2.7 28.5 ± 1.8 29.8 ± 4.9 29.1 ± 3.8 30.4 ± 3.9 
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Tab. 54. Calculations of activation energy and rate constants for 
2,3-dimethoxy-6-nitrobenzaldehyde. 
ln (1-RCY) 
Time  
(min) 
80 °C 100 °C 120 °C 130 °C 140 °C 150 °C 
5 -0.0284 -0.0834 -0.0758 -0.1779 -0.2433 -0.2269 
10 -0.0513 -0.1177 -0.1851 -0.2256 -0.3313 -0.3355 
20 -0.0976 -0.1520 -0.1779 -0.2408 -0.3638 -0.3538 
30 -0.1222 -0.1625 -0.1912 -0.2421 -0.3216 -0.3439 
60 -0.1347 -0.1497 -0.1803 -0.2549 -0.3300 -0.3624 
Temp. 
(°C) 
Best linear graph for  
ln (1-RCY) vs time  
Correlation 
coefficient k’ (min
-1) ln k’ 
80 Y= - 9.1667E-4 – 0.0051 X -1.00 0.0051 -5.2785 
100 Y= 0.0082 – 0.0118 X -0.97 0.0118 -4.4396 
120 Y= - 0.0056 – 0.0185 X -0.995 0.0185 -4.000 
130 Y= - 0.0217 – 0.0226 X -0.95 0.0226 -3.7898 
140 Y= - 0.0259 – 0.0331X -0.97 0.0331 -3.4082 
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Tab. 55. Crystal data, data collection and structure refinement for 
2,3-dimethoxy-6-nitrobenzaldehyde 
Empirical formula C9H9NO5 
Formula weight 211.17 
Temperature 213 (2) K 
Wavelength/radiation 1.54184 A / CuK/a 
Crystal system/space group Monoclinic / P21 /c 
Unit cell dimensions 
a= 4.0807 (4) Å 
b= 14.6077 (17) Å 
c= 15.7792 (15) Å 
alpha = 90 deg. 
beta = 97.230 deg. 
gamma = 90 deg.  
Volume 933.11 (16) Å3 
Z 4 
Density 1.503 mg/m3 
F(000) 440 
Crystal size 0.50 x 0.20 x 0.50 mm 
Reflections collected 2473 
Reflections (lattice) 13.194 to 26.3045 deg. 
Independent reflections 1578 [R(int)= 0.0424] 
Reflections observed 1225 
Criterion for observation > 2 sigma (I) 
Absorption correction DIFABS 
Max. and min transmission 0.682 and 0.216 
Measurement method Omega 
Standard reflections 3 
Structure solution SHELXS-97 (Sheldrick, 1990) 
Structure refinement SHELXS-97 (Sheldrick, 1997) 
Molecular graphics PLATON 
Refinement method Full-matrix least-squares on F2 
Data/restraints/parameters 1578 / 0 / 172 
Final R indices [i>2sigma[I]] R1= 0.0526 
wR2= 0.1380 
Goodness of fit on F2 1.027 
Final R indices (all) R1/Wr2 0.0715 / 0.1527 
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